
<html lang="en"     class="pb-page"  data-request-id="96f77fcd-58a4-4de9-b028-fa0fccb1f48b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-17;article:article:10.1021/acs.jmedchem.0c00828;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists" /></meta><meta name="dc.Creator" content="Martin  Cooper" /></meta><meta name="dc.Creator" content="Antonio  Llinas" /></meta><meta name="dc.Creator" content="Peter  Hansen" /></meta><meta name="dc.Creator" content="Moya  Caffrey" /></meta><meta name="dc.Creator" content="Asim  Ray" /></meta><meta name="dc.Creator" content="Stina  Sjödin" /></meta><meta name="dc.Creator" content="Igor  Shamovsky" /></meta><meta name="dc.Creator" content="Hiroki  Wada" /></meta><meta name="dc.Creator" content="Tina  Jellesmark Jensen" /></meta><meta name="dc.Creator" content="Ulf  Sivars" /></meta><meta name="dc.Creator" content="Leif  Hultin" /></meta><meta name="dc.Creator" content="Ulf  Andersson" /></meta><meta name="dc.Creator" content="Sara  Lundqvist" /></meta><meta name="dc.Creator" content="Karin  Gedda" /></meta><meta name="dc.Creator" content="Lisa  Jinton" /></meta><meta name="dc.Creator" content="Nina  Krutrök" /></meta><meta name="dc.Creator" content="Richard  Lewis" /></meta><meta name="dc.Creator" content="Paul  Jansson" /></meta><meta name="dc.Creator" content="Cristina  Gardelli" /></meta><meta name="dc.Description" content="Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exe..." /></meta><meta name="Description" content="Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 12, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00828" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00828" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00828" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00828" /></link>
        
    
    

<title>Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00828" /></meta><meta property="og:title" content="Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0028.jpeg" /></meta><meta property="og:description" content="Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exerts pleiotropic effects including the stimulation of growth hormone secretion and subsequent increase of insulin-like growth factor-1 levels, an important mediator of muscle growth and repair. Ghrelin also acts on inflammation, appetite, and adipogenesis and therefore has been considered a promising therapeutic target for catabolic conditions. We previously reported on the synthesis and properties of an indane based series of ghrelin receptor full agonists which led to a sustained increase of insulin-like growth factor-1 in a dog pharmacodynamic study. Herein we report on the identification of a series of pyrrolidine or piperidine based full agonists and attempted optimization to give compounds with profiles suitable for progression as clinical candidates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00828"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00828">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00828&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00828&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00828&amp;href=/doi/10.1021/acs.jmedchem.0c00828" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9705-9730</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00756" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00852" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Martin Cooper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Cooper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Cooper">Martin Cooper</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonio Llinas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonio Llinas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">DMPK Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Llinas">Antonio Llinas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Hansen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Hansen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Hansen">Peter Hansen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moya Caffrey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moya Caffrey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Moya++Caffrey">Moya Caffrey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Asim Ray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Asim Ray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Asim++Ray">Asim Ray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stina Sjödin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stina Sjödin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stina++Sj%C3%B6din">Stina Sjödin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Igor Shamovsky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Igor Shamovsky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Igor++Shamovsky">Igor Shamovsky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2881-9531" title="Orcid link">http://orcid.org/0000-0002-2881-9531</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiroki Wada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiroki Wada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiroki++Wada">Hiroki Wada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tina Jellesmark Jensen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tina Jellesmark Jensen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Early Clinical Development, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tina++Jellesmark+Jensen">Tina Jellesmark Jensen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulf Sivars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Sivars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Sivars">Ulf Sivars</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leif Hultin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leif Hultin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">In Vivo Imaging Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leif++Hultin">Leif Hultin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulf Andersson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulf Andersson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulf++Andersson">Ulf Andersson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sara Lundqvist</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sara Lundqvist</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sara++Lundqvist">Sara Lundqvist</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karin Gedda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Gedda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Precision Medicine, Oncology R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Gedda">Karin Gedda</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lisa Jinton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Jinton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Jinton">Lisa Jinton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nina Krutrök</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nina Krutrök</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioscience Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Krutr%C3%B6k">Nina Krutrök</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard Lewis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard Lewis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Lewis">Richard Lewis</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9404-8520" title="Orcid link">http://orcid.org/0000-0001-9404-8520</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Jansson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Jansson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Projects Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Jansson">Paul Jansson</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Cristina Gardelli</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristina Gardelli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry Department, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +46 31 7761567. Fax: +46 31 7763792. Email: <a href="/cdn-cgi/l/email-protection#6201100b11160b0c034c05031006070e0e0b22031116100318070c0701034c010d0f"><span class="__cf_email__" data-cfemail="91f2e3f8e2e5f8fff0bff6f0e3f5f4fdfdf8d1f0e2e5e3f0ebf4fff4f2f0bff2fefc">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1169-2180" title="Orcid link">http://orcid.org/0000-0003-1169-2180</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00828&amp;href=/doi/10.1021%2Facs.jmedchem.0c00828" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9705–9730</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 12, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 May 2020</li><li><span class="item_label"><b>Published</b> online</span>12 August 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00828" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00828</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9705%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BCooper%252C%2BAntonio%2BLlinas%252C%2BPeter%2BHansen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.0c00828%26title%3DIdentification%2Band%2BOptimization%2Bof%2BPyrrolidine%2BDerivatives%2Bas%2BHighly%2BPotent%2BGhrelin%2BReceptor%2BFull%2BAgonists%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9730%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00828"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">976</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00828" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Cooper&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Llinas&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Hansen&quot;},{&quot;first_name&quot;:&quot;Moya&quot;,&quot;last_name&quot;:&quot;Caffrey&quot;},{&quot;first_name&quot;:&quot;Asim&quot;,&quot;last_name&quot;:&quot;Ray&quot;},{&quot;first_name&quot;:&quot;Stina&quot;,&quot;last_name&quot;:&quot;Sjödin&quot;},{&quot;first_name&quot;:&quot;Igor&quot;,&quot;last_name&quot;:&quot;Shamovsky&quot;},{&quot;first_name&quot;:&quot;Hiroki&quot;,&quot;last_name&quot;:&quot;Wada&quot;},{&quot;first_name&quot;:&quot;Tina&quot;,&quot;last_name&quot;:&quot;Jellesmark Jensen&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Sivars&quot;},{&quot;first_name&quot;:&quot;Leif&quot;,&quot;last_name&quot;:&quot;Hultin&quot;},{&quot;first_name&quot;:&quot;Ulf&quot;,&quot;last_name&quot;:&quot;Andersson&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;Lundqvist&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Gedda&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Jinton&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Krutrök&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Lewis&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Jansson&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9705-9730&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00828&quot;},&quot;abstract&quot;:&quot;Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exerts pleiotropic effects including the stimulation of growth hormone secretion and subsequent increase of insulin-like growth factor-1 levels, an important mediator of muscle growth and repair. Ghrelin also acts on inflammation, appetite, and adipogenesis and therefore has been considered a promising therapeutic target for catabolic conditions. We previously reported on the synthesis and properties of an indane based series of ghrelin receptor full agonists which led to a sustained increase of insulin-like growth factor-1 in a dog pharmacodynamic study. Herein we report on the identification of a series of pyrrolidine or piperidine based full agonists and attempted optimization to give compounds with profiles suitable for progression as clinical candidates.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00828&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00828" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00828&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00828" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00828&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00828" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00828&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00828&amp;href=/doi/10.1021/acs.jmedchem.0c00828" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00828" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00828" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00828%26sid%3Dliteratum%253Aachs%26pmid%3D32787075%26genre%3Darticle%26aulast%3DCooper%26date%3D2020%26atitle%3DIdentification%2Band%2BOptimization%2Bof%2BPyrrolidine%2BDerivatives%2Bas%2BHighly%2BPotent%2BGhrelin%2BReceptor%2BFull%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9705%26epage%3D9730%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292164" title="Pyrrolidines">Pyrrolidines</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Muscle atrophy and cachexia are common comorbidities among patients suffering from cancer, chronic obstructive pulmonary disease, and several other chronic diseases. The peptide hormone ghrelin exerts pleiotropic effects including the stimulation of growth hormone secretion and subsequent increase of insulin-like growth factor-1 levels, an important mediator of muscle growth and repair. Ghrelin also acts on inflammation, appetite, and adipogenesis and therefore has been considered a promising therapeutic target for catabolic conditions. We previously reported on the synthesis and properties of an indane based series of ghrelin receptor full agonists which led to a sustained increase of insulin-like growth factor-1 in a dog pharmacodynamic study. Herein we report on the identification of a series of pyrrolidine or piperidine based full agonists and attempted optimization to give compounds with profiles suitable for progression as clinical candidates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Ghrelin is a 28 amino acid hormone that is synthesized and secreted by X/A-like cells, often called ghrelin cells, localized within the oxyntic glands of the mucosa of the gastric fundus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is highly conserved across several species and broadly expressed indicating its physiological importance.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> O-<i>n</i>-octanoylation on the serine 3 residue of ghrelin, mediated by the ghrelin <i>O</i>-acyl-transferase (GOAT), is required for binding to and activation of its cognate receptor, the type 1a growth hormone secretagogue receptor (GHS-R1a). GHS-R1a is a seven transmembrane G-protein-coupled receptor expressed predominantly in the hypothalamus and in the pituitary gland. Ghrelin mediates multiple biological activities, including stimulation of growth hormone (GH) secretion and effects on appetite and food intake, metabolism, inflammation, cardiac output, and gastric motility. Since its discovery, regulation of food intake has been the most studied function of this hormone. Many studies have been directed to find new ghrelin antagonists and inverse agonists to treat metabolic disorders related to obesity, such as type-2 diabetes mellitus.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This has proven to be a difficult task for the medicinal chemists since very small changes on the chemotype structure can have divergent pharmacological effects (partial-full agonist, antagonist, inverse agonist).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> However, we were particularly interested in its ability to increase endogenous GH and elevate the plasma level of insulin-like growth factor-1 (IGF-1), both positive regulators of skeletal muscle hypertrophy, and consequently in its potential application to ameliorate muscle atrophy and cachexia. As common comorbidities in chronic diseases, such as cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, and acquired immunodeficiency syndrome (AIDS), muscle atrophy and cachexia are associated with increased weakness and decreased functional capacity. The use of ghrelin to reduce cachexia and increase functional capacity in cachectic patients with COPD has clinical precedence.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> In a previous paper,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> we described the synthesis and characterization of a series of compounds, based on an indane scaffold, which were potent, full agonists at the ghrelin receptor. From this series, compounds that showed limited brain penetrance and long half-life were investigated for their ability to increase the IGF-1 secretion in dog, and in particular compound <b>1</b>, with good in vivo efficacy and acceptable pharmacokinetics in the preclinical species, was selected for further evaluation. However, compound <b>1</b> suffered from activity on the μ1-opioid receptor, an off-target activity that made it unsuitable for further progression in the intended patient population. Thus, an alternative series was sought, which retained the key pharmacophore features of the indane series, but with improved selectivity and PK profiles that would make them suitable as potential clinical candidates. In this regard, we herein describe the design and synthesis of the potent full agonist compounds <b>2a</b> and <b>3a</b> with pyrrolidine and piperidine cores, respectively, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Subsequently we describe the optimization of these new series, leading to the identification of the very selective compound <b>12j</b> with excellent potency and a PK profile consistent with a low predicted dose to man.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported indane compound <b>1</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> related pyrrolidine and piperidine compounds <b>2a</b> and <b>3a</b>, and optimized compound <b>12j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Unfortunately, due to a combination of a suboptimal permeability and P-glycoprotein (Pgp)-mediated efflux, oral absorption of compound <b>12j</b> and related compounds was poor in rodent species which would have had an impact on attainable exposure during preclinical safety studies. Also, while bioavailability in the dog was much higher, considerable variability in exposure between animals was observed, and this, coupled with low permeability observed in human intestinal tissue, led to the decision not to progress <b>12j</b> into preclinical development; however exploration of the pharmacology of this series of ghrelin receptor full agonists continued.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Initial preparation of the pyrrolidine stereoisomers <b>2a</b> and <b>4</b> was from the commercially available racemic <i>trans</i> 1-<i>tert</i>-butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate <b>17</b>, according to the procedure outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Thus, coupling with 5-methyl-1<i>H</i>-indole-2-carboxylic acid using HATU and DIPEA in DMF gave amide <b>18</b> in excellent yield. Removal of the Boc group with TMSCl in EtOH followed by reaction with benzenesulfonyl chloride in the presence of pyridine gave sulfonamide <b>19</b>. Subsequent hydrolysis of the ester with lithium hydroxide and coupling with <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, using HATU and DIPEA in DMF, gave predominately the racemic <i>trans</i> isomer <b>20</b> plus a minor isomeric product which was separated by RP preparative HPLC and identified as the <i>cis</i>-isomer <b>5</b>. This was presumed to have arisen from epimerization α to the amide carbonyl during either the ester hydrolysis or the subsequent amide coupling step. The purified compound <b>20</b> was subjected to chiral HPLC to furnish the <i>trans</i> isomers <b>2a</b> and <b>4</b>. Stereochemical assignments were initially made based upon precedence for order of elution of related compounds and subsequently confirmed by comparison to <b>2a</b> synthesized from the common intermediate <b>44</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolidine Stereoisomers <b>2a</b>, <b>4</b>, and <b>rac-5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, rt, 16 h; (b) (i) TMSCl, EtOH; (ii) benzenesulfonyl chloride, pyridine, DCM, 4 h; (c) (i) LiOH, THF, MeOH, H<sub>2</sub>O, rt, 3 h; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, 20 °C, 16 h; (d) chiral HPLC.</p></p></figure><div class="NLM_p">Initial synthesis of the piperidine compounds <b>3a</b>, <b>6</b>, and <b>7</b> was performed from the commercially available racemic (<i>trans</i>)-methyl 4-(<i>tert</i>-butoxycarbonylamino)piperidine-3-carboxylate <b>21</b> according to the procedure outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Thus, reaction with benzenesulfonyl chloride in the presence of Et<sub>3</sub>N gave sulfonamide <b>22</b>. Removal of the Boc group and coupling with 5-methyl-1<i>H</i>-indole-2-carboxylic acid using HATU and DIPEA in DMF proceeded smoothly to give the amide <b>23</b>. Subsequent hydrolysis of the ester with lithium hydroxide and a second HATU coupling with <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine gave predominately the racemic <i>trans</i> isomer <b>24</b> plus a minor isomeric product which, following separation by preparative HPLC and further purification by achiral SFC chromatography, was confirmed as the <i>cis</i> racemic isomer <b>7</b>. The purified racemic mixture <b>24</b> was subjected to chiral preparative SFC chromatography to furnish the <i>trans</i> isomers <b>3a</b> and <b>6</b>. The relative stereochemistry for <b>24</b> and <b>7</b> was confirmed by NMR, and the absolute stereochemistry for <b>3a</b> and <b>6</b> was confirmed by comparison to a second batch of <b>3a</b> subsequently synthesized from the common chiral intermediate <b>25</b> prepared according to literature procedures.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus, coupling with 5-methyl-1<i>H</i>-indole-2-carboxylic acid using HBTU and Et<sub>3</sub>N in MeCN gave amide <b>26</b> in excellent yield. Removal of the Boc group with TFA provided the free piperidine <b>27</b> that by reaction with benzenesulfonyl chloride gave the sulfonamide ethyl ester <b>28</b>. This was submitted to hydrolysis and subsequent coupling with <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine in the presence of HBTU and Et<sub>3</sub>N in DMSO to give the enantiomerically pure compound <b>3a</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Piperidine Enantiomers <b>3a</b>, <b>6</b>, and <b>rac-7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzenesulfonyl chloride, Et<sub>3</sub>N, DCM, 4 h; (b) (i) TFA, DCM, 10 min.; (ii) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, rt, 16 h; (c) (i) LiOH, THF, H<sub>2</sub>O, 35 °C, 1 h; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, rt, 16 h; (d) chiral SFC chromatography; (e) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HBTU, Et<sub>3</sub>N, MeCN, rt, 0.5 h; (f) TFA, DCM; (g) NaOH 1M, THF, 40 °C, 4 h; (h) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, DMSO, 0.5 h.</p></p></figure><div class="NLM_p">The piperidine derivatives <b>3b</b>–<b>e</b> and <b>3g</b> were prepared according to a more convergent route as described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Compound <b>32</b> was a common intermediate, some of the compounds were prepared and tested as racemates (<b>3b</b>, <b>3e</b>, and <b>3g</b>), while some racemic mixtures were submitted to chiral separation, and the pure enantiomers were tested (<b>3c</b>, <b>3d</b>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Piperidine Derivatives <b>3b</b>–<b>e</b> and <b>3g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CbzCl, NaHCO<sub>3</sub>, DCM, 0 °C, then rt overnight; (b) TFA, DCM; (c) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, 20 °C, overnight; (d) LiOH, MeCN, H<sub>2</sub>O, 35 °C, 1 h; (e) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, 20 °C, 16 h; (f) H<sub>2</sub>, 5% Pd/C, MeOH; (g) R<sub>1</sub>SO<sub>2</sub>Cl or nicotinoyl chloride, Et<sub>3</sub>N, MeCN, rt, 2 h; (h) chiral SFC chromatography.</p></p></figure><div class="NLM_p">From the chiral building block <b>27</b>, the chiral compounds <b>3f</b>, <b>11a</b>, and <b>11b</b> were made without use of chiral chromatography, following <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Piperidine Derivatives <b>11a</b>,<b>b</b> and <b>3f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RSO<sub>2</sub>Cl, Et<sub>3</sub>N, DCM; (b) NaOH 1N, THF, H<sub>2</sub>O, 35 °C, 1 h; (c) (<i>S</i>)-1-methylpiperidin-3-amine or <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, DMSO; (d) (<i>S</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate, HBTU, Et<sub>3</sub>N, DCM, closed vial, 45 min; (e) TFA, DCM, 0.5 h.</p></p></figure><div class="NLM_p">Synthesis of the alternative piperidine regioisomers <b>8</b> and <b>9</b> was from the ethyl 3-oxopiperidine-4-carboxylate hydrochloride via the procedure outlined in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Thus, reaction of the oxopiperidine with benzenesulfonyl chloride in the presence of Et<sub>3</sub>N gave the sulfonamide <b>35</b>. Condensation with NH<sub>4</sub>OAc gave the enamine <b>36</b> that was reduced with NaBH(OAc)<sub>3</sub> in MeCN in the presence of acetic acid to give <b>37</b> as a mixture of diastereoisomers. Coupling with 5-methyl-1<i>H</i>-indole-2-carboxylic acid using HBTU and Et<sub>3</sub>N in DCM proceeded smoothly to give the amide <b>38</b> as a 4:1 mixture of <i>cis</i>:<i>trans</i> isomers. Hydrolysis of the ethyl ester with NaOH, followed by coupling with <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, in MeCN gave the diamide <b>39</b> that was submitted to preparative HPLC to afford the two racemic isomers, <i>trans</i><b>8</b> and <i>cis</i><b>9</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of the Alternative Piperidine Regioisomers <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzenesulfonyl chloride, Et<sub>3</sub>N, DCM, 16 h; (b) NH<sub>4</sub>OAc, EtOH, 50 °C, 1.5 h; (c) NaBH(OAc)<sub>3</sub>, AcOH, MeCN, 1 h; (d) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HBTU, Et<sub>3</sub>N, DCM, 20 °C, 1 h; (e) (i) NaOH, H<sub>2</sub>O, THF; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, MeCN, 20 °C, 1 h; (f) RP preparative HPLC.</p></p></figure><div class="NLM_p">For the synthesis of subsequent analogs of the pyrrolidine compound <b>2a</b>, a common intermediate was sought that would enable library synthesis in which the two amide side-chains and the sulfonamide could be independently varied. Thus, compound <b>44</b> was designed, and the synthesis is outlined in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Formation of the enamine <b>41</b> from the readily available keto ester <b>40</b> and (<i>S</i>)-α-methylbenzylamine was accomplished in high yield following literature procedures.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Reduction of the enamine with sodium borohydride, which was known to occur with reasonable diastereoselectivity, gave <b>42</b> with the required 4R stereochemistry but predominately as the <i>cis</i> isomer. However, epimerization, using DBU in MeOH, converted this to a 3:1 mixture in favor of the required <i>trans</i> isomer. This ratio was further improved by conversion to the hydrochloride salt and crystallization to give <b>43</b> in >98% de. Removal of the α-methylbenzyl group, by catalytic hydrogenation over 10% Pd/C, furnished the key intermediate <b>44</b>, isolated as the hydrochloride salt.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a></div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyrrolidine Common Intermediate <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>S</i>)-α-methylbenzylamine, MeOH, AcOH;<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> (b) NaBH<sub>4</sub>, AcOH, MeCN, 0–5 °C, 20 h; (c) (i) DBU (0.2 equiv), MeOH, 50 °C, 4 h; (ii) HCl, 1,4-dioxane, EtOAc, 0–3 °C, 1 h; (d) H<sub>2</sub> 4 bar, 10% Pd/C, EtOH, rt, 20 h.</p></p></figure><div class="NLM_p">Synthesis of final compounds <b>2a</b>–<b>g</b> and <b>10a</b>–<b>g</b> could thus be efficiently achieved by varying the order of steps, according to methods A and B, as exemplified in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. Additionally method C, which employs compound <b>43</b> as key intermediate as exemplified in <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>, could be used to reduce the overall number of steps where it is desired to vary the aromatic amide substitution as in the case of the synthesis of compounds <b>12a</b>–<b>m</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Methods A and B for Synthesis of Final Compounds <b>2a</b>–<b>g</b> and <b>10a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, NMM, DMF, 20 °C, 16 h; (b) LiOH, H<sub>2</sub>O, THF; (c) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, Et<sub>3</sub>N, DCM–DMF, 20 °C, 16 h; (d) TMSCl, MeOH; (e) benzenesulfonyl chloride, pyridine, DCM, rt, 16 h; (f) mono Boc-protected diamine or <i>N</i>-Me diamine, HATU, Et<sub>3</sub>N, DMF, 20 °C, 16 h.</p></p></figure><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Method C: Synthesis of Final Compounds <b>12a</b>–<b>m</b>, <b>16b</b>, and <b>16d</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, DCM; (b) benzenesulfonyl chloride, pyridine, DCM, 16 h; (c) LiOH, H<sub>2</sub>O, MeOH, THF, 1 h; (d) mono Boc-protected diamine, HATU, NMM, DMF, 20 °C, 16 h; (e) H<sub>2</sub>, Pd(OH)<sub>2</sub>, EtOH; (f) aromatic carboxylic acid, HATU, NMM, DMF, 20 °C, 16 h; (g) HCO<sub>2</sub>H, 60 °C, 30 min; (h) HCHO, HCO<sub>2</sub>H, 90 °C, 30 min; (i) HCO<sub>2</sub>Et, reflux, 1.5 h; (j) Ac<sub>2</sub>O, NaHCO<sub>3</sub>, MeTHF.</p></p></figure><div class="NLM_p">Method A: Amide coupling of compound <b>44</b> with aromatic acids gave compound <b>45</b>, and subsequent ester hydrolysis followed by a second amide coupling gave intermediate <b>46</b>. Removal of the Boc protective group and reaction with sulfonyl chlorides then furnished compounds <b>2a</b>–<b>g</b> with varied sulfonamide substitutions.</div><div class="NLM_p">Method B: Removal of the Boc protection from <b>45</b> followed by reaction with benzenesulfonyl chloride gave intermediate <b>47</b> which could be subjected to ester hydrolysis and then to amide coupling to furnish compounds <b>10a</b>–<b>g</b>.</div><div class="NLM_p">Method C: Removal of the Boc protection group from <b>43</b> and then reaction with benzenesulfonyl chloride could be accomplished with selective reaction on the pyrrolidine nitrogen to give intermediate <b>48</b>. Standard ester hydrolysis followed by amide formation with mono Boc protected diamines yielded intermediate <b>49</b> with no acylation observed on the hindered secondary amine. Removal of the α-methylbenzyl protecting group proceeded slowly under catalytic hydrogenation and did not generally go to completion. However, the resulting mixture could be taken directly to the next stage as residual compound <b>49</b> did not react in the subsequent coupling reaction and could be removed by extraction into dilute hydrochloric acid. Finally, removal of the Boc protection proceeded smoothly to give final products <b>12a</b>–<b>m</b> and <b>16b</b>.</div><div class="NLM_p">In some cases, a degree of epimerization was observed during the hydrolysis step resulting in the formation of the <i>cis</i> isomers as byproducts which were often difficult to separate from the <i>trans</i> isomers by preparative HPLC. However, by performance of ester hydrolysis under acidic rather than basic conditions and replacing diisopropylamine with the less basic <i>N</i>-methylmorpholine in the amide coupling reactions, formation of <i>cis</i> isomers could be avoided.</div><div class="NLM_p">Methylation by formaldehyde of compound <b>12j</b> led to compound <b>16d</b>. Acylation with HCO<sub>2</sub>Et or Ac<sub>2</sub>O led to compounds <b>16e</b> and <b>16f</b>. In an analog manner to the synthesis of compounds <b>12a</b>–<b>m</b>, also compounds <b>14</b>, <b>15</b>, and <b>16b</b> were synthesized.</div><div class="NLM_p">The N-methylated compounds <b>16a</b> and <b>16c</b> were obtained by reductive methylation of compound <b>48</b> followed by hydrogenolysis of the α-methylbenzyl group and derivatization according to the procedure outlined in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>.</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of N-Methylated Compounds<b>16a</b> and <b>16c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCHO, HCO<sub>2</sub>H, 90 °C, 15 min; (b) H<sub>2</sub> 4 bar, 10% Pd/C, MeOH, 20 °C, 3 h; (c) 5-(2-chlorophenyl)isoxazole-3-carboxylic acid, HATU, NMM, DMF, 20 °C, 1 h; (d) H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, THF, 70 °C, 16 h; (e) <i>tert-</i>butyl (3<i>S</i>)-3-aminopiperidine-1-carboxylate or <i>tert-</i>butyl (3<i>S</i>)-3-(methylamino)piperidine-1-carboxylate, HATU, NMM, DMF, 20 °C, 1 h; (f) HCO<sub>2</sub>H, 60 °C, 30 min.</p></p></figure><div class="NLM_p">For the synthesis of the α-methylated derivatives, such as <b>13b</b>, it was necessary to build the pyrrolidine ring from scratch according to the method described in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>. Coupling of dimethyl 2-methylfumarate and <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine, under acid catalysis via a [2 + 3] cycloaddition, gave the pyrrolidine diester <b>55</b> as a racemic mixture of <i>trans</i> isomers. Removal of the benzyl group by hydrogenolysis followed by reaction with benzenesulfonyl chloride gave compound <b>56</b>. Selective monohydrolysis of the less-hindered ester of <b>56</b> to give <b>57b</b> was attempted using 1 equiv of NaOH; however an inseparable mixture of <b>57a</b> and <b>57b</b> contaminated with diacid was obtained. This crude mixture was taken forward into the subsequent Curtius rearrangement step in which the initially formed isocyanates were reacted with benzyl alcohol to give a mixture of benzyl carbamates <b>58a</b> and <b>58b</b>. Hydrolysis of the remaining ester groups followed by the coupling of the resulting acids with <i>tert</i>-butyl (3<i>S</i>)-3-aminopiperidine-1-carboxylate and the hydrogenolysis of the benzylcarbamate gave a mixture of amides <b>59a</b> and <b>59b</b>. Amide coupling and removal of the Boc protective group furnished a mixture of <b>13a</b> and <b>13b</b> from which <b>13b</b> (but not <b>13a</b>) was isolated in pure form by preparative reverse-phase HPLC.</div><figure id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0017.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of the α-Methyl Compound <b>13b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, toluene 0 °C, 0.5 h, 49%; (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, MeOH, 20 °C, 24 h; (c) PhSO<sub>2</sub>Cl, NaHCO<sub>3</sub> (aq), MeTHF, 20 °C, 18 h, then 40 °C, 3 h, 72%; (d) NaOH<sub>(aq)</sub>, THF, MeOH, 0–10 °C, 3 h, then 20 °C, 20 h, 82% (crude); (e) diphenyl phosphorazidate, Et<sub>3</sub>N, toluene, 8 h, BnOH, 1 h, 53% (crude); (f) NaOH, THF, MeOH, 15 min; (g) <i>tert</i>-butyl (3<i>S</i>)-3-aminopiperidine-1-carboxylate, HATU, Et<sub>3</sub>N, DMF, 20 °C, 0.5 h; (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>, EtOH, 20 °C, 3 days; (i) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, Et<sub>3</sub>N, DMF, 20 °C, 0.5 h; (j) HCO<sub>2</sub>H, 60 °C, 0.5 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Much effort has been made to clarify the effects and mechanism of action of ghrelin in the CNS and peripheral tissues. The effect of ghrelin modulators as a function of their brain access is a topic still largely discussed in the literature for ghrelin receptors. It is still unclear if ghrelin needs to cross the blood–brain barrier (BBB) in order to have an effect. Since the GSH-R1a is also present on vagal afferents, some studies suggest that ghrelin stimulated food intake comes exclusively via the vagus nerve;<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> however other studies in rodents have shown that gut vagal afferents are not necessary for the orexigenic effect of peripherally injected ghrelin.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> According to these studies, it is likely that both circulating ghrelin crossing the BBB and ghrelin coming directly from the stomach through the vagus nerve are responsible for the central actions.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> On the basis of this information and due to the serious (CNS)-related side effects of a ghrelin agonist entering the brain, i.e., insomnia and addiction, we hypothesized that a full ghrelin agonist could be designed to show the desired effect on the GH/IGF-1 axis without penetrating the brain.</div><div class="NLM_p">We have previously reported the identification of the potent ghrelin full agonist compound <b>1</b> which was based on an indane scaffold.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This compound showed limited brain/plasma levels and high clearance in rat PK studies but an acceptable half-life in the dog. In a dog PD study, compound <b>1</b> produced a sustained increase of IGF-1, which supported our initial hypothesis that CNS penetration is not a requirement for affecting the GH/IGF-1 axis. Unfortunately, activity on the μ1-opioid receptor made the indane compound unsuitable as a potential drug candidate. Alternative structural classes that maintained the key pharmacophore features of the indane series were investigated.</div><div class="NLM_p">To explain structure–activity relationship of GHSR agonists, we used structure-based molecular modeling studies based on homology model of human GHSR built on the X-ray structure of the agonist-bound human adenosine A<sub>2A</sub> receptor (Brookhaven PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK">3QAK</a>) as described in our previous publication.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Ligand-binding pocket of adenosine receptors is known to be located in the middle of the 7TM bundle of helices along the long axis of the GPCR geometry.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This suits well to the long narrow shape of many small-molecule GHSR ligands.<a onclick="showRef(event, 'ref5 ref19'); return false;" href="javascript:void(0);" class="ref ref5 ref19">(5,19)</a> However, the X-ray structure of the agonist-bound rat neurotensine receptor 1 was recently successfully used as the template for homology modeling of GHSR binding site for narrow long reverse agonists.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> This challenged us to try and look at the structure–activity relationship of our small-molecule GHSR agonists retrospectively through the new homology model. Putative binding mode of GHSR agonists was obtained using a homology model of human GHSR based on the X-ray structure of agonist-bound rat neurotensine receptor 1 as a crystallographic template (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which shows 39.4% sequence identity with GHSR.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The choice of this template protein was made based on its highest sequence identity and sequence similarity with GHSR among GPCR proteins with resolved structures.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Since the purpose of our lead optimization efforts was to design GHSR agonists, it was crucial to create the homology model in active GPCR conformation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The homology model was created by the program MOE (release 2019.01, Chemical Computing Group Inc.). Putative binding modes of the GHSR agonists under study in the GHSR homology model were defined by local energy minimization using high-quality all-atom OPLS3e force field<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and GB/SA effective solvation model<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> as incorporated into MacroModel (Schrodinger LLC), which involved the bound agonist and nearby amino acid side chains of GHSR located closer than 7 Å from the ligand. Initial orientation of the GHSR agonists under study within the homology model prior to geometry optimization of the ligand-GHSR complex was obtained using residue E124, the recognized salt-bridge anchor for basic nitrogens of GHSR ligands,<a onclick="showRef(event, 'ref25 ref5 ref19'); return false;" href="javascript:void(0);" class="ref ref25 ref5 ref19">(25,5,19)</a> while placing the conformationally rigid indole–carboxamide moiety of <b>1</b> and <b>2a</b> along the long axis of the receptor toward the extracellular loops through residue R283.<a onclick="showRef(event, 'ref25 ref26 ref5'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref5">(25,26,5)</a> The obtained binding modes of the GHSR agonists along with the long axis of the homology model and bound ligands are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Despite differences in structure and pharmacology, the binding mode of our agonists within the homology model of GHSR shares eight neighboring residues with that of the inverse agonist compound 47 described by Daina et al., namely, E124, R199, Q120, R283, F279, F286, F309, and F312.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Residues S123, E124, and F279 have been defined as the hottest binding hits in a recent multidisciplinary study of binding of a peptidomimetic agonist G-7039 to a homology model of GHSR.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, important residues of the identified binding site F119, Q120, S123, E124, R199, F279, R283, F286, and F309 have been demonstrated to be the strongest mutational hits for binding of a number of agonists.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27−29)</a></div><figure id="fig2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of putative binding modes of compounds <b>1</b> (orange carbons) and <b>2a</b> (turquoise carbons) in human ghrelin receptor homology model obtained by molecular mechanical energy minimization using MacroModel (Schrodinger LLC). This homology model was built using the program MOE (Chemical Computing Group)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the X-ray crystallographic structure of the agonist-bound rat neurotensine receptor 1 as a template (PDB access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Energy minimization included high-quality all-atom OPLS3e force field<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and GB/SA effective solvation model<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> as incorporated into MacroModel and involved the bound ligand and nearby amino acid side chains of ghrelin receptor located closer than 7 Å from ligand. Nonpolar hydrogens are omitted for clarity. The area of structural differences between indanes and pyrrolidines (piperidines) is highlighted by the red circle. Ligand–receptor H-bonds are shown by red dashed lines. New H-bonding interactions with the new cores are likely made by residue S123. Residues F119 and S123 are known to constitute the efficacy switch region.<a onclick="showRef(event, 'ref21 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref28">(21,28)</a> Approximate direction of the long axis of the homology model and the rigid indole–carboxamide moiety of bound molecules toward the extracellular loops is indicated by the green arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our lead optimization strategy was to investigate other cores that would retain the binding mode and conformation of the two amide side-chains of indanes. The aim was to enhance the attractive nondesolvation-related interactions of the ligand with nearby residues of the ghrelin receptor. Contribution of these interactions to the binding energy of buried ligand can be assessed by the value of ligand-lipophilicity efficiency, LLE = pIC<sub>50</sub> – log <i>D</i>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The increase of LLE during lead optimization stage is essential as this would prevent more potent compounds from becoming too hydrophobic, which would lead to multiple unwanted side effects.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Correspondingly, potency of a better ghrelin receptor agonist was expected to be based on a balance of hydrophobic and polar interactions of the new core with the binding site. Molecular modeling of putative ligand–receptor complex suggested that neighboring polar residue S123 could likely be reached by the new cores. Of particular interest were the pyrrolidine and piperidine cores with phenyl sulfonamide substitution, as in <b>2a</b> and <b>3a</b>, since overlay of <b>2a</b> with compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) showed a particularly good overlap of the key pharmacophore features for both compounds, while the phenyl ring was expected to make new hydrophobic interactions with residues M96, L100, F309, F312, and Y313, and the sulfonyl group a new H-bond with S123; hence these compounds were selected for synthesis. For comparison, pyrrolidine compounds <b>4</b> (enantiomer of <b>2a</b>) and <b>5</b> (racemic <i>cis</i> isomer), piperidine compounds <b>6</b> (enantiomer of <b>3a</b>) and <b>7</b> (racemic <i>cis</i> isomer), and the alternative piperidine regioisomers <b>8</b> (racemic <i>trans</i> isomer) and <b>9</b> (racemic <i>cis</i> isomer) were also synthesized and tested, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. As the optimized indane compound <b>1</b> had the LLE value of 6, a significant increase of this value for compounds with the new cores was expected as a sign of new attractive polar interactions with the ghrelin receptor.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding, Functional Assay Potency, Agonism (%), log <i>D</i>, and LLE of Compounds <b>1</b>, <b>2a</b>–<b>3a</b>, <b>4</b>–<b>9</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0018.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">binding<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">functional assay<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">pEC<sub>50</sub> and agonism (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">log <i>D</i><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">LLE<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">8.8 (89)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">9.1 (93)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">9.1 (98)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">7.4 (79)</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">464</td><td class="colsep0 rowsep0" align="char" char=".">6.5 (72)</td><td class="colsep0 rowsep0" align="char" char=".">317</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="."><5.3</td><td class="colsep0 rowsep0" align="char" char=".">>4970</td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char="."><3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">249</td><td class="colsep0 rowsep0" align="char" char=".">7.2 (93)</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6.5 (81)</td><td class="colsep0 rowsep0" align="char" char=".">316</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5.9 (68)</td><td class="colsep0 rowsep0" align="char" char=".">1220</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">In vitro assay. Binding assay to detect compounds binding to the GHS-R1a expressed in HEK293 cells, by competing with [<sup>125</sup>I]-ghrelin. Values are the mean of at least 2 independent determinations.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">In vitro assay. Agonist activation of the ghrelin receptor results in a production of IP1. IP1 is accumulated in the cell in the presence of LiCl and measured by time-resolved fluorescence. Values are the mean of at least 2 independent determinations. The assay validation resulted in a CIR value of ±0.07 and an MDR value of 0.1 (on a log scale) when tested at 2 separate occasions.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Distribution coefficient expressing partitioning of compounds between 1-octanol and aqueous buffer at pH 7.4.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Ligand-lipophilicity efficiency (pIC<sub>50</sub> – log <i>D</i>).</p></div></div></div><div class="NLM_p">Gratifyingly, both the pyrrolidine compound <b>2a</b> and the piperidine compound <b>3a</b>, with lower log <i>D</i>, were found to be full agonists, equipotent in the binding assay and more potent in the functional assay than the indane compound <b>1</b>. The <i>trans</i> and <i>cis</i> isomers of the alternative piperidine regioisomers, compounds <b>8</b> and <b>9</b>, were less potent with reduced agonism. As expected, the enantiomeric compounds <b>4</b> and <b>6</b> as well as the <i>cis</i> racemates <b>5</b> and <b>7</b> were all less potent, and all, except <b>7</b>, had reduced agonism.</div><div class="NLM_p">Initial attempts to optimize the lead compounds <b>2a</b> and <b>3a</b> focused upon replacements within the phenyl sulfonamide core, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. As seen in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the subpocket that encloses this core is of a hydrophobic nature with only one polar residue, S123, that likely H-bonds sulfonamide oxygen. This means changes within the aromatic moiety of the core are not expected to affect the values of LLE significantly, whereas the structure of the sulfonamide linker is likely essential. If the homology model and the hypothetical binding mode describe important features of the ligand–receptor interactions, this trend has to be retained. Results of <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> are indeed consistent with the structure of hypothesized subpocket as the compound potency is driven by lipophilicity with the exception of compound <b>3g</b> with the amide linker, which does not fit. Residue S123 has previously been defined as the most important for free energy of binding of peptidomimetic agonist G-7039 with GHSR<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and furthermore together with F119 constitutes an efficacy switch region.<a onclick="showRef(event, 'ref21 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref28">(21,28)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding, Functional Assay Potency, Agonism (%), log <i>D</i>, LLE, Rat Hepatocytes Clearance, and Rat PK Data of Compounds <b>2a</b>–<b>g</b> and <b>3a</b>–<b>g</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0019.gif" alt="" id="gr14" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0020.gif" alt="" id="gr22" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a–e</sup></sup><p class="last">See footnotes in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t2fn2"><sup><sup>f</sup></sup><p class="last">In vitro clearance in rat hepatocytes ((μL/min)/(1 × 10<sup>6</sup>)).</p></div><div class="footnote" id="t2fn3"><sup><sup>g</sup></sup><p class="last">Harlan–Han Wistar rat pharmacokinetics, iv; <i>n</i> = 2, <i>t</i><sub>1/2</sub> (h), and Cl ((mL/min)/kg).</p></div><div class="footnote" id="t2fn4"><sup><sup>h</sup></sup><p class="last"><i>Trans</i> racemate.</p></div></div><div></div></div><div class="NLM_p">Among the compounds tested in rat pharmacokinetic studies, a significant lack of correlation between in vitro and in vivo clearance was observed. Consistently, the effective in vivo half-lives of this series were shorter than predicted with a lower exposure (as measured by area under the curve) consistent with a higher in vivo clearance. This was a general trend for all compounds in the series. The reason behind this in vivo clearance underprediction was not due to an extrahepatic clearance mechanism but rather to a misleading experimental underestimation of in vitro Cl<sub>int</sub> values. The poor intrinsic permeability of these compounds coupled with large efflux values (Pgp transporters) caused the compound uptake into the hepatocyte cells to become the rate limiting step (as opposite to the metabolism rate itself) which caused the false impression of compounds being stable and the consequent bad IVIV correlation.</div><div class="NLM_p">Consequently, in an effort to improve metabolic stability, initial focus was placed on replacements for the dimethylaminoethyl side-chain, whereby the basic nitrogen is incorporated into a ring, and maintaining the two-carbon link between the basic nitrogen and the amide nitrogen. This strategy led to the identification of (pyrrolidin-2-yl)methyl and 3-piperidyl as potent replacements of the acyclic amino side-chain, and a series of related pyrrolidine (<b>10a</b>–<b>g</b>) and piperidine (<b>11a</b>,<b>b</b>) compounds were prepared and tested, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. These compounds are generally very potent, have higher LLE values than indanes, and are full agonists when the basic nitrogen is methylated or is the secondary amine. There is more than 10-fold difference in potency observed between the unmethylated 3-piperidyl epimers (<b>10f</b> and <b>10g</b>) but less difference between the methylated isomers (<b>10d</b> and <b>10e</b>) as also is observed between the methylated (pyrrolidin-2-yl)methyl isomers (<b>10b</b> and <b>10c</b>). The N-alkylation on the piperidine nitrogen atom does not change the functional activity of this series of compounds. This is in contrast to what was observed on a piperidine substituted quinazoline series deeply investigated for the treatment of diabetes and obesity with ghrelin antagonists.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In general, intrinsic metabolic clearance, measured in rat hepatocytes and human microsomes, is significantly lower for the unmethylated secondary amines relative to the analogous methylated tertiary amines. In particular the (<i>S</i>)-3-piperidyl compound <b>10g</b> in the pyrrolidine series has an attractive profile with excellent potency and good in vitro metabolic stability. However, in view of poor in vivo PK observed for earlier compounds, permeability in Caco-2 cells was determined for several compounds, and these data consistently showed low permeability (<i>P</i><sub>app</sub>AtB) and high efflux ratios, with piperidines not showing any permeability improvement over the pyrrolidines.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Assay Potency, Agonism (%), log <i>D</i>, LLE, Rat Hepatocytes, and Human Liver Microsomes Clearance and Permeability Data of Compounds <b>10a</b>–<b>g</b> and <b>11a</b>,<b>b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0021.gif" alt="" id="gr15" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0022.gif" alt="" id="gr23" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a–d</sup></sup><p class="last">See footnotes b–e in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</p></div><div class="footnote" id="t3fn2"><sup><sup>e</sup></sup><p class="last">See footnote f in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</p></div><div class="footnote" id="t3fn3"><sup><sup>f</sup></sup><p class="last">In vitro clearance in human liver microsomes ((μL/min)/mg).</p></div><div class="footnote" id="t3fn4"><sup><sup>g</sup></sup><p class="last">Apparent permeability across human Caco-2 cell monolayers at pH 7.4: <i>P</i><sub>app</sub>AtB is apparent permeability coefficient in apical to basolateral direction; <i>P</i><sub>app</sub>BtA is apparent permeability coefficient in basolateral to apical direction (1 × 10<sup>–6</sup> cm/s).</p></div></div><div></div></div><div class="NLM_p">In view of the excellent potency and good metabolic stability of compound <b>10g</b>, the main focus was placed on the pyrrolidine series with (<i>S</i>)-3-piperidylamides. While compound <b>10g</b> did not show significant inhibition against a panel of cytochrome P450 enzymes (IC<sub>50</sub> > 30 μM for isoforms 3A4, 2D6, 2C9, 2C19 and equal to 9 μM for 1A2), there was nevertheless concern that metabolism of the indole group might be associated with reactive metabolite formation which could give rise to idiosyncratic liver toxicity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Indeed, covalent adducts were detected when compound <b>10g</b> was incubated with human microsomes in the presence of glutathione, which indicated the likely formation of reactive peroxide and/or benzoquinone imine metabolites.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Therefore, an alternative to the indole group of <b>10g</b> was sought and a series of monocyclic and biaryl replacements were prepared, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional Assay Potency, Agonism (%), log <i>D</i>, LLE, Rat Hepatocytes and Human Liver Microsomes Clearance, Permeability, Efflux Ratio, and Solubility Data of Compounds <b>12a</b>–<b>m</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0023.gif" alt="" id="gr16" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0024.gif" alt="" id="gr24" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a–g</sup></sup><p class="last">See footnotes in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</p></div><div class="footnote" id="t4fn2"><sup><sup>h</sup></sup><p class="last">Efflux ratio is <i>P</i><sub>app</sub>BtA/<i>P</i><sub>app</sub>AtB.</p></div><div class="footnote" id="t4fn3"><sup><sup>i</sup></sup><p class="last">Solubility determined from dried-DMSO stock solutions in aqueous buffer at pH = 7.4.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></p></div></div><div></div></div><div class="NLM_p">Initially five-membered monocyclic replacements for indole were investigated, and in general these were polar molecules with weak potency. Methylthiazole <b>12a</b> and 3-cyclopropylpyrazole <b>12b</b> were tolerated but quite weak, and the N-alkylated imidazole <b>12c</b> was inactive. The loss of activity of <b>12c</b> is explained by the significant drop in log <i>D</i> caused by basicity of imidazole. More significant increases in potency were observed upon addition of a phenyl ring as in <b>12d</b>. Thus, a series of biaryl compounds with varied five-membered rings and substituted phenyl groups was investigated. These compounds were generally potent, and it was observed that addition of a 2-chloro substituent on the phenyl ring led to a significant increase in potency as exemplified by matched pairs <b>12d/12j</b> and <b>12i</b>/<b>12k</b>. Compound <b>12i</b>, the 4-chloro analogue of <b>12j</b>, was less potent. Molecular modeling studies suggest that the potent-boosting effect of the 2-chloro substituent in <b>12j</b>, <b>12k</b>, and <b>12m</b> is due to the out-of-plane effect of this group on the conformation of the conjugated biaryl moiety, which results in attractive cation−π interaction of the 2-chlorophenyl with R199 of GHSR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The Caco-2 permeability values were low for all compounds in this series. For the biaryl compounds, very high efflux ratios were observed, whereas for the less lipophilic monocyclic compounds, efflux ratios were lower, but this did not reflect in an increased apparent permeability. Additionally, for many of the biaryl compounds, aqueous solubility was lower to the extent to reduce bioavailability, and unsurprisingly all compounds tested in rat PK had no or negligible bioavailability, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. However, acceptable bioavailability was in general consistently observed for compounds tested in dog with the difference between the species being attributed to a decreased expression of Pgp in the gastrointestinal tract of our dogs.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Long half-lives were associated with low clearances and high volumes of distribution in both species.</div><figure id="fig3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0003.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of putative binding modes of <b>2a</b> (turquoise carbons) and <b>12j</b> (pink carbons) in human ghrelin receptor homology model obtained by molecular mechanical energy minimization using MacroModel (Schrodinger LLC). The homology model was built using the program MOE (Chemical Computing Group)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the X-ray crystallographic structure of the agonist-bound rat neurotensine receptor 1 as a template (PDB access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nonpolar hydrogens are omitted for clarity. The conformational out-of-plane effect of 2-chloro-substituent within the biaryl moiety of <b>12j</b> leads to the attractive cation−π interaction with the side chain of R199.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Rat and Dog Pharmacokinetic Data of Compounds <b>12d</b>, <b>12e</b>, and <b>12j</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat PK<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">dog PK<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Cl</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (iv)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">Cl</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (iv)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="."><1.8</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="char" char=".">13.8</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char="."><1.0</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Harlan–Han Wistar rat and dog pharmacokinetics, iv and po, <i>n</i> = 2: Cl ((mL/min)/kg), volume of distribution (L/kg), <i>t</i><sub>1/2</sub> (h), and oral bioavailability (%).</p></div></div></div><div class="NLM_p">Compounds <b>12d</b> and <b>12j</b> were selected for further evaluation to assess improvements in the safety profile. Both compounds were found to have a clean secondary pharmacology profile against a broad counterscreening panel (CEREP), while, unlike for the indole compounds, covalent adducts were not detected following incubations with human microsomes in the presence of glutathione, indicating a reduced risk of hepatotoxicity. Compounds <b>12d</b> and <b>12j</b> also showed reduced interactions with μ- and κ-opiate receptors compared to the initial lead compound <b>1</b>, <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Comparison of OPR Receptor Data for Compounds <b>1</b>, <b>12d</b>, and <b>12j</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">κ-OP<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">μ-OPR<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">binding pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">agonism<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a>pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">antagonism pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">binding pIC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">agonism<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">antagonism pEC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char="."><5.1</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char="."><4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char="."><4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char="."><4</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char="."><4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">κ-Opioid receptor.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">μ-Opioid receptor.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Agonist activity at the κ and μ opioid receptors, expressed in transfected CHO cells, was determined by measuring their effects on cAMP modulation using the HTRF detection method. The reported values for compounds <b>1</b> and <b>12j</b> are the geometric mean, <i>n</i> = 2. For range and protocol see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_002.pdf" class="ext-link">Supporting Information</a>.</p></div></div></div><div class="NLM_p">On the basis of the overall profile, compounds <b>12d</b> and <b>12j</b> were profiled further, <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. Compound <b>12j</b> showed high potency and full agonism also in HEK293 cells transfected with dog ghrelin receptor and was therefore selected to be studied in the dog PK/PD model.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Dog Functional Potency, Agonism, LLE, Plasma Protein Binding, and Dog and Human Hepatocytes Clearance of Compounds <b>12d</b> and <b>12j</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">dog functional assay<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (agonism (%))</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">LLE<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PPB<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> for rat, dog, h</th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> for dog, h HEP<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">8.1 (81)</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">10, 12, 9</td><td class="colsep0 rowsep0" align="left">4, <1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">9.1 (92)</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">2.4, 3.5, 3.3</td><td class="colsep0 rowsep0" align="left">7.4, 6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">In HEK293 cells transfected with dog ghrelin receptor.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Ligand-lipophilicity efficiency.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">Plasma protein binding (% free).</p></div><div class="footnote" id="t7fn4"><sup><sup>d</sup></sup><p class="last">In vitro clearance in dog and human hepatocytes ((μL/min)/(1 × 10<sup>6</sup>)).</p></div></div></div><div class="NLM_p">This model was designed to determine the increase of IGF-1 and duration of effect while simultaneously providing pharmacokinetic data. This study compared the effect on IGF-1 plasma levels over 48 h following single doses of 0.8 mg/kg and 3 mg/kg by oral gavage to five dogs, and results are outlined, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. For the higher dose, >45% increase in IGF-1 compared to the <i>t</i> = 0 value was observed for the full duration of the experiment which correlated with sustained free plasma levels above EC<sub>50</sub> (dotted line), based upon EC<sub>50</sub> = 0.9 nM in the dog IP-1 assay and after adjusting for 3.5% free fraction in dog plasma. For the lower dose, a sustained but lower magnitude increase in IGF-1 was observed which returned to close to normal levels after a further 48 h (not shown). These data support the hypothesis that a ghrelin agonist with a long half-life will produce a dose-related sustained increase in IGF-1 and identifies <b>12j</b> as a potential tool compound to investigate the effects of sustained rather than pulsed increases in IGF-1 on muscle wasting.</div><figure id="fig4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0004.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dog PK/PD data for <b>12j</b>: IGF-1 increase from baseline (left) and plasma concentration (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the favorable in vitro and in vivo profile already discussed, compound <b>12j</b> became the front-runner in the selection of potential preclinical development candidates. However, there were inevitable concerns over the poor oral absorption in rodent (hamster, mouse, and rat) species and the implications for achieving adequate exposure in toxicology studies. Moreover, while bioavailability in dogs was much higher, greater than 2-fold dose normalized AUC, variability between animals was subsequently observed with a trend for lower exposure in females compared to males, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0005.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fabs in different species of compounds <b>12d</b> and <b>12j</b>: pink dot, female; yellow triangle, male; blue diamond and gray diamond, undefinied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, in view of a perceived risk of poor and variable absorption in humans, an Ussing chamber experiment was conducted to measure permeability of compounds <b>12d</b> and <b>12j</b> across human and rat jejunum tissue. The results of these experiments are outlined in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and show both compounds to be strongly effluxed with low apparent permeabilities (<i>P</i><sub>app</sub>) < 1 × 10<sup>–6</sup> cm/s. Upon the basis of a comparison with human jejunal <i>P</i><sub>app</sub> data for known clinical compounds,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> for which the fraction absorbed is known from human PK experiments, such low <i>P</i><sub>app</sub> values would predict for low (<10%) fraction absorbed in humans.</div><figure id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0006.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ussing chamber permeability (<i>P</i><sub>app</sub>) of compounds <b>12j</b> and <b>12d</b> in rat (green) and human (purple) jejunum tissue: AtB = apical to basal; BtA = basal to apical permeability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Thus, on the basis of predicted poor absorption in humans, compound <b>12j</b> was not progressed to preclinical development. However, attempts were made to identify either possible prodrugs or derivatives of <b>12j</b> with improved passive permeability but still avoiding brain exposure at the same time. The main approaches were based on (i) reduction of the number of H-bond acceptors through replacement of the sulfonamide with an amide link or directly linked aromatics, but no increase of permeability was observed (unpublished data), (ii) modulation of H-bond strength through increased steric hindrance (<b>13b</b>), or (iii) reduction of the number of H-bond donors through incorporation into a ring (<b>14</b>), methylation (<b>16a</b>–<b>d</b>), or acylation (<b>16e</b>,<b>f</b>), <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Tables <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Analogs with Modified Basic Side Chain, Compounds <b>13b</b>, <b>14</b>, and <b>15</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0025.gif" alt="" id="gr25" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">functional assay<a class="ref internalNav" href="#t8fn1" aria-label="a–c">a–c</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (agonism (%))<a class="ref internalNav" href="#t8fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">log <i>D</i><a class="ref internalNav" href="#t8fn1" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> rat HEP<a class="ref internalNav" href="#t8fn2" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> HLM<a class="ref internalNav" href="#t8fn2" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">h Caco-2<a class="ref internalNav" href="#t8fn2" aria-label="f">f</a><i>P</i><sub>app</sub>AtB (ER)<a class="ref internalNav" href="#t8fn2" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">solubility (μM)<a class="ref internalNav" href="#t8fn2" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">7.6 (97)</td><td class="colsep0 rowsep0" align="left">25.8</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">0.035 (170)</td><td class="colsep0 rowsep0" align="left">271</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">8.6 (98)</td><td class="colsep0 rowsep0" align="left">2.24</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">0.53 (32)</td><td class="colsep0 rowsep0" align="left">265</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">9.0 (102)</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">9.7</td><td class="colsep0 rowsep0" align="left">0.44 (17)</td><td class="colsep0 rowsep0" align="left">503</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a–c</sup></sup><p class="last">See footnotes a–c in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</p></div><div class="footnote" id="t8fn2"><sup><sup>d–h</sup></sup><p class="last">See footnotes e–i in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</p></div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Derivatives of <b>12j</b> with Fewer H-Bond Donors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0026.gif" alt="" id="gr26" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">functional assay<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (agonism (%))<a class="ref internalNav" href="#t9fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">log <i>D</i><a class="ref internalNav" href="#t9fn1" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> rat HEP<a class="ref internalNav" href="#t9fn1" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">Cl<sub>int</sub> HLM<a class="ref internalNav" href="#t9fn1" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">h Caco-2<a class="ref internalNav" href="#t9fn1" aria-label="f">f</a><i>P</i><sub>app</sub>AtB (ER)<a class="ref internalNav" href="#t9fn1" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">solubility (μM)<a class="ref internalNav" href="#t9fn1" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">9.0 (103)</td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.060 (425)</td><td class="colsep0 rowsep0" align="left">655</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.9 (88)</td><td class="colsep0 rowsep0" align="left">12.37</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">0.11 (220)</td><td class="colsep0 rowsep0" align="left">113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">7.6 (95)</td><td class="colsep0 rowsep0" align="left">25.06</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.075 (365)</td><td class="colsep0 rowsep0" align="left">553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>9.5</td><td class="colsep0 rowsep0" align="left"><0.32</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">106</td><td class="colsep0 rowsep0" align="left">1.3 (16)</td><td class="colsep0 rowsep0" align="left">503</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">formyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.8 (90)</td><td class="colsep0 rowsep0" align="left">166.4</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">97</td><td class="colsep0 rowsep0" align="left">>259</td><td class="colsep0 rowsep0" align="left">0.96 (25)</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">acetyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.9 (91)</td><td class="colsep0 rowsep0" align="left">132.5</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">196</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">0.75 (41)</td><td class="colsep0 rowsep0" align="left"><0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a–h</sup></sup><p class="last">See footnotes in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>.</p></div></div></div><div class="NLM_p">Compound <b>13b</b>, with the methyl substituent α to the amide carbonyl, was synthesized with the indole rather than the biaryl group of <b>12j</b> to avoid increase of lipophilicity. Comparison with the corresponding analog <b>10g</b> indicates nearly a 100-fold reduction in potency as a result of the methylation, which is probably due to altered relative conformation of the two amide side-chains. The compounds <b>14</b> and <b>15</b> retained good potency and both had improved, although Caco-2 AtB permeability was still low and the increased clearance in human microsomes was a concern for these compounds.</div><div class="NLM_p">Regrettably the efflux properties were not altered by the methylation of the amide nitrogens, as in <b>16a</b>–<b>c</b>, and permeability was not significantly improved. Methylation of the amide linking of the piperidine ring also had a significant impact on potency as can be seen with <b>16b</b> and <b>16c</b>. Consistent with previous observations for compounds <b>10b</b>,<b>c</b>,<b>d</b>,<b>e</b> and <b>11a</b>, methylation of the basic secondary amine as in <b>16d</b> was associated with increased potency but also decreased metabolic stability as was evident by higher intrinsic clearance in rat hepatocytes and in human microsomes and hepatocytes. The acylated compounds <b>16e</b> and <b>16f</b> also had higher intrinsic clearances as well as significantly reduced potency and, as expected, had a much better apparent (Caco <i>P</i><sub>app</sub>AtB ∼ 1 1 × 10<sup>–6</sup> cm/s) and intrinsic permeability (Caco <i>P</i><sub>app</sub>AtB with efflux inhibited ∼70 1 × 10<sup>–6</sup> cm/s). These compounds <b>16d</b>–<b>f</b> were also considered as potential prodrugs if resulting in formation of <b>12j</b> as the main metabolite (compounds <b>16a</b>–<b>c</b> were too stable to be considered as valid prodrugs alternatives).</div><div class="NLM_p">Thus, a metabolite identification study was performed to compare metabolic pathways of <b>16d</b>–<b>f</b> with <b>12j</b> in rat, dog, and human hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). The compounds were incubated in the presence of either fresh rat or dog hepatocytes or cryopreserved human hepatocytes for 120 min (<b>16e</b> and <b>16f</b> were incubated in rat hepatocytes for 40 min), and main metabolites were identified by LCMSMS. Compounds observed were <b>12j</b>, metabolites resulting from oxidation of the piperidine ring (identified as M – 2 or M + 16), and unidentified metabolites resulting from reactions of the remainder of the molecule (observed M + 323 or M – 124). The results show varying degrees of conversion of parent compound with formation of the desired <b>12j</b> as a major metabolite in all cases except in the case of the acetyl derivative <b>16f</b>, where <b>12j</b> was not detected after the incubations in hepatocytes in any of the species.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Metabolism Pathway of Potential Prodrugs in Rat, Dog, and Human Hepatocytes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">rat metabolites (%)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">dog metabolites (%)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">human metabolites (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><b>12j</b></th><th class="colsep0 rowsep0" align="center" char=".">oxid.</th><th class="colsep0 rowsep0" align="center" char=".">other</th><th class="colsep0 rowsep0" align="center" char=".">parent</th><th class="colsep0 rowsep0" align="center" char="."><b>12j</b></th><th class="colsep0 rowsep0" align="center" char=".">oxid.</th><th class="colsep0 rowsep0" align="center" char=".">other</th><th class="colsep0 rowsep0" align="center" char=".">parent</th><th class="colsep0 rowsep0" align="center" char="."><b>12j</b></th><th class="colsep0 rowsep0" align="center" char=".">oxid.</th><th class="colsep0 rowsep0" align="center" char=".">other</th><th class="colsep0 rowsep0" align="center" char=".">parent</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">99</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16d</b></td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16e</b></td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16f</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr></tbody></table></div></div><div class="NLM_p">Thus, in view of in vitro evidence supporting potential formation of <b>12j</b> as a major metabolite, compounds <b>16d</b>–<b>f</b> were tested in in vivo rat PK experiments, with simultaneous analysis for the parent and the active compound <b>12j</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. Results for <b>16d</b> and <b>16e</b> show a significant increase of absorption of parent compound corresponding to a bioavailability of 9% and 4% and a Fabs of 13% and 10%, respectively, which is in agreement with the observed increased in permeability, and despite being still low, it is a major improvement compared to the undetectable bioavailability (<1%) of compound <b>12j</b>. However, levels of the desired metabolite <b>12j</b> were well below those of the parent with AUC<sub>0–<i>t</i></sub> for the metabolite corresponding to 6% and 19% of the parent AUC<sub>0-t</sub> for the iv and oral doses, respectively.</div><figure id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0007.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pharmacokinetics of <b>16d</b> in male HW rats, dose 1 mg/kg (iv), 2.8 mg/kg (oral): blue dot, parent <b>16d</b>; orange dot, metabolite <b>12j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In similar experiments, <b>16e</b> had 4% bioavailability with metabolite AUC<sub>0–<i>t</i></sub> corresponding to 1% and 8% of parent AUC<sub>0–<i>t</i></sub> for iv and oral doses, respectively, while <b>16f</b> had <1% bioavailability, and in agreement with the results from the metabolic study performed previously in vitro rat hepatocytes, no levels of the active metabolite <b>12j</b> were detected. Thus, on the basis of these results, although an improvement in bioavailability was observed for <b>16d</b> and <b>16e</b>, they were considered too metabolically stable to be developed as potential prodrugs for <b>12j</b>. Research is ongoing to identify a more permeable compound that could allow us to make a more robust dose to human predictions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have reported the discovery of a new series of pyrrolidine and piperidine bis-amides as ghrelin full agonists that were derived from a previously reported indane series. Optimization of compounds in this series led to the identification of the pyrrolidine compound <b>12j</b> with sub-nM in vitro potency, long half-life in rat and dog PK, sustained dose-dependent activity in a dog IGF-1 model, and a safety profile suitable for progression to preclinical development. However, compounds in this series are generally good substrates for efflux transporters as was evident from the low AtB permeability in Caco-2 cells and the negligible oral bioavailability in rat PK. Some compounds did nevertheless have much higher oral bioavailability in dogs, although this was variable and gender dependent. The potential impact of efflux upon intestinal absorption in humans is of key importance, and based upon experiments using human jejunum tissue, predicted human bioavailability for <b>12j</b> was too low for it to be considered as a suitable clinical candidate.</div><div class="NLM_p last">Attempts to improve bioavailability, primarily by reducing H-bonding potential and hence increasing the intrinsic permeability and diminishing the substrate potential of the compounds against Pgp transporters, led to identification of derivatives <b>16d</b>–<b>f</b> with higher in vitro permeability. These compounds had high in vitro clearance, with <b>12j</b> identified as a major metabolite in rat, dog, and human hepatocytes; hence they were considered as potential prodrugs for <b>12j</b> rather than drug candidates in their own right. However, while low but significant bioavailability was observed in rat PK studies, detected levels of <b>12j</b> were too low for these compounds to be progressed as prodrugs. Nevertheless, these studies highlighted the effectiveness of reducing H-bonding potential, in terms of improving bioavailability. Hence, the focus was put on modifications to the core structure that will facilitate bigger changes in this regard, and these results will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72881" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72881" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Chemistry</h3><div class="NLM_p last">All solvents and chemicals purchased from commercial suppliers where used as received. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen atmosphere using dry solvents. Proton (<sup>1</sup>H) and carbon (<sup>13</sup>C) NMR spectra were recorded at room temperature, unless otherwise specified. Solutions were typically prepared in deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>), deuterated chloroform (CDCl<sub>3</sub>), or deuterated methanol (CD<sub>3</sub>OD) with chemical shifts referenced to solvent as an internal standard. <sup>1</sup>H NMR data are reported indicating the chemical shift (δ), the multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; p, quintet; m, multiplet; br, broad; dd, doublet of doublets; etc.), the coupling constant (<i>J</i>) in Hz, and the integration (e.g., 1H). Silica gel chromatography was carried out using silica gel 60 (0.040–0.063 mm, Merck) or prepacked Biotage KP-SIL. Cation/anion exchange columns were Isolute SCX-2, Isolute CBA, and Isolute NH<sub>2</sub>. Preparative HPLC was performed with a Waters Fraction Lynx system with integrated MS detection or Gilson GX-281 with integrated UV detection using Waters Sunfire C18 OBD 5 μm, XBridge BEH C18 OBD 5 μm, Xselect CSH C18 OBD 5 μm or Kromasil C8 10 μm columns. Preparative chiral HPLC was performed with a Waters FractionLynx system with integrated MS detection or Gilson GX-281 with integrated UV detection using Chiralpak IB, Chiralpak IA, or Chiralpak IB IC 5 μm and Lux cellulose-4 5 μm columns. Preparative SFC was performed with a Waters Prep100 SFC system with integrated MS detection using CelluCoat column, particle size 5 μm, mobile phase 30% EtOH/DEA 100/0.5 in CO<sub>2</sub>, 150 bar or 25% or 30% MeOH/DEA 100/0.5 in CO<sub>2</sub>, 120 bar, flow 80 or 100 mL/min, detection 290–310 nm, temperature 40 °C. All compounds were purified to ≥95% purity as judged by HPLC with UV and MS analysis. LCMS was run on either a Waters Acquity TQD with a Waters Acquity UPLC LC/MS/MS system or Agilent HP 1100 LC/MS system, both equipped with a diode array UV detector from 220 to 350 nm and a mass spectrometer (ESI or APCI) with the following conditions: Waters Acquity UPLC BEH C18 column, elution gradient with a flow rate of 1 mL/min, and 2–95% acetonitrile in an aqueous 46 mM ammonium carbonate/ammonia buffer at pH 10, Waters Acquity UPLC HSS C18 column 1.8 μm, elution gradient with a flow rate of 1 mL/min, and 2–95% acetonitrile in an aqueous 10 mM formic acid/1 mM ammonium formate buffer at pH 3, or Waters Symmetry C18 column 3.5 μm, 2.1 mm × 30 mm, elution gradient with a flow rate of 0.7 mL/min, and 15–95% acetonitrile in water with 0.1% trifluoroacetic acid over 2.7 min and then 95% for 0.3 min. Chiral analyses were performed by following these SFC conditions: CelluCoat column, 250 mm × 4.6 mm, particle size 5 μm, mobile phase 30% EtOH/DEA 100/0.5 in CO<sub>2</sub>, 150 bar, flow 4 mL/min, detection 290 nm, temperature 40 °C. Accurate mass was determined using HRMS experiments performed on a Waters Acquity, Waters 2777, or Waters 2700 UV–HPLC system and a Waters Xevo G2 TOF, Waters LCT Premiere, Waters LCT, or Waters QTOF micro mass spectrometer. Optical rotation was measured with an ADP600 polarimeter system at the sodium D-line of 589 nm at specified conditions.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)pyrrolidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>2a</b>) and <i>N</i>-((3<i>S</i>,4<i>R</i>)-4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)pyrrolidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>4</b>)</h3><div class="NLM_p last">The racemate <b>20</b> was submitted to chiral separation to obtain the two enantiomers <b>2a</b> (29.7 mg, 21.3%) and <b>4</b> (26.3 mg, 18.8%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.06 (s, 6H), 2.16–2.25 (m, 2H), 2.35 (s, 3H), 2.99–3.14 (m, 4H), 3.20 (dd, <i>J</i> = 9.8, 7.7 Hz, 1H), 3.49 (dd, <i>J</i> = 9.8, 7.4 Hz, 1H), 3.57 (dd, <i>J</i> = 9.7, 8.7 Hz, 1H), 4.44 (p, <i>J</i> = 7.2 Hz, 1H), 7.01 (dd, <i>J</i> = 8.2, 1.5 Hz, 2H), 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.37 (s, 1H), 7.64–7.68 (m, 2H), 7.71–7.74 (m, 1H), 7.80–7.85 (m, 2H), 7.90 (t, <i>J</i> = 5.5 Hz, 1H), 8.48 (d, <i>J</i> = 7.4 Hz, 1H), 11.42 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 498 (M + H)<sup>+</sup>. (<b>2a</b>) HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 498.2175. Found: 498.2211. Ee 98.7 <b>(4)</b> HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 498.2175. Found: 498.2169. Ee 97.7. The stereochemical assignments were confirmed by comparison with the compound <b>2a</b> synthesized from the common intermediate <b>44</b>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-((3<i>R</i>,4<i>S</i>)-4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)pyrrolidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>2a</b>), Second Procedure</h3><div class="NLM_p last">(3<i>S</i>,4<i>R</i>)-<i>tert</i>-Butyl 3-((2-(dimethylamino)ethyl)carbamoyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1-carboxylate <b>46</b> (36 mg, 0.08 mmol) was dissolved in MeOH (2 mL), and TMSCl (0.01 mL, 0.08 mmol) was added to this at 0 °C. The mixture was allowed to warm to rt and stirred overnight. The solution was concentrated in vacuo and then dissolved in DCM (2 mL). Pyridine (0.041 mL, 0.50 mmol) was added and the mixture cooled to 0 °C. Benzenesulfonyl chloride (44.5 mg, 0.25 mmol) was then added, and the mixture was stirred at rt for 16 h. EtOAc was added and the solution washed with sat. NaHCO<sub>3</sub> and brine. After concentration of the solution, the crude residue was purified by column chromatography (EtOAc/heptane 30%), which afforded compound <b>2a</b> (7.2 mg, 18%) whose NMR spectrum was overlapping with the NMR obtained from the corresponding product synthesized from compound <b>17</b> in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Representative chemistry is reported for the synthesis of compound <b>2a</b>. Similar procedure was applied to the synthesis of compounds <b>2b</b>–<b>g</b>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-3-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>3a</b>) and <i>N</i>-((3<i>R</i>,4<i>R</i>)-3-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>6</b>)</h3><div class="NLM_p last"><i>N</i>-(<i>trans-</i>3-(2-(Dimethylamino)ethylcarbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide <b>24</b> (406 mg, 0.79 mmol) was submitted to separation by chiral SFC chromatography (CelluCoat column, mobile phase 30% EtOH/DEA 100/0.5 in CO<sub>2</sub>). The two enantiomers were obtained. <b>6</b>: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59 (qd, <i>J</i> = 12.6, 3.5 Hz, 1H), 1.91–1.96 (m, 5H), 2.01–2.18 (m, 2H), 2.31–2.40 (m, 6H), 2.68 (td, <i>J</i> = 11.5, 4.2 Hz, 1H), 2.96–3.10 (m, 2H), 3.71 (dd, <i>J</i> = 10.7 Hz, 2H), 3.87–3.95 (m, 1H), 6.95 (d, <i>J</i> = 1.9 Hz, 1H), 6.98 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 7.28 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (s, 1H), 7.65–7.71 (m, 3H), 7.74–7.79 (m, 4H), 8.10 (d, <i>J</i> = 8.7 Hz, 1H), 11.39 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>. [α]<sub>589</sub> = −116° (CHCl<sub>3</sub> + HCO<sub>2</sub>H, concn 0.5 g/100 mL, 20 °C). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 512.2331. Found: 512.2349. Ee 99.8. <b>3a</b>: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.59 (qd, <i>J</i> = 12.6, 3.5 Hz, 1H), 1.91–1.96 (m, 5H), 2.01–2.18 (m, 2H), 2.31–2.40 (m, 6H), 2.68 (td, <i>J</i> = 11.5, 4.2 Hz, 1H), 2.96–3.10 (m, 2H), 3.71 (dd, <i>J</i> = 10.7 Hz, 2H), 3.87–3.95 (m, 1H), 6.95 (d, <i>J</i> = 1.9 Hz, 1H), 6.98 (dd, <i>J</i> = 8.4, 1.3 Hz, 1H), 7.28 (d, <i>J</i> = 7.6 Hz, 1H), 7.35 (s, 1H), 7.65–7.71 (m, 3H), 7.74–7.79 (m, 4H), 8.10 (d, <i>J</i> = 8.7 Hz, 1H), 11.39 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>. [α]<sub>589</sub> = +119° (CHCl<sub>3</sub> + HCO<sub>2</sub>H, concn 0.5 g/100 mL, 20 °C). HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 512.2331. Found: 512.2365. Ee 95.5. The absolute configuration of compound <b>3a</b> was confirmed by the stereoselective synthesis reported below.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-3-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>3a</b>, Second Procedure)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-Ethyl-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-3-carboxylate <b>28</b> (0.75 g, 1.60 mmol) was dissolved in THF (20 mL) to give a colorless solution. To the stirred solution 1 M NaOH (8 mL, 8.00 mmol) was added, and the reaction mixture was heated with stirring at 40 °C for 4 h. The reaction mixture was then acidified by the addition of 1 M HCl (9 mL). THF was removed in vacuo and the product precipitated from the residual aqueous solution. The product was isolated by filtration, washed with water on the filter, to afford the acid intermediate (0.65 g) as a white solid. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 442 (M + H)<sup>+</sup>. This acid (200 mg, 0.45 mmol) was then dissolved in DMSO (3 mL), and Et<sub>3</sub>N (95 μL, 0.68 mmol) was added to give a colorless solution. To the stirred solution, HBTU (189 mg, 0.50 mmol) and <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine (43.9 mg, 0.50 mmol) were added, and the mixture was stirred for 30 min. The crude mixture was purified on preparative HPLC to give a compound (0.09 g) as a white solid. The material had 95% ee and identical optical rotation to the [α]<sub>589</sub> = +119° obtained above (<b>3a</b>). The compounds were also proven identical by co-injection on the same analytical chiral SFC system used previously for separating the enantiomers and by <sup>1</sup>H NMR.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(Racemic <i>cis</i>-3-(2-(Dimethylamino)ethylcarbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>7</b>)</h3><div class="NLM_p last">An impurity in the reaction sequence toward <b>24</b>, which was believed to have arised from epimerization in the hydrolysis step was isolated during the purification and proved to be the <i>cis</i>-racemate <b>7</b> (35 mg) that was isolated and characterized. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.72–1.80 (m, 1H), 2.04 (s, 6H), 2.08–2.13 (m, 1H), 2.18 (t, <i>J</i> = 6.4 Hz, 2H), 2.35 (s, 3H), 2.82–2.87 (m, 1H), 3.02–3.14 (m, 3H), 3.18–3.27 (m, 3H), 4.37–4.44 (m, 1H), 6.95 (s, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 8.3 Hz, 1H), 7.36 (s, 1H), 7.69 (t, <i>J</i> = 7.7 Hz, 2H), 7.76 (t, <i>J</i> = 7.2 Hz,1H), 7.79 (d, <i>J</i> = 7.6 Hz, 2H), 7.92–7.99 (m, 2H), 11.45 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 512.2331. Found: 512.2379.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>trans-</i><i>N</i>-4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>8</b>) and <i>cis</i>-<i>N</i>-4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>9</b>)</h3><div class="NLM_p">The crude diamide <b>39</b> was submitted to preparative HPLC to give isomers <i>trans</i><b>8</b> 0.025g (7%) and <i>cis</i><b>9</b> 0.051g (15%).</div><div class="NLM_p"><b>8</b>: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.65–1.75 (m, 1H), 1.8–1.88 (m, 1H), 1.98 (s, 6H), 2.03–2.15 (m, 3H), 2.16–2.23 (m, 1H), 2.28–2.33 (m, 1H), 2.35 (s, 3H), 2.97–3.11 (m, 2H), 3.70 (d, <i>J</i> = 11.4 Hz, 1H), 3.78 (dd, <i>J</i> = 11.2, 4.6 Hz, 1H), 4.05–4.15 (m, 1H), 6.93 (s, 1H), 7.00 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.7 Hz, <i>1H</i>), 7.35 (s, 1H), 7.50 (t, <i>J</i> = 5.4 Hz, 1H), 7.62–7.68 (m, 2H), 7.74 (t, <i>J</i> = 7.2 Hz 1H), 7.76–7.81 (m, 2H), 8.07 (d, <i>J</i> = 8.3 Hz, 1H), 11.46 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 512.2331. Found: 512.2355.</div><div class="NLM_p last"><b>9</b>: <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.72–1.79 (m, 1H), 1.98 (s, 6H), 2.09–2.22 (m, 3H), 2.37 (s, 3H), 2.58–2.64 (dt, 1H), 2.70–2.78 (m, 1H), 2.78–2.84 (m, 1H), 2.95–3.12 (m, 2H), 3.33–3.40 (m, 1H), 3.52 (dd, <i>J</i> = 11.2, 6.3 Hz, 1H), 4.36–4.44 (m, 1H), 6.99–7.06 (m, 2H), 7.32 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (s, 1H), 7.61–7.67 (t, <i>J</i> = 7.0 Hz, 2H), 7.71 (t, <i>J</i> =7.5 Hz, 1H), 7.74–7.79 (m, 3H), 7.85 (d, <i>J</i> = 7.5 Hz, 1H), 11.51 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 512.2331. Found: 512.2360.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-Methyl-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-(((<i>R</i>)-pyrrolidin-2-ylmethyl)carbamoyl)-pyrrolidin-3-yl)-1<i>H</i>-indole-2-carboxamide (<b>10a</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>R</i>)-Methyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate <b>47</b> (53 mg, 0.12 mmol) was dissolved in THF (2 mL). LiOH (12 mg, 0.48 mmol) was dissolved in water, and the solution was added. The mixture was then stirred at rt for 30 min. EtOAc was added and the mixture washed with aq NH<sub>4</sub>Cl and brine. After drying over Na<sub>2</sub>SO<sub>4</sub>, the solution was concentrated in vacuo. This was dissolved in DMF (2 mL), (<i>R</i>)-<i>tert</i>-butyl 2-(aminomethyl)pyrrolidine-1-carboxylate (35.1 mg, 0.18 mmol), Et<sub>3</sub>N (0.024 mL, 0.18 mmol), and HATU (66.7 mg, 0.18 mmol) were added to the mixture, and it was stirred at rt overnight. EtOAc was added and the solution washed with sat. NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. This was dissolved in MeOH (2 mL), and TMSCl (8.38 μL, 0.07 mmol) was added. The mixture was then stirred at rt overnight. The solution was concentrated in vacuo and purified by preparative HPLC which afforded compound <b>10a</b> (17.10 mg, 28%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.22–1.31 (m, 1H), 1.51–1.66 (m, 2H), 1.65–1.73 (m, 1H), 2.35 (s, 3H), 2.71–2.79 (m, 1H), 2.81–2.88 (m, 1H), 2.94–3.04 (m, 2H), 3.07–3.15 (m, 3H), 3.23 (dd, <i>J</i> = 9.9, 7.8 Hz, 1H), 3.48–3.52 (m, 1H), 3.54–3.59 (m, 1H9, 4.46 (p, <i>J</i> = 7.2 Hz, 1H), 6.99–7.03 (m, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.37 (s, 1H), 7.64–7.69 (m, 2H), 7.70–7.75 (m, 1H), 7.80–7.86 (m, 2H), 8.19–8.24 (m, 1H), 8.56 (d, <i>J</i> = 7.4 Hz, 1H), 11.44 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 510 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>31</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 510.2175. Found: 510.2217. Representative chemistry is reported for the synthesis of compound <b>10a</b>. Similar procedure was applied to the synthesis of compounds <b>10b</b>–<b>g</b>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-1-((2-Chlorophenyl)sulfonyl)-3-(((<i>S</i>)-1-methylpiperidin-3-yl)carbamoyl)-piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>11a</b>)</h3><div class="NLM_p last">Compound <b>34</b> was a common intermediate for <b>11a</b>,<b>b</b>. (3<i>S</i>,4<i>S</i>)-1-((2-Chlorophenyl)sulfonyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylic acid <b>34</b> (52 mg, 0.11 mmol), HBTU (49.7 mg, 0.13 mmol), and Et<sub>3</sub>N (0.030 mL, 0.22 mmol) were dissolved in DMSO (1 mL) to give a colorless solution. (<i>S</i>)-1-Methylpiperidin-3-amine (13.72 mg, 0.12 mmol) was added, and the obtained mixture was stirred in a closed vial for 45 min. The reaction mixture was concentrated and the residue was purified on preparative HPLC, giving compound <b>11a</b> (27 mg, 43%) as a colorless solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.03–1.14 (m, 1H), 1.30–1.45 (m, 2H), 1.50–1.61 (m, 3H), 1.75 (s + m, 4H), 1.91–1.97 (m, 1H), 2.23 (d, <i>J</i> = 8.9 Hz, 1H), 2.26–2.32 (m, 1H), 2.35 (s, 3H), 2.59 (td, <i>J</i> = 11.1, 3.4 Hz, 1H), 2.91 (td, <i>J</i> = 12.8, 2.2 Hz, 1H), 2.97 (t, <i>J</i> = 12.2 Hz, 1H), 3.55–3.63 (m, 1H), 3.76 (dd, <i>J</i> = 12.6, 2.8 Hz, 2H), 4.12 (qd, <i>J</i> = 11.6, 4.3 Hz, 1H), 6.96–7.00 (m, 2H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.36 (s, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 1H), 7.58 (td, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.70 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.74 (dd, <i>J</i> = 8.0, 1.4 Hz, 1H), 8.01 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 1H), 11.43 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 572 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>28</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 572.2098. Found: 572.2116.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-1-((2-Chlorophenyl)sulfonyl)-3-((<i>S</i>)-piperidin-3-ylcarbamoyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>11b</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-1-((2-Chlorophenyl)sulfonyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylic acid <b>34</b> (50 mg, 0.11 mmol), HBTU (47.8 mg, 0.13 mmol), and Et<sub>3</sub>N (0.029 mL, 0.21 mmol) were dissolved in DCM (2 mL) to give a colorless solution. To the solution, (<i>S</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate (23.14 mg, 0.12 mmol) dissolved in DCM (0.5 mL) was added, and the obtained mixture was stirred in a closed vial for 45 min. A heavy precipitation was noticed in the vial, and LC-MS showed full conversion to the intermediate. To the reaction was added TFA (0.8 mL, 10.38 mmol), and the reaction was stirred for 30 min. The reaction mixture was evaporated and the product was purified on preparative HPLC, giving compound <b>11b</b> (7 mg, 12%) as a colorless solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.23–1.37 (m, 2H), 1.50–1.60 (m, 2H), 1.67–1.73 (m, 1H), 1.95 (d, <i>J</i> = 13.5 Hz, 1H), 2.07–2.13 (m, 1H), 2.36 (s, 3H), 2.36–2.39 (m, 1H), 2.58–2.65 (m, 1H), 2.66–2.71 (m, 2H), 2.90 (td, <i>J</i> = 13.0, 2.0 Hz, 1H), 2.93–2.99 (m, 1H), 3.51–3.57 (m, 2H), 3.72–3.82 (m, 2H), 4.07–4.16 (m, 1H), 6.97–7.01 (m, 2H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.38 (s, 1H), 7.58 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 7.70 (td, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.74 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.80 (bs, 1H), 8.01 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 8.21 (bs, 1H), 11.44 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 558 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 558.1942. Found: 558.1948.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-Methyl-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-((<i>S</i>)-piperidin-3-ylcarbamoyl)pyrrolidin-3-yl)thiazole-2-carboxamide (<b>12a</b>)</h3><div class="NLM_p last">A solution of HATU (46.2 mg, 0.12 mmol) in DMF (0.25 mL) was added to a solution containing (<i>S</i>)-<i>tert</i>-butyl 3-((3<i>S</i>,4<i>R</i>)-4-amino-1-(phenylsulfonyl)pyrrolidine-3-carboxamido)piperidine-1-carboxylate <b>50</b> (39 mg, 0.11 mmol), <i>N</i>-methyl-morpholine (0.024 mL, 0.22 mmol), and 4-methylthiazole-2-carboxylic acid (16 mg, 0.11 mmol) in DMF (0.75 mL). The mixture was then stirred at rt for 1 h, diluted with water (5 mL) and NaHCO<sub>3</sub> solution (1 mL), extracted into EtOAc (2 × 3 mL), and evaporated. The residue was dissolved in formic acid (0.42 mL, 11.05 mmol) and then heated at 60 °C for 0.5 h. 2 M HCl (0.1 mL) was added, the solution was evaporated to dryness by Genevac, and the crude material was purified by prep HPLC to give compound <b>12a</b> (12.4 mg, 24%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.21–1.32 (m, 1H), 1.32–1.43 (m, 1H), 1.55–1.65 (m, 1H), 1.65–1.72 (m, 1H), 2.22–2.28 (m, 1H), 2.43 (s, 3H), 2.44–2.49 (m, 1H), 2.76–2.82 (m, 1H), 2.82–2.87 (m, 1H), 3.04 (q, <i>J</i> = 7.9 Hz, 1H), 3.15 (dd, <i>J</i> = 9.7, 7.7 Hz, 1H), 3.21 (dd, <i>J</i> = 9.7, 7.7 Hz, 1H), 3.45–3.57 (m, 3H), 4.44 (p, <i>J</i> = 7.7 Hz, 1H), 7.60 (d, 1H), 7.65 (t, <i>J</i> = 7.7 Hz, 2H), 7.70–7.74 (m, 1H), 7.80–7.83 (m, 2H), 7.97 (d, <i>J</i> = 7.5 Hz, 1H), 8.30 (s, 1H), 8.92 (d, <i>J</i> = 7.9 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 478 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>S<sub>2</sub> + H<sup>+</sup> [M + H]: 478.1583. Found: 478.1615.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(2-Chlorophenyl)-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-((<i>S</i>)-piperidin-3-ylcarbamoyl)pyrrolidin-3-yl)isoxazole-3-carboxamide Hydrochloride Salt (<b>12j</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.34–1.47 (m, 1H), 1.56–1.68 (m, 1H), 1.70–1.87 (m, 2H), 2.53–2.60 (m, 1H), 2.79 (td, <i>J</i> = 12.2, 3.0 Hz, 1H), 3.02 (q, <i>J</i> = 7.4 Hz, 1H), 3.06–3.12 (m, 1H), 3.14 (dd, <i>J</i> = 12.2, 3.7 Hz, 1H), 3.24 (ddd, <i>J</i> = 13.0, 9.9, 7.2 Hz, 2H), 3.47–3.61 (m, 2H), 3.79–3.92 (m, 1H), 4.50 (p, <i>J</i> = 7.3 Hz, 1H), 7.36 (s, 1H), 7.53–7.62 (m, 2H), 7.64–7.75 (m, 4H), 7.80–7.85 (m, 2H), 7.92–7.97 (m, 1H), 8.33 (d, <i>J</i> = 7.4 Hz, 1H), 8.85 (s, 2H), 9.15 (d, <i>J</i> = 7.4 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 558/560 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>5</sub>S + H<sup>+</sup> [M + H]: 558.1578. Found: 558.1586. Representative chemistry is reported for the synthesis of compound <b>12a</b>. Similar procedure was applied to the synthesis of compounds <b>12b</b>–<b>m</b>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[<i>trans-</i>1-(Benzenesulfonyl)-4-methyl-4-[[(3<i>S</i>)-3-piperidyl]carbamoyl]pyrrolidin-3-yl]-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>13b</b>)</h3><div class="NLM_p">To a solution of the mixture of the regioisomers <b>59a</b> and <b>59b</b> (100 mg, 0.21 mmol) and 5-methyl-1<i>H</i>-indole-2-carboxylic acid (0.046 g, 0.26 mmol) in DMF (0.5 mL) a solution of <i>N</i>-methylmorpholine (0.031 mL, 0.28 mmol) in DMF (0.5 mL) was added, followed by HATU (102 mg, 0.27 mmol). After 30 min, the reaction mixture was quenched by addition of NaHCO<sub>3</sub> aq solution (6 mL) and stirred for 2 h. The mixture was then partitioned between water (8 mL) and EtOAc (8 mL). The organic layer was washed with 1 M HCl (8 mL) and brine (2 mL) and evaporated in vacuo. The residue was dissolved in formic acid (0.82 mL, 21.43 mmol) and heated to 60 °C for 2 h and then cooled to rt. 2 M HCl (0.2 mL) was added and the solution evaporated in vacuo. The residue was purified by prep HPLC to give compound <b>13b</b> (10 mg, 9%). <sup>1</sup>H NMR (500 MHz, MeOD) δ 1.12 (d, <i>J</i> = 4.0 Hz, 3H), 1.45–1.60 (m, 2H), 1.70–1.80 (m, 1H), 1.80–1.92 (m, 1H), 2.40 (s, 3H), 2.41–2.47 (m, 1H), 2.52–2.67 (m, 2H), 2.86–2.93 (m, 1H), 3.03 (ddd, <i>J</i> = 32.5, 12.4, 3.5 Hz, 1H), 3.17 (dd, <i>J</i> = 10.4, 3.4 Hz, 1H), 3.66–3.75 (m, 2H), 3.81 (dd, <i>J</i> = 10.4, 1.2 Hz, 1H), 4.91 (td, <i>J</i> = 8.2, 6.2 Hz, 1H), 7.07 (dd, <i>J</i> = 8.5, 1.4 Hz, 1H), 7.10 (dd, <i>J</i> = 3.1, 0.8 Hz, 1H), 7.3–7.34 (m, 1H), 7.38 (s, 1H), 7.63–7.69 (m, 2H), 7.7–7.75 (m, 1H), 7.87–7.91 (m, 2H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 524 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>33</sub>N<sub>5</sub>O<sub>4</sub>S + H<sup>+</sup> [M + H]: 524.2332. Found: 524.2336.</div><div class="NLM_p last">Compounds <b>14</b> and <b>15</b> were synthesized in an analogous manner to the synthesis of compound <b>12a.</b></div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-[(3<i>R</i>,4<i>S</i>)-1-(Benzenesulfonyl)-4-(3<i>S</i>-piperidylcarbamoyl)pyrrolidin-3-yl]-5-(2-chlorophenyl)-<i>N</i>-methyl-isoxazole-3-carboxamide (<b>16a</b>)</h3><div class="NLM_p last">H<sub>2</sub>SO<sub>4</sub> (0.159 mL, 2.98 mmol) was added to a solution of (3<i>S</i>,4<i>R</i>)-methyl 4-(5-(2-chlorophenyl)-<i>N</i>-methylisoxazole-3-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate <b>53</b> (300 mg, 0.60 mmol) in THF (6 mL) and water (1 mL). The mixture was heated to 70 °C for 16 h and then at 80 °C for 3 h. Further water (1 mL) was added, and heating continued at 80 °C for 24 h. 1,4-Dioxane (3 mL) was added and the mixture heated at reflux for 6 h. The mixture was cooled to rt, diluted with water (30 mL), and extracted with EtOAc (30 mL). Organic extracts were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to give (3<i>S</i>,4<i>R</i>)-4-(5-(2-chlorophenyl)-<i>N</i>-methylisoxazole-3-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylic acid <b>54</b> (351 mg). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 490 (M + H)<sup>+</sup>. HATU (60.8 mg, 0.16 mmol) was added to a stirred solution of the carboxylic acid <b>54</b> (87 mg, 0.13 mmol), <i>tert</i>-butyl (3S)-3-aminopiperidine-1-carboxylate (29.3 mg, 0.15 mmol), and <i>N</i>-methylmorpholine (0.018 mL, 0.17 mmol) in DMF (2 mL). After 1 h the reaction was complete. The mixture was diluted with NaHCO<sub>3</sub> solution (10 mL) and stirred for 1 h, then diluted with water (10 mL) and extracted with EtOAc (20 mL). Organics were washed with 1 M HCl (20 mL) and then brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated in vacuo. The residue was dissolved in formic acid (0.511 mL, 13.32 mmol) and the solution heated to 60 °C for 30 min. The solution was cooled to rt, 2 M HCl (0.1 mL) added, and the mixture evaporated to dryness in vacuo. The residue was dissolved in DMSO and purified by HPLC to give compound <b>16a</b> (40.9 mg, 53.7%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15–1.41 (m, 2H), 1.55 (ddt, <i>J</i> = 4.33, 8.06, and 20.92 Hz, 1H), 1.34–1.64 (m, 1H), 2.15 (dd, <i>J</i> = 9.31 and 11.55 Hz, 0.6 H), 2.15 (dd, <i>J</i> = 9.31 and 11.55 Hz, 0.4 H), 2.30–2.42 (m, 1H), 2.71 (t, <i>J</i> = 12.96 Hz, 1H), 2.75–2.86 (m, 1H), 2.90 (s, 1.6 H), 2.93 (t, <i>J</i> = 9.64 Hz, 0.6 H), 2.99 (s, 1.4 H), 3.08 (t, <i>J</i> = 9.27 Hz, 0.4 H), 3.15 (q, <i>J</i> = 8.93 Hz, 1H), 3.37–3.49 (m, 2H), 3.47–3.59 (m, 1H), 3.63 (q, <i>J</i> = 8.91, 9.41 Hz, 1H), 4.57 (q, <i>J</i> = 8.09 Hz, 0.6 H), 4.96 (q, <i>J</i> = 8.09 Hz, 0.4 H), 7.13 (s, 0.6 H), 7.21 (s, 0.4 H), 7.53–7.73 (m, 5.6 H), 7.75–7.79 (m, 0.4 H), 7.79–7.83 (m, 1H), 7.83–7.87 (m, 1H), 7.95 (ddd, <i>J</i> = 2.24, 4.28, 623 Hz, 1H), 7.99 (t, <i>J</i> = 6.54 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 572 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>5</sub>S + H<sup>+</sup> [M + H]: 572.1734. Found: 572.1732. Compound <b>16b</b> was synthesized in an analogous manner to the synthesis of compound <b>12a.</b></div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[(3<i>R</i>,4<i>S</i>)-1-(Benzenesulfonyl)-4-[(1-methyl-3<i>S</i>-piperidyl)carbamoyl]pyrrolidin-3-yl]-5-(2-chlorophenyl)-<i>N</i>-methylisoxazole-3-carboxamide (<b>16c</b>)</h3><div class="NLM_p last">Compound <b>16c</b> was obtained in a similar manner to compound <b>16a</b> by using <i>tert</i> butyl (3<i>S</i>)-3-(methylamino)piperidine-1-carboxylate. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) data undisclosed, mixture of 4 rotameric forms. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 586 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>28</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>5</sub>S + H<sup>+</sup> [M + H]: 586.1891. Found: 586.1878.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-[(3<i>R</i>,4<i>S</i>)-1-(Benzenesulfonyl)-4-[[(3<i>S</i>)-1-methyl-3-piperidyl]carbamoyl]pyrrolidin-3-yl]-5-(2-chlorophenyl)isoxazole-3-carboxamide (<b>16d</b>)</h3><div class="NLM_p last">5-(2-Chlorophenyl)-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-((<i>S</i>)-piperidin-3-ylcarbamoyl)pyrrolidin-3-yl)isoxazole-3-carboxamide hydrochloride salt <b>12j</b> (139.5 mg, 0.25 mmol) was dissolved in formic acid (0.95 mL, 24.75 mmol), formaldehyde (0.184 mL, 2.5 mmol) was added, and the mixture was heated at 90 °C for 30 min. To the mixture cooled down to rt, 2 M hydrochloric acid (0.1 mL) was added and the mixture evaporated in vacuo. The residual gum did not crystallize and was submitted to HPLC purification to give compound <b>16d</b> (83 mg, 58%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.07–1.12 (m, 1H), 1.36–1.45 (m, 1H), 1.54–1.62 (m, 2H), 1.62–1.71 (m, 1H), 1.79–1.90 (m, 1H), 2.04 (s, 3H), 2.34–2.42 (m, 1H), 2.44–2.49 (m, 1H), 3.03 (q, <i>J</i> = 7.90 Hz, 1H), 3.18 (ddd, <i>J</i> = 7.52, 9.86, and 19.93 Hz, 2H), 3.51 (dd, <i>J</i> = 7.45 and 9.86 Hz, 1H), 3.54–3.59 (m, 1H), 3.59–3.66 (m, 1H), 4.43 (p, <i>J</i> = 7.42 Hz, 1H), 7.30 (s, 1H), 7.53–7.62 (m, 2H), 7.63–7.76 (m, 4H), 7.80–7.86 (m, 3H), 7.93 (dd, <i>J</i> = 1.82 and 7.67 Hz, 1H), 9.05 (d, <i>J</i> = 7.48 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 572 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>5</sub>S + H<sup>+</sup> [M + H]: 572.1734. Found: 572.1758.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-[(3<i>R</i>,4<i>S</i>)-1-(Benzenesulfonyl)-4-[[(3<i>S</i>)-1-formyl-3-piperidyl]carbamoyl]pyrrolidin-3-yl]-5-(2-chlorophenyl)isoxazole-3-carboxamide (<b>16e</b>)</h3><div class="NLM_p last">5-(2-Chlorophenyl)-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-((<i>S</i>)-piperidin-3-ylcarbamoyl)pyrrolidin-3-yl)isoxazole-3-carboxamide hydrochloride salt <b>12j</b> (139.5 mg, 0.25 mmol) was dissolved in formic acid (0.95 mL, 24.75 mmol), heated at 60 °C for 0.5 h, and evaporated in vacuo. The residual gum was redissolved in HCOOEt (2 mL) and the solution heated at reflux for 1.5 h. To the same solution acetic anhydride (0.1 mL) and NaHCO<sub>3</sub> aq solution (1 mL) were added, and the reaction mixture was heated at 60 °C for 1 h. The mixture was diluted with water (20 mL) and extracted with EtOAc (20 mL × 2). The organic phase was washed with 1 M HCl (10 mL), then 1 M NaOH (10 mL), then brine, dried (MgSO<sub>4</sub>), and evaporated to give compound <b>16e</b> (112 mg, 76%) as a 3:2 mixture of rotamers. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.23–1.52 (m, 2H), 1.55–1.65 (m, 0.6 H), 1.65–1.73 (m, 0.4 H), 1.73–1.81 (m, 1H), 2.54–2.51 (m, 0.4 H), 2.89 (dd, <i>J</i> = 7.66 and 12.95 Hz, 0.6 H), 2.94–3.02 (m, 1H), 3.02–3.12 (m, 1.6 H), 3.20 (ddd, <i>J</i> = 1.78, 5.25, and 10.05 Hz, 2.4 H), 3.40–3.54 (m, 3H), 3.54–3.66 (m, 2H), 4.44 (p, <i>J</i> = 7.12 Hz, 0.6 H), 4.48 (p, <i>J</i> = 712 Hz, 0.4 H), 7.31 (s, 0.4H), 7.32 (s, 0.6 H), 7.57 (dtt, <i>J</i> = 1.58, 7.47, and 20.74 Hz, 2H), 7.64–7.69 (m, 2H), 7.69–7.77 (m, 2H), 7.78–7.87 (m, 2.6 H), 7.91–7.99 (m, 1.4 H), 8.02 (d, <i>J</i> = 7.49 Hz, 0.44 H), 8.08 (d, <i>J</i> = 7.49 Hz, 0.56H), 9.10 (dd, <i>J</i> = 7.38 and 10.52 Hz, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 586/588 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>6</sub>S + H<sup>+</sup> [M + H]: 586.1527. Found: 586.1549.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-[(3<i>R</i>,4<i>S</i>)-4-[[(3<i>S</i>)-1-Acetyl-3-piperidyl]carbamoyl]-1-(benzenesulfonyl)pyrrolidin-3-yl]-5-(2-chlorophenyl)isoxazole-3-carboxamide (<b>16f</b>)</h3><div class="NLM_p last">To a rapidly stirred 2-phase solution of 5-(2-chlorophenyl)-<i>N</i>-((3<i>R</i>,4<i>S</i>)-1-(phenylsulfonyl)-4-((<i>S</i>)-piperidin-3-ylcarbamoyl)pyrrolidin-3-yl)isoxazole-3-carboxamide <b>12j</b> (100 mg, 0.18 mmol) in methyl THF (2 mL) and sodium bicarbonate solution (1.792 mL, 1.79 mmol) was added acetic anhydride (0.034 mL, 0.36 mmol). After 5 min, a precipitate had formed. To the mixture were added TBME (8 mL) and water (8 mL), and stirring continued for 15 min. The precipitated solid was collected by filtration, washed with a small volume of water, and then partially dried by suction and washed with TBME (3 × 1 mL). The solid was dried in vacuo overnight at 40 °C to give compound <b>16f</b> (93 mg, 86%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) (3:2 mixture of rotamers) δ 1.22–1.50 (m, 2H), 1.57–1.79 (m, 2H), 1.82 (s, 1.75 H), 1.94 (s, 1.25 H), 2.42–2.49 (m, 1H), 2.94–3.25 (m, 5H), 3.40–3.64 (m, 5H), 4.42 (p, <i>J</i> = 6.97 Hz, 0.4H), 4.49 (p, <i>J</i> = 6.97 Hz, 0.6H), 7.31 (s, 0.6H), 7.33 (s, 0.4H), 7.57 (dtd, <i>J</i> = 1.59, 7.46, 7.44, and 16.58 Hz, 2H), 7.63–7.78 (m, 4H), 7.78–7.88 (m, 2H), 7.94 (dd, <i>J</i> = 1.87 and 7.62 Hz, 1H), 9.18 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 600/602 (M + H)<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i> calculated for C<sub>28</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>6</sub>S + H<sup>+</sup> [M + H]: 600.1683. Found: 600.1690.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>trans-</i>1-<i>tert</i>-Butyl 3-Ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1,3-dicarboxylate (<b>18</b>)</h3><div class="NLM_p last"><i>trans-</i>1-<i>tert</i>-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate <b>17</b> (500 mg, 1.94 mmol) was dissolved in DMF (10 mL). 5-Methyl-1<i>H</i>-indole-2-carboxylic acid (407 mg, 2.32 mmol), HATU (883 mg, 2.32 mmol), and DIPEA (0.406 mL, 2.32 mmol) were added to the solution, and the mixture was stirred at rt for 16 h. EtOAc was added, and the mixture was washed sequentially with water and brine. The solution was concentrated in vacuo and purified by column chromatography (EtOAc/heptane 25–30%) to afford compound <b>18</b> (400 mg, 50%) as an oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.26 (t, <i>J</i> = 7.1 Hz, 3H), 1.49 (s, 9H), 2.45 (s, 3H), 3.10–3.24 (m, 1H), 3.29–3.46 (m, 1H), 3.65–3.85 (m, 2H), 3.90–4.03 (m, 1H), 4.16–4.26 (m, 2H), 4.75–4.86 (m, 1H), 6.34 (s, 1H), 6.80 (d, <i>J</i> = 1.4 Hz, 1H), 7.15 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 7.33 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (s, 1H), 9.07 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 416 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>trans-</i>Ethyl 4-(5-Methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate (<b>19</b>)</h3><div class="NLM_p last"><i>trans-</i>1-<i>tert</i>-Butyl 3-ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1,3-dicarboxylate <b>18</b> (400 mg, 0.96 mmol) was dissolved in EtOH (10 mL). TMSCl (1 mL, 7.82 mmol) was added to the solution, and the mixture was stirred at rt for 16 h. The solution was then concentrated in vacuo to give the free amine (275 mg). This was dissolved in DCM (10 mL) and pyridine (0.115 mL, 1.43 mmol). After cooling to 0 °C, benzenesulfonyl chloride (126 mg, 0.71 mmol) was added to the mixture and it was stirred at rt for 4 h. DCM was added, and the solution was washed with sat. NaHCO<sub>3</sub> and brine. After concentration, the crude residue was purified by column chromatography (EtOAc/heptane 30%), which afforded compound <b>19</b> as a solid (139 mg, 32%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05 (t, <i>J</i> = 7.1 Hz, 3H), 2.36 (s, 3H), 3.06–3.18 (m, 2H), 3.39 (dd, <i>J</i> = 10.2, 7.2 Hz, 1H), 3.51–3.58 (m, 1H), 3.60–3.66 (m, 1H), 3.92–4.02 (m, 2H), 4.48–4.56 (m, 1H), 6.97 (s, 1H), 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.29 (d, <i>J</i> = 8.5 Hz, 1H), 7.38 (s, 1H), 7.66 (t, <i>J</i> = 7.5 Hz, 2H), 7.73 (t, <i>J</i> = 7.4 Hz, 1H), 7.84 (d, <i>J</i> = 7.1 Hz, 2H), 8.57 (d, <i>J</i> = 7.4 Hz, 1H), 11.44 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 456 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>trans-</i>4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)pyrrolidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>20</b>)</h3><div class="NLM_p last"><i>trans-</i>Ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate <b>19</b> (139 mg, 0.31 mmol) was dissolved in THF (5 mL) and MeOH (5 mL). 2 M LiOH (5 mL, 10.00 mmol) was added, and the mixture was stirred at rt for 3 h. After acidification with HCl to pH 3, the product was extracted into EtOAc, washed with brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave a crude product. This was dissolved in DCM (3 mL) and DMF (3 mL), and <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2,-diamine (29.7 mg, 0.28 mmol) was added, followed by HATU (128 mg, 0.34 mmol) and DIPEA (0.059 mL, 0.34 mmol). The mixture was then stirred at rt for 20 h. EtOAc was added and the mixture washed with sat. NaHCO<sub>3</sub> and brine. After drying over Na<sub>2</sub>SO<sub>4</sub>, the solution was concentrated in vacuo and triturated with EtOAc/Et<sub>2</sub>O to give the <i>trans</i> compound <b>20</b> (88 mg, 57%) as a solid, plus traces of <i>cis</i> isomer <b>5</b>. <b>20</b>: <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.07 (s, 6H), 2.16–2.26 (m, 2H), 2.37 (s, 3H), 3.01–3.14 (m, 4H), 3.21 (dd, <i>J</i> = 9.8, 7.7 Hz, 1H), 3.50 (dd, <i>J</i> = 9.8, 7.4 Hz, 1H), 3.55–3.62 (m, 1H), 4.45 (p, <i>J</i> = 7.2 Hz, 1H), 7.02 (dd, <i>J</i> = 8.5, 1.4 Hz, 2H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.38 (s, 1H), 7.67 (t, <i>J</i> = 7.6 Hz, 2H), 7.72–7.76 (m, 1H), 7.82–7.86 (m, 2H), 7.91 (t, <i>J</i> = 5.3 Hz, 1H), 8.50 (d, <i>J</i> = 7.3 Hz, 1H), 11.43 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 498 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>trans-</i>Methyl 4-(<i>tert</i>-Butoxycarbonylamino)-1-(phenylsulfonyl)piperidine-3-carboxylate (<b>22</b>)</h3><div class="NLM_p last"><i>trans-</i>Methyl 4-(<i>tert</i>-butoxycarbonylamino)piperidine-3-carboxylate <b>21</b> (1.0 g, 1 equiv) and Et<sub>3</sub>N (3.0 mL, 5.6 equiv) were stirred in dry DCM (25 mL) at 0–4 °C (ice-bath) under inert gas while benzenesulfonyl chloride (0.8 mL, 1.107 g, 1.62 equiv) was added slowly over 5 min. Stirring was continued for 60 min in the ice-bath and then 3 h at rt. Solvents were evaporated, and the residue was taken up in a dioxane–water–Et<sub>3</sub>N mixture (15/5/3 mL) and stirred overnight. The mixture was diluted with EtOAc (200 mL) and washed subsequently with saturated NaHCO<sub>3</sub> (2 × 100 mL) and brine (50 mL). The organics were separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to give compound <b>22</b> as a light brown foam (1.62 g, 100%). <sup>1</sup>H NMR (500 MHz, CD<sub>2</sub>Cl<sub>2</sub>) δ 1.38 (s, 9H), 1.47–1.60 (m, 2H), 1.99–2.07 (m, 1H), 2.44 (td, <i>J</i> = 12.1, 8.6 Hz, 1H), 2.49–2.62 (m, 2H), 3.53–3.61 (m, 1H), 3.65 (s, 3H), 3.72 (d, <i>J</i> = 10.8 Hz, 1H), 3.83 (d, <i>J</i> = 11.3 Hz, 1H), 7.56–7.59 (m, 2H), 7.63–7.67 (m, 1H), 7.74–7.78 (m, 2H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 399 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>trans-</i>Methyl 4-(5-Methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-3-carboxylate (<b>23</b>)</h3><div class="NLM_p last">(<i>trans</i>)-Methyl 4-(<i>tert</i>-butoxycarbonylamino)-1-(phenylsulfonyl)piperidine-3-carboxylate <b>22</b> (1.61 g, 3.64 mmol) was taken up in DCM (15 mL), TFA (10 mL) was added, and the mixture was stirred at rt for 10 min and then evaporated, coevaporated with aqueous 2 M HCl (4 × 10 mL) and toluene (5 × 10 mL). The residual compound (1.306 g, 90% pure) was used in the subsequent step without further purification. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.63–1.72 (m, 1H), 2.05–2.12 (m, 1H), 2.52–2.60 (m, 2H), 2.86 (td, <i>J</i> = 10.2, 4.2 Hz, 1H), 3.57–3.64 (m, 1H), 3.68 (s, 3H), 3.78 (ddd, <i>J</i> = 12.3, 4.2, 1.7 Hz, 1H), 7.67 (t, <i>J</i> = 7.4 Hz, 2H), 7.72–7.78 (m, 3H), 8.33 (s, 2H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 299 (M + H)<sup>+</sup>. The obtained intermediate as the hydrochloride salt (1.30 g, 3.49 mmol, 1.0 equiv, 90% pure) was dissolved in dry DMF (25 mL) together with 5-methyl-1<i>H</i>-indole-2-carboxylic acid (0.673 g, 3.84 mmol, 1.1 equiv), HATU (1.727 g, 4.54 mmol, 1.3 equiv), and DIPEA (4.0 mL, 2.97 g, 6.6 equiv). The obtained mixture was stirred overnight at rt to give a crude that was taken up in EtOAc (350 mL) and washed with saturated NaHCO<sub>3</sub> (300 mL) and brine (4 × 200 mL). The organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to a brown syrup. To this DCM (20 mL) was added and a precipitate came out which was filtered, washed with some DCM, and dried in a stream of air to give the product <b>23</b> (0.7 g) as a white solid. The DCM solutions were concentrated to a smaller volume and applied on a silica gel column for purification (DCM:MeOH gradient from 99:1 to 10:1), which afforded another 1.0 g of compound, in total 1.7 g (100%) of <b>23</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.70 (qd, <i>J</i> = 12.4, 4.1 Hz, 1H), 1.87–1.94 (m, 1H), 2.35 (s, 3H), 2.52–2.59 (m, 2H), 2.76 (td, <i>J</i> = 10.4, 3.9 Hz, 1H), 3.50 (s, 3H), 3.68 (d, <i>J</i> = 11.6 Hz, 1H), 3.83 (d, <i>J</i> =10.8 Hz, 1H), 4.00–4.10 (m, 1H), 6.97 (d, <i>J</i> = 1.5 Hz, 1H), 6.99 (dd, <i>J</i> = 8.5, 1.3 Hz, 1H), 7.28 (d, <i>J</i> = 8.4 Hz, 1H), 7.37 (s, 1H), 7.68 (t, <i>J</i> = 7.4 Hz, 2H), 7.74–7.80 (m, 3H), 8.35 (d, <i>J</i> = 8.6 Hz, 1H), 11.41 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 456 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(<i>trans-</i>3-(2-(Dimethylamino)ethylcarbamoyl)-1-(phenylsulfonyl)piperidin-4-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>24</b>)</h3><div class="NLM_p last"><i>trans-</i>Methyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-3-carboxylate <b>23</b> (1.23 g, 2.70 mmol) was stirred in THF (30 mL), and a solution of LiOH (0.4 g, 16.70 mmol) in water (30 mL) was added. The mixture was stirred under nitrogen for 1 h. The mixture was poured into 1 N HCl, extracted into EtOAc, dried over MgSO<sub>4</sub>, and evaporated in vacuo to give the corresponding carboxylic acid (1.20 g) as a white solid. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 442 (M + H)<sup>+</sup>. The carboxylic acid (1.20 g, 2.70 mmol), <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine (1.0 mL, 0.807 g, 9.15 mmol), HATU (1.19 g, 3.12 mmol), and DIPEA (1.8 mL, 10 mmol) were taken in dry DMF (15 mL) and stirred overnight at rt. The mixture was taken in EtOAc (400 mL) and washed in succession with sat. aq NaHCO<sub>3</sub> (400 mL) and brine (4 × 250 mL) respectively. The organics were collected, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated to a brown foam. The residue (∼1.5 g) was subjected to HPLC purification to give compound <b>24</b> (410 mg, 30%) as a light brown solid. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 512 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (3<i>S</i>,4<i>S</i>)-1-<i>tert</i>-Butyl 3-Ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-1,3-dicarboxylate (<b>26</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-1-<i>tert</i>-Butyl 3-ethyl 4-aminopiperidine-1,3-dicarboxylate <b>25</b> (0.56 g, 2.06 mmol), prepared according to the procedure reported in literature,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and Et<sub>3</sub>N (0.573 mL, 4.11 mmol) were added in MeCN (20 mL) to give a colorless solution. To the stirred solution, 5-methyl-1<i>H</i>-indole-2-carboxylic acid (0.36 g, 2.06 mmol) and HBTU (0.79 g, 2.10 mmol) were added. The reaction was stirred for 30 min at rt. The solvents were removed in vacuo and the residue was purified on silica gel column, using heptane:EtOAc, to give compound <b>26</b> (0.8 g, 90%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.16 (t, <i>J</i> = 6.7 Hz, 3H), 1.26–1.34 (m, 2H), 1.48 (s, 9H), 2.19 (dd, <i>J</i> = 12.2, 3.3 Hz, 1H), 2.45 (s, 3H), 2.48–2.59 (m, 1H), 2.84–2.98 (m, 1H), 2.99–3.16 (m, 1H), 4.12 (q, <i>J</i> = 7.1 Hz, 2H), 4.16–4.27 (m, 1H), 4.29–4.40 (m, 1H), 6.22 (bs, 1H), 6.75 (d, <i>J</i> = 2.0 Hz, 1H), 7.13 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.42 (s, 1H), 9.07 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 430 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (3<i>S</i>,4<i>S</i>)-Ethyl-4-[(5-methyl-1<i>H</i>-indole-2-carbonyl)amino]piperidine-3-carboxylate (<b>27</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-1-<i>tert</i>-Butyl 3-ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-1,3-dicarboxylate <b>26</b> (0.75 g, 1.75 mmol) was dissolved in DCM (15 mL) to give a colorless solution. To the solution TFA (5 mL, 64.90 mmol) was added, and the mixture was stirred for 1 h and then concentrated, giving an oil. The oil was taken up in EtOH (99%) and was applied onto a SCX ion exchange cartridge (10 g), prewashed with EtOH. The bead was washed with EtOH (50 mL), water (50 mL), and again EtOH (50 mL), before the product was released with 2 M ammonia in EtOH (75 mL). The ammonia solutions were concentrated in vacuo, giving <b>27</b> (0.58 g, quantitative yield) as an off-white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.16 (t, <i>J</i> =7.0 Hz, 3H), 1.43–1.54 (m, 1H), 2.17–2.23 (m, 1H), 2.45 (s, 3H), 2.55 (td, <i>J</i> = 10.8, 4.1 Hz, 1H), 2.80 (td, <i>J</i> =12.5, 2.6 Hz, 1H), 2.94 (dd, <i>J</i> =12.1, 11.0 Hz, 1H), 3.14 (d, <i>J</i> =12.8 Hz, 1H), 3.32 (dd, <i>J</i> =12.8, 3.9 Hz, 1H), 4.11 (q, <i>J</i> = 7.0 Hz, 2H), 4.28–4.38 (m, 1H), 6.23 (d, <i>J</i> = 8.3 Hz, 1H), 6.76 (s, 1H), 7.12 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.32 (d, <i>J</i> = 8.6 Hz, 1H), 7.42 (s, 1H), 9.13 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 330 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (3<i>S</i>,4<i>S</i>)-Ethyl-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-3-carboxylate (<b>28</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-Ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylate <b>27</b> (0.59 g, 1.79 mmol) and Et<sub>3</sub>N (0.300 mL, 2.15 mmol) were dissolved in DCM (20 mL) to give a colorless solution. To the stirred mixture benzenesulfonyl chloride (0.323 g, 1.83 mmol) dissolved in a small volume of DCM was added. The reaction was stirred for 30 min and the crude reaction mixture was concentrated and purified on a silica gel column, with heptane:EtOAc, to give compound <b>28</b> (0.75 g, 89%) as a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.13 (t, <i>J</i> = 7.0 Hz, 3H), 1.68–1.77 (m, 1H), 2.22–2.30 (m, 1H), 2.44 (s, 3H), 2.50 (td, <i>J</i> = 12.3, 2.8 Hz, 1H), 2.65 (t, <i>J</i> = 12.5 Hz, 1H), 2.75 (td, <i>J</i> = 11.2, 3.8 Hz, 1H), 2.93 (s, 1H), 3.86–3.92 (m, 1H), 4.02–4.07 (m, 1H), 4.10 (q, <i>J</i> = 7.0 Hz, 2H), 6.21 (d, <i>J</i> = 8.3 Hz, 1H), 6.77 (d, <i>J</i> = 2.0 Hz, 1H), 7.12 (dd, <i>J</i> = 8.5, 1.5 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.42 (s, 1H), 7.55–7.62 (m, 2H), 7.63–7.70 (m, 1H), 7.77–7.84 (m, 2H), 8.97 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 470 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (3<i>S</i>,4<i>S</i>)-Ethyl-1-((2-chlorophenyl)sulfonyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylate (<b>33</b>, R = 2-Cl-phenyl)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-Ethyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylate <b>27</b> (0.18 g, 0.57 mmol) and TEA (0.191 mL, 1.37 mmol) were dissolved in DCM (5 mL) to give a colorless solution. To the stirred solution a solution of 2-chlorobenzene-1-sulfonyl chloride (0.145 g, 0.68 mmol) in DCM (2 mL) was added, and the obtained solution was stirred for 1 h. The crude reaction mixture was added onto a small silica gel column and product was eluted with heptane:EtOAc 3:1 to 2:1, which gave compound <b>33</b> (0.275 g, 98%) as a colorless solid. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 504 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (3<i>S</i>,4<i>S</i>)-1-((2-Chlorophenyl)sulfonyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>S</i>)-Ethyl 1-((2-chlorophenyl)sulfonyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)piperidine-3-carboxylate <b>33</b> (0.28 g, 0.57 mmol) in THF (10 mL) and water (3 mL) gave a colorless solution. 1 M NaOH (2 mL, 2.00 mmol) was added, and the reaction mixture was stirred for 2 h at rt. The reaction mixture was acidified by the addition of 1 M HCl (2.5 mL), and the THF was removed in vacuo. Water (10 mL) was added, and the product was isolated by extraction into EtOAc (2 × 25 mL). The extracts were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave compound <b>34</b> (0.27 g, quantitative yield) as a colorless solid glass. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.54–1.65 (m, 1H), 1.91 (d, <i>J</i> = 13.7, 3.8 Hz, 1H), 2.35 (s, 3H), 2.70 (td, <i>J</i> = 10.8, 4.1 Hz, 1H), 3.00–3.09 (m, 2H), 3.72 (d, <i>J</i> = 13.6 Hz, 1H), 3.90 (ddd, <i>J</i> = 13.9, 3.9, 1.7 Hz, 1H), 4.18–4.29 (m, 1H), 6.98–7.01 (m, 2H), 7.29 (d, <i>J</i> = 8.4, 1H), 7.37 (s, 1H), 7.55–7.61 (m, 1H), 7.68–7.76 (m, 2H), 8.03 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 8.38 (d, <i>J</i> = 8.7 Hz, 1H), 11.40 (s, 1H), 12.55 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 476 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Ethyl 3-Oxo-1-(phenylsulfonyl)piperidine-4-carboxylate (<b>35</b>)</h3><div class="NLM_p last">Ethyl 3-oxopiperidine-4-carboxylate hydrochloride (2.5 g, 12.04 mmol) and benzenesulfonyl chloride (2.127 g, 12.04 mmol) in DCM (40 mL) were slurried to give a light brownish suspension. Et<sub>3</sub>N (4.20 mL, 30.11 mmol) was added to the stirred mixture, and the reaction was allowed to stir overnight. The crude mixture was diluted with DCM to 100 mL, washed with 1 M HCl (40 mL) and brine (30 mL), and finally dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave an amber syrup, which was purified on silica, heptane:EtOAc 7:1 to 2:1 gradient, giving compound <b>35</b> (3.0 g, 80%) as a clear oil, which crystallized slowly to give a colorless solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.29 (t, <i>J</i> = 7.1 Hz, 3H), 2.36–2.44 (m, 2H), 3.21 (t, <i>J</i> = 5.8 Hz, 2H), 3.72 (s, 2H), 4.21 (q, <i>J</i> = 7.1 Hz, 2H), 7.53–7.60 (m, 2H), 7.60–7.66 (m, 1H), 7.78–7.84 (m, 2H), 12.02 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 312 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Ethyl 5-Amino-1-(phenylsulfonyl)-1,2,3,6-tetrahydropyridine-4-carboxylate (<b>36</b>)</h3><div class="NLM_p last">Ethyl 3-oxo-1-(phenylsulfonyl)piperidine-4-carboxylate <b>35</b> (2.88 g, 9.25 mmol) and ammonium acetate (2.139 g, 27.75 mmol) were slurried in EtOH (50 mL) as a white suspension. The flask was sealed with a stopper, and the reaction mixture was stirred at 50 °C for 90 min. The reaction mixture was concentrated in vacuo in order to remove most of the EtOH, taken up in EtOAc (100 mL), washed with a saturated Na<sub>2</sub>CO<sub>3</sub> solution (100 mL), brine (30 mL), and then dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave compound <b>36</b> (2.8 g, 99%) as an oil, which solidified to a white solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.26 (t, <i>J</i> = 7.1 Hz, 3H), 2.40 (t, <i>J</i> = 5.9 Hz, 2H), 3.19 (t, <i>J</i> = 5.9 Hz, 2H), 3.67 (s, 2H), 4.13 (q, <i>J</i> = 7.1 Hz, 2H), 5.90 (bs, 2H), 7.52–7.59 (m, 2H), 7.59–7.66 (m, 1H), 7.79–7.83 (m, 2H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 311 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Ethyl 3-Amino-1-(phenylsulfonyl)piperidine-4-carboxylate (<b>37</b>, Mixture of <i>Cis</i>/<i>Trans</i> Isomers)</h3><div class="NLM_p last">Ethyl 5-amino-1-(phenylsulfonyl)-1,2,3,6-tetrahydropyridine-4-carboxylate <b>36</b> (0.5 g, 1.61 mmol) was dissolved in MeCN (10 mL) and acetic acid (5 mL) to give a colorless solution. NaBH(OAc)<sub>3</sub> (1.024 g, 4.83 mmol) was added in one portion, and the reaction was left to stir for 60 min. The reaction mixture was partitioned between 1 M NaOH (100 mL) and EtOAc (100 mL). The organic phase was washed with water (50 mL), brine (50 mL), and finally dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave a crude oil which was taken up in MeOH (5 mL), acidified with 1 M HCl, and applied onto a SCX ion exchanger, prewashed with MeOH. The SCX column was washed with MeOH, water and MeOH. Finally, the product was released from the column with 2 M NH<sub>3</sub> in MeOH (25 mL). The ammonia solutions were concentrated in vacuo, giving compound <b>37</b> (0.32 g, 64%) as a clear viscous oil. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 313 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Ethyl 3-(5-Methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-4-carboxylate (<b>38</b>, Mixtures of <i>Cis</i>/<i>Trans</i> Isomers)</h3><div class="NLM_p last">Ethyl 3-amino-1-(phenylsulfonyl)piperidine-4-carboxylate <b>37</b> (0.32 g, 1.02 mmol) was dissolved in DCM (15 mL) to give a colorless solution. 5-Methyl-1<i>H</i>-indole-2-carboxylic acid (0.179 g, 1.02 mmol), HBTU (0.427 g, 1.13 mmol), and finally Et<sub>3</sub>N (0.357 mL, 2.56 mmol) were added to the stirred mixture. The reaction was stirred for 60 min, and the crude reaction mixture was purified on silica, giving 420 mg of an off white solid. The solid was slurried in heptane:EtOAc 2:1, and the suspension was stirred for 20 min before the solid was isolated by filtration and washed on the filter with Et<sub>2</sub>O, giving compound <b>38</b> (0.36 g, 74%) as a fine, white solid. The white solid contained a 4:1 mixture of the <i>cis</i>:<i>trans</i> according to LC–MS and <sup>1</sup>H NMR. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 470 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(4-((2-(Dimethylamino)ethyl)carbamoyl)-1-(phenylsulfonyl)piperidin-3-yl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>39</b>, Mixtures of Isomers)</h3><div class="NLM_p last">Ethyl 3-(5-methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)piperidine-4-carboxylate <b>38</b> (0.33 g, 0.70 mmol) was dissolved in THF (15 mL) to give a colorless solution. To the stirred solution, 1 M NaOH (3.51 mL, 3.51 mmol) and water (5 mL) were added. The mixture was stirred for 2 h at rt and the reaction was then acidified with 1 M HCl (4 mL), giving precipitation of product, which was extracted into EtOAc (2 × 30 mL). The organic phases were then washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. Filtration and evaporation gave 0.31 g of the corresponding acid, as a mixture of <i>cis</i>:<i>trans</i> isomers. The acid (0.32 g, 0.72 mmol) and HBTU (0.330 g, 0.87 mmol) were added in MeCN (10 mL), and to this stirred solution <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine (0.077 g, 0.87 mmol) and Et<sub>3</sub>N (0.303 mL, 2.17 mmol) were added. The reaction mixture was stirred for 1 h and then concentrated in vacuo to give the crude product <b>39</b>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (4<i>R</i>)-1-<i>tert</i>-Butyl 3-Methyl 4-(((S)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate (<b>42</b>)</h3><div class="NLM_p last">(<i>S</i>)-1-<i>tert</i>-Butyl 3-methyl 4-((1-phenylethyl)amino)-1<i>H</i>-pyrrole-1,3(2<i>H</i>,5<i>H</i>)-dicarboxylate <b>41</b> (12.99 g, 37.50 mmol) in MeCN (90 mL) was treated with acetic acid (19.32 mL, 337.48 mmol). The reaction mixture was cooled to −9 °C, and NaBH<sub>4</sub> (4.26 g, 112.49 mmol) was added in small portions over 40 min. The reaction mixture was allowed to warm to 10 °C. Further NaBH<sub>4</sub> (2.128 g, 56.25 mmol) was added in two portions and the reaction was stirred between 0 and 10 °C for 20 h. To this, EtOAc (150 mL), water (100 mL), and 2 M NaOH (100 mL) were then added at 0 °C. The layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic layers were washed with brine and dried over Mg<sub>2</sub>SO<sub>4</sub>. The volatiles were evaporated off and coevaporated several times with toluene to give compound <b>42</b> (12.99 g, 99%). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 349 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-Methyl-4-(((<i>S</i>)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate, Hydrochloride Salt (<b>43</b>)</h3><div class="NLM_p last">(4<i>R</i>)-1-<i>tert</i>-Butyl 3-methyl 4-(((<i>S</i>)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate <b>42</b> (12.3 g, 35.30 mmol) in MeOH (100 mL) was treated with DBU (2.64 mL, 17.65 mmol) and heated at 50 °C for 4 h. The mixture was allowed to cool to rt, and MeOH was removed under reduced pressure. EtOAc and 4% NaHCO<sub>3</sub> were added. The layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic layers were washed with brine, dried over Mg<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The residue was dissolved in EtOAc (140 mL) and cooled in an ice/water bath. 4 M HCl in dioxane (8.21 mL, 32.83 mmol) was then added dropwise over 5 min. The reaction mixture was allowed to stir at 0–3 °C for 1 h. The resulting solid was filtered off and recrystallized from MeCN to afford compound <b>43</b> as hydrochloride salt (4.60 g). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.37 (s, 9H), 1.64 (d, <i>J</i> = 6.6 Hz, 3H), 3.36–3.52 (m, 3H), 3.62 (s, 3H), 3.67–3.81 (m, 3H), 4.46–4.58 (m, 1H), 7.37–7.50 (m, 3H), 7.63 (d, <i>J</i> = 7.2 Hz, 2H), 9.96–10.28 (m, 2H).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-Methyl-4-aminopyrrolidine-1,3-dicarboxylate (<b>44</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-methyl 4-(((<i>S</i>)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate, hydrochloride salt <b>43</b> (2.1 g, 5.45 mmol) was dissolved in DCM, and 1 M NaOH solution was added until the solution reached pH 10. The aqueous phase was back-extracted with DCM, and the combined organic phases were washed with brine and dried through a phase separator affording the free amine. This amine was dissolved in EtOH (20 mL), and 10% Pd/C (0.3 g, 2.82 mmol) was added. The compound was hydrogenated at 4 bar and rt for 20 h. The Pd catalyst was removed by filtration through Celite, the volatiles were removed in vacuo, and the residue was coevaporated 3 times with toluene to afford compound <b>44</b> (1.29 g, 84%) as a light brownish oil. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.39 (s, 9H), 2.11 (s, 2H), 2.73–2.84 (m, 1H), 2.91 (q, <i>J</i> = 9.1 Hz, 1H), 3.29–3.38 (m, 1H), 3.41–3.52 (m, 2H), 3.52–3.59 (m, 1H), 3.63 (s, 3H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 245 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-Methyl-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1,3-dicarboxylate (<b>45</b>)</h3><div class="NLM_p last">A mixture of 5-methyl-1<i>H</i>-indole-2-carboxylic acid (2.04 g, 11.64 mmol), (3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-butyl 3-methyl-4-aminopyrrolidine-1,3-dicarboxylate <b>44</b> (2.8 g, 11.46 mmol) and <i>N</i>-methylmorpholine (3.78 mL, 34.39 mmol) in DMF (25 mL) was treated with HATU (4.79 g, 12.61 mmol). The reaction mixture was stirred at rt overnight under nitrogen. The reaction mixture was then partitioned between EtOAc and ∼4% aqueous NaHCO<sub>3</sub>. The layers were separated, and the aqueous phase was back-extracted with EtOAc. The combined organic layers were washed with aqueous NaHCO<sub>3</sub> and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness. The residue was purified by column chromatography (30–40% EtOAc/heptane) to afford compound <b>45</b> (4.07 g, 88%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.55 (s, 9H), 2.50 (s, 3H), 3.28–3.43 (m, 2H), 3.57–3.67 (m, 1H), 3.76 (s, 3H), 3.78–3.87 (m, 2H), 4.75–4.87 (m, 1H), 7.15 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.20 (d, <i>J</i> = 1.4 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (s, 1H), 8.75 (d, <i>J</i> = 7.4 Hz, 1H), 11.59 (s, 1H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 402 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (3<i>S</i>,4<i>R</i>)-<i>tert</i>-Butyl 3-((2-(Dimethylamino)ethyl)carbamoyl)-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1-carboxylate (<b>46</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-methyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1,3-dicarboxylate <b>45</b> (1.25 g, 3.00 mmol) was dissolved in THF (10 mL), and a solution of LiOH (288 mg, 12 mmol) in water (10 mL) was added at 0 °C. The mixture was allowed to warm to rt and was stirred overnight. EtOAc was added, and the mixture was washed with 20% aqueous NH<sub>4</sub>Cl and brine. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford the corresponding carboxylic acid (800 mg). This was dissolved in DMF (5 mL) and DCM (5 mL), and <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine (0.341 g, 3.87 mmol), Et<sub>3</sub>N (0.540 mL, 3.87 mmol), and HATU (1.472 g, 3.87 mmol) were added to the mixture at 0 °C. The mixture was allowed to warm to rt and stirred overnight. EtOAc was added and the mixture washed with 20% aqueous NaHCO<sub>3</sub> and brine. The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford compound <b>46</b> (1.00 g, 73%). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 458 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (3<i>S</i>,4<i>R</i>)-Methyl 4-(5-Methyl-1<i>H</i>-indole-2-carboxamido)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate (<b>47</b>)</h3><div class="NLM_p last">(3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-Butyl 3-methyl-4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-1,3-dicarboxylate <b>45</b> (500 mg, 1.25 mmol) was dissolved in MeOH (10 mL). TMSCl (0.159 mL, 1.25 mmol) was added, and the mixture was stirred at rt overnight. The solution was concentrated in vacuo, which afforded the HCl salt of (3<i>S</i>,4<i>R</i>)-methyl 4-(5-methyl-1<i>H</i>-indole-2-carboxamido)pyrrolidine-3-carboxylate (400 mg). This was dissolved in DCM (10 mL), pyridine (1.342 mL, 16.59 mmol) was added to the mixture, and it was cooled to 0 °C. Benzenesulfonyl chloride (586 mg, 3.32 mmol) was then added and mixture allowed to warm to rt and stirred overnight. EtOAc was added, and the solution was washed sequentially with 1 M HCl, sat. NaHCO<sub>3</sub>, and brine. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub> and purified by column chromatography (EtOAc/pentane, 20%), which afforded the desired compound <b>47</b> (200 mg, 36%). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 442 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (3<i>S</i>,4<i>R</i>)-Methyl 4-(((<i>S</i>)-1-Phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate (<b>48</b>)</h3><div class="NLM_p last">TFA (2 mL, 25.96 mmol) was added to a solution of (3<i>S</i>,4<i>R</i>)-1-<i>tert</i>-butyl 3-methyl-4-(((<i>S</i>)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate, HCl <b>43</b> (2.0 g, 5.20 mmol) in DCM (2 mL), and the mixture was stirred at rt for 4 h. The mixture was evaporated in vacuo to dryness, and the residue was suspended in NaHCO<sub>3</sub> solution (25 mL). A solution of benzenesulfonyl chloride (0.804 mL, 6.24 mmol) in toluene (20 mL) was added and the mixture stirred rapidly at rt for 16 h. The phases were separated, and the aqueous layer was extracted with EtOAc (20 mL). The combined organic extracts were dried (MgSO<sub>4</sub>) and evaporated in vacuo to give the desired compound <b>48</b> (2.32 g, 87%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.13 (d, <i>J</i> = 6.6 Hz, 3H), 2.75 (dd, <i>J</i> = 9.7, 6.0 Hz, 1H), 2.89 (dt, <i>J</i> = 8.2, 5.8 Hz, 1H), 3.01–3.08 (m, 1H), 3.10 (dd, <i>J</i> = 9.7, 6.7 Hz, 1H), 3.26 (dd, <i>J</i> = 10.2, 5.9 Hz, 1H), 3.41 (dd, <i>J</i> = 10.1, 8.4 Hz, 1H), 3.49 (s, 3H), 3.52–3.56 (m, 1H), 3.63–3.70 (m, 1H), 7.20–7.25 (m, 3H), 7.26–7.33 (m, 2H), 7.62 (t, <i>J</i> = 7.7 Hz, 2H), 7.68–7.74 (m, 3H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 389 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>)-<i>tert</i>-Butyl 3-((3<i>S</i>,4<i>R</i>)-4-(((<i>S</i>)-1-Phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxamido)piperidine-1-carboxylate (<b>49</b>)</h3><div class="NLM_p last">A solution of LiOH (0.284 g, 11.84 mmol) in water (2.5 mL) was added to a stirred solution of (3<i>S</i>,4<i>R</i>)-methyl 4-(((<i>S</i>)-1-phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate <b>48</b> (2.3 g, 5.92 mmol) in THF (20 mL) and MeOH (5 mL). The resulting homogeneous solution was maintained at 20 °C for 1 h. It was then diluted with water (40 mL) and acidified to pH 5–6 by dropwise addition of dilute HCl. The resulting solid was collected by filtration, washed with water (3 × 2 mL) and then EtOAc (3 × 2 mL) and dried in vacuo to give the pure acid intermediate (3<i>S</i>,4<i>R</i>)-4-(((<i>S</i>)-1-phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxylic acid (0.95 g). This was dissolved in DMF (8 mL), and (<i>S</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate (1.186 g, 5.92 mmol) was added, followed sequentially by <i>N</i>-methylmorpholine (1.30 mL, 11.84 mmol) and HATU (2.251 g, 5.92 mmol). The reaction mixture was stirred at rt for 15 min, diluted with NaHCO<sub>3</sub> solution (40 mL), and extracted with EtOAc (2 × 40 mL). The combined organic extracts were dried (MgSO<sub>4</sub>) and evaporated in vacuo. The residue was subjected to column chromatography (20–100% EtOAc/heptane) to give compound <b>49</b> (1.02 g, 31%). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 1.30 (d, <i>J</i> = 6.5 Hz, 3H), 1.43 (s, 9H), 1.44–1.56 (m, 2H), 1.68–1.75 (m, 1H), 1.83–1.90 (m, 1H), 2.62–2.74 (m, 2H), 2.92–2.99 (m, 1H), 3.01–3.11 (m, 3H), 3.13–3.21 (m, 1H), 3.48–3.54 (m, 1H), 3.61–3.74 (m, 3H), 3.80 (d, <i>J</i> = 11.8 Hz, 1H), 7.22–7.29 (m, 3H), 7.29–7.35 (m, 2H), 7.54–7.60 (m, 2H), 7.64–7.73 (m, 3H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 557 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>S</i>)-<i>tert</i>-Butyl 3-((3<i>S</i>,4<i>R</i>)-4-Amino-1-(phenylsulfonyl)pyrrolidine-3-carboxamido)piperidine-1-carboxylate (<b>50</b>)</h3><div class="NLM_p last">Pd(OH)<sub>2</sub>/C (150 mg, 1.07 mmol) was added to a solution of (<i>S</i>)-<i>tert</i>-butyl 3-((3<i>S</i>,4<i>R</i>)-4-(((<i>S</i>)-1-phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxamido)piperidine-1-carboxylate <b>49</b> (1 g, 1.80 mmol) in EtOH (20 mL) under nitrogen. The suspension was stirred under 4 bar hydrogen for 6 days. The catalyst was then removed by filtration through Celite and the filtrate was evaporated in vacuo to give the crude compound <b>50</b> (0.86 g). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 353 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Methyl (3<i>S</i>,4<i>R</i>)-1-(Benzenesulfonyl)-4-[methyl-[(1<i>S</i>)-1-phenylethyl]amino]pyrrolidine-3-carboxylate (<b>51</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>R</i>)-methyl 4-(((<i>S</i>)-1-phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate <b>48</b> (270 mg, 0.70 mmol) in formic acid (2666 μL, 69.50 mmol) was added formaldehyde (517 μL, 6.95 mmol). The mixture was heated at 90 °C for 15 min and then cooled to rt. 2 M hydrochloric acid (1 mL) was added, and the mixture was evaporated in vacuo. The residual gum was coevaporated from toluene (5 mL) to give compound <b>51</b> (270 mg, 88%) hydrochloride salt as a gum. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 403 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Methyl (3<i>S</i>,4<i>R</i>)-1-(Benzenesulfonyl)-4-(methylamino)pyrrolidine-3-carboxylate (<b>52</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>R</i>)-methyl 4-(methyl((<i>S</i>)-1-phenylethyl)amino)-1-(phenylsulfonyl)pyrrolidine-3-carboxylate, HCl <b>51</b> (0.27 g, 0.62 mmol) in MeOH (20 mL), Pd/C (0.033 g, 0.03 mmol) was added under nitrogen. The mixture was stirred under 4 bar hydrogen for 3 h. The mixture was filtered through a Celite pad, washing with further methanol, and the filtrate was evaporated to give compound <b>52</b> (0.205 g, 100%) as a hydrochloride. Mass spectrum (ESI) <i>m</i>/<i>e</i> = 299 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Methyl (3<i>S</i>,4<i>R</i>)-1-(Benzenesulfonyl)-4-[[5-(2-chlorophenyl)isoxazole-3-carbonyl]methylamino]pyrrolidine-3-carboxylate (<b>53</b>)</h3><div class="NLM_p last">Methyl (3<i>S</i>,4<i>R</i>)-1-(benzenesulfonyl)-4-(methylamino)pyrrolidine-3-carboxylate <b>52</b> was dissolved in DMF (4 mL), and then 5-(2-chlorophenyl)isoxazole-3-carboxylic acid (0.144 g, 0.65 mmol) and <i>N</i>-methylmorpholine (0.149 mL, 1.35 mmol) were added, followed by HATU (0.281 g, 0.74 mmol). After 1 h, NaHCO<sub>3</sub> solution (20 mL) was added and the mixture stirred for 1 h, then water (20 mL) was added, and the mixture extracted with EtOAc (20 mL). Organics were washed with 1 M HCl (20 mL) and then brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated in vacuo, and then the residue was coevaporated with THF to give a crude product <b>53</b> (0.30 g, 97%). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 504 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>trans-</i>Dimethyl 1-Benzyl-3-methylpyrrolidine-3,4-dicarboxylate (<b>55</b>)</h3><div class="NLM_p last">A solution of dimethyl 2-methylfumarate (1 mL, 7.02 mmol) and <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine (1.796 mL, 7.02 mmol) in anhydrous toluene (5 mL) was cooled to 0 °C under nitrogen. To this mixture TFA was added (0.541 mL, 7.02 mmol) dropwise over 15 min. The mixture was stirred at 0 °C for a further 15 min and then quenched by addition of NH<sub>4</sub>Cl solution (5 mL). After 15 min, the mixture was diluted with water (50 mL), acidified with 2 M HCl, and extracted with TBME (50 mL). The aqueous phase was adjusted to pH > 10 by addition of NaOH and extracted with TBME (50 mL). The organic extracts were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to give compound <b>55</b> (1.0 g, 49%) as an oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.46 (s, 3H), 2.70 (d, <i>J</i> = 9.3 Hz, 1H), 2.76–2.90 (m, 3H), 3.08–3.15 (m, 1H), 3.59–3.66 (m, 8H), 7.12–7.37 (m, 5H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 292 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>trans-</i>Dimethyl 3-Methyl-1-(phenylsulfonyl)pyrrolidine-3,4-dicarboxylate (<b>56</b>)</h3><div class="NLM_p last">A solution of <i>trans-</i>dimethyl 1-benzyl-3-methylpyrrolidine-3,4-dicarboxylate <b>55</b> (0.98 g, 3.36 mmol) in MeOH (20 mL) was flushed thoroughly with nitrogen, and then Pd(OH)<sub>2</sub>/C (0.472 g, 3.36 mmol) was added. The mixture was hydrogenated at 4 bar for 24 h, then filtered through a Celite pad, washed with MeOH, and the filtrate was evaporated in vacuo to dryness. This solid was dissolved in a mixture of methyl THF (15 mL) and NaHCO<sub>3</sub> aq solution (13.5 mL). Benzenesulfonyl chloride (0.477 mL, 3.70 mmol) was added and the resulting 2-phase mixture stirred rapidly at rt for 18 h. The mixture was diluted with water (15 mL) and extracted with EtOAc (2 × 30 mL). The organic extracts were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to give compound <b>56</b> (0.822 g, 72%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.24 (s, 3H), 3.13–3.18 (m, 1H), 3.22 (d, <i>J</i> = 10.4 Hz, 1H), 3.36 (s, 3H), 3.42 (dd, <i>J</i> = 10.0, 7.2 Hz, 1H), 3.49 (s, 3H), 3.63 (dt, <i>J</i> = 10.0, 3.9 Hz, 2H), 7.63–7.67 (m, 2H), 7.70–7.75 (m, 1H), 7.79–7.83 (m, 2H). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 342 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Mixture of <i>trans-</i>1-(Benzenesulfonyl)-4-methoxycarbonyl-3-methyl-pyrrolidine-3-carboxylic Acid (<b>57a</b>) and <i>trans-</i>1-(Benzenesulfonyl)-4-methoxycarbonyl-4-methylpyrrolidine-3-carboxylic Acid (<b>57b</b>)</h3><div class="NLM_p last">A solution of <i>trans-</i>dimethyl 3-methyl-1-(phenylsulfonyl)pyrrolidine-3,4-dicarboxylate <b>56</b> (0.81 g, 2.38 mmol) in THF (10 mL) and MeOH (2.5 mL) was cooled to 0 °C, and 1 M NaOH solution (2.38 mL, 2.38 mmol) was added. The mixture was allowed to warm to 10 °C, stirred for 3 h, then warmed to rt and stirred for 20 h. The reaction mixture was then cooled to 0 °C, and further 1 M NaOH solution (1.19 mL, 1.19 mmol) was added. After 1 h the mixture was diluted with water (20 mL), acidified with 2 M HCl, and extracted with EtOAc (2 × 20 mL). The organic extracts were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to give a crude mixture of compounds <b>57a</b> and <b>57b</b> (0.64 g, 82% crude). Mass spectrum (ESI) (−ve) = 326 (M – H)<sup>−</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Mixture of <i>trans-</i>Methyl-1-(benzenesulfonyl)-4-(benzyloxycarbonylamino)-4-methyl-pyrrolidine-3-carboxylate (<b>58a</b>) and <i>trans-</i>Methyl-1-(benzenesulfonyl)-4-(benzyloxycarbonylamino)-3-methyl-pyrrolidine-3-carboxylate (<b>58b</b>)</h3><div class="NLM_p last">A mixture of regioisomers <b>57a</b> and <b>57b</b> (630 mg, 1.92 mmol), diphenyl phosphorazidate (0.456 mL, 2.12 mmol), and Et<sub>3</sub>N (0.295 mL, 2.12 mmol) in dry toluene (20 mL) were heated to reflux under nitrogen for 8 h. Benzyl alcohol (1.0 mL, 9.62 mmol) was added, and the mixture was refluxed for 1 h. The mixture was then cooled to rt, diluted with NaHCO<sub>3</sub> aq solution, and extracted with EtOAc (20 mL). The organics were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified by column chromatography (20–100% EtOAc/heptane) to give a mixture of compounds <b>58a</b> and <b>58b</b> (443 mg, 53% crude). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 433 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Mixture of <i>tert</i>-Butyl (3<i>S</i>)-3-[<i>trans-</i>1-(Benzenesulfonyl)-4-(benzyloxycarbonylamino)-4-methyl-pyrrolidine-3-carbonyl]amino]piperidine-1-carboxylate (<b>59a</b>) and <i>tert</i>-Butyl (3<i>S</i>)-3-[<i>trans-</i>1-(Benzenesulfonyl)-4-(benzyloxycarbonylamino)-3-methylpyrrolidine-3-carbonyl]amino]piperidine-1-carboxylate (<b>59b</b>)</h3><div class="NLM_p last">To a solution of the mixture of the regioisomers <b>58a</b> and <b>58b</b> (443 mg, 1.02 mmol) in THF (20 mL) and MeOH (4 mL), 1 M NaOH solution (4.10 mL, 4.10 mmol) was added. The mixture was heated to reflux for 15 min, cooled to rt, diluted with water (40 mL), acidified with 2 M HCl, extracted with EtOAc (2 × 20 mL), dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo. This was dissolved in DMF (4 mL), and Et<sub>3</sub>N (0.175 mL, 1.26 mmol) and (<i>S</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate (231 mg, 1.15 mmol) were added, followed by HATU (438 mg, 1.15 mmol). After 30 min, the mixture was diluted with NaHCO<sub>3</sub> aq solution (20 mL), stirred for 2 h, and then extracted with EtOAc (2 × 20 mL). The organic extracts were dried (MgSO<sub>4</sub>), filtered, and evaporated. The residue was dissolved in EtOH (20 mL), the flask was flushed with nitrogen, and Pd(OH)<sub>2</sub>/C (36.7 mg, 0.05 mmol) was added. The resulting mixture was stirred under 4 bar hydrogen at rt for 3 days. The catalyst was removed by filtration through a small pad of Celite, washing with EtOH (3 × 5 mL). The filtrate was evaporated in vacuo and then the residue coevaporated with THF (10 mL) to give a mixture of the regioisomers <b>59a</b> and <b>59b</b> (480 mg). Mass spectrum (ESI) <i>m</i>/<i>e</i> = 467 (M + H)<sup>+</sup>.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Biological Evaluation. Protocol for Ghrelin Receptor Binding Assay</h3><div class="NLM_p last">The assay detects compound binding to the GHS-R1a receptor when competing with [<sup>125</sup>I]-ghrelin in membranes prepared from HEK293s cell line. Test compounds or DMSO (1 μL per well, final DMSO concentration 0.5%) were plated in 96-well assay plates (Greiner V-bottom PP). 150 μL of cell membranes (final concentration 8 μg/well) in assay buffer (50 mM Tris, 5 mM MgCl<sub>2</sub>, 0.01% BSA; pH 7.4) supplemented with methyl arachidonyl fluorophosphonate (MAFP, 1 μg/well; Sigma) was added to the plates. 50 μL of [His[<sup>125</sup>I]]-h ghrelin (final concentration 75 pM; PerkinElmer) in assay buffer was added followed by 1 h incubation at room temperature. The bound and unbound isotope was separated by filtration, using polyethyleneimine (PEI) pretreated (200 μL of 50% PEI per well; Aldrich) filter plates (96-well Millipore, catalog no. MSFCNXB50). Following filtration the plates were washed 8 times with 200 μL/well of ice-cold wash buffer (50 mM Tris, 5 mM MgCl<sub>2</sub>, 50 mM NaCl; pH 7.4). The amount of membrane-bound radioligand was then quantified (Wallac Trilux Microbeta). Effect of the compounds was expressed as a percentage of maximal effect of (<span class="smallcaps smallerCapital">d</span>-Arg1, <span class="smallcaps smallerCapital">d</span>-Phe5, <span class="smallcaps smallerCapital">d</span>-Trp7,9, Leu11)-SubstanceP. The concentration and percent effect of the test compound were fitted using a sigmoidal dose–response model (Genedata Screener), and potency (IC<sub>50</sub>) was determined. The results obtained in this assay are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Protocol for Ghrelin IP1 Agonist Assay</h3><div class="NLM_p">In HEK293s cells stably expressing human GHS receptor,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> agonist activity was assessed by measuring intracellular myo-inositol 1 phosphate (IP1) using the IP-One Tb (HTRF) assay kit (Cisbio International).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Solutions were prepared as described by the supplier. Test compounds or DMSO (200 nL per well, final DMSO concentration 1%) were plated in 384-well assay plates (Greiner Lumitrac 200). Cryopreserved cells were thawed, washed in Dulbecco’s modified Eagle medium (DMEM; Invitrogen) containing 10% fetal calf serum (FCS; Hyclone), and resuspended in stimulation buffer (10 mM HEPES, 1 mM CaCl<sub>2</sub>, 0.5 mM MgCl<sub>2</sub>, 4.2 mM KCl, 146 mM NaCl, 5.5 mM glucose, 50 mM LiCl, pH 7.4; supplied in the assay kit) supplemented with 0.02% bovine serum albumin (BSA; Sigma) to a density of 0.75 × 10<sup>6</sup> cells/mL. Cell suspension (20 μL/well) was added to the compound plate and incubated for 90 min at 37 °C in 5% CO<sub>2</sub>/95% air. Following lysis of cells using lysis buffer (supplied in the assay kit) in the presence of IP1-d2 (5 μL/well) and anti-IP1 cryptate (5 μL/well) for 60 min at room temperature, fluorescence was measured on the Pherastar (BMG Labtech) at 612 and 665 nm, respectively. The effect of the compounds was expressed as a percentage of maximal effect of GHRP-6 (5 μM; Bachem). The concentration and percent effect of the test compound were fitted using a sigmoidal dose–response model (Genedata Screener), and potency (EC<sub>50</sub>) and efficacy (% agonism) were determined. Compounds were considered active in the agonist assay when efficacy was >30% and as full agonists when efficacy was >85%. The results obtained in this assay are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>.</div><div class="NLM_p last">The dog IP1 agonist assay was run according to the same protocol using HEK293s cells stably expressing the dog GHS receptor. Cell density was 0.5 × 10<sup>6</sup> cells/mL, and the compound incubation time was 60 min. The effect of the compounds was expressed as a percentage of maximal effect of capromorelin (3.33 μM; Apac). The results obtained in this assay is shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Animal Study Protocol</h3><div class="NLM_p last">The present study was approved by the local ethical committee in Gothenburg (2010-04-01).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Experimental Procedures</h3><div class="NLM_p last">All dogs were fed at 14:30 each day, starting at least 1 week before the first experiment and after the last sample on study day. All dogs were weighed and orally dosed at 7:30. Blood samples were obtained before dosing, 15, 30, and 45 min and 1, 2, 4, 7, 12, and 24 h after dose. The blood was collected in K2E EDTA coated BD Vacutainer 2 mL vials and centrifuged at 4 °C, 3.0<i>g</i> for 5 min, and 125 μL of plasma was transferred to 0.5 mL Eppendorf tubes or 96-well plates (compound level) and kept frozen (<−20 °C compound level, <−80 °C, IGF-1) until analysis. The total blood volume obtained was minimized for each blood sample. The maximally allowed volume was 13 mL per experiment.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Bioanalytical Procedures</h3><div class="NLM_p last">IGF-1 was determined with an IGF-1 ELISA kit purchased from Mediagnost, Germany, catalog no. E20. The assay is performed according to the manufacturer’s instructions. The primary readout is the change in IGF-1 levels from baseline in relation to plasma levels of the compound. Paired student <i>T</i> test is used for statistical check at each time point. Changes with <i>P</i> values below 5% were considered to be significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00828" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00828?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00828</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Biological data for the enantiomers of compounds <b>3c</b> and <b>3d</b>, <b>3c′</b> and <b>3d′</b>, respectively; analytical data of compounds <b>2b</b>–<b>g</b>, <b>3f</b>, <b>10b</b>–<b>g</b>, <b>12b</b>–<b>i</b>, <b>12k</b>–<b>m</b>, <b>14</b>, <b>15</b>, and <b>16b</b>; synthesis and corresponding analytical data of compounds <b>3b</b>–<b>e</b> and <b>3g</b>; atomic coordinates of the GHSR homology model based on the X-ray structure of agonist-bound rat neurotensine receptor 1 (accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>) as a template with bound agonists <b>1</b>, <b>2a</b>, and <b>12j</b>; range and protocol for secondary pharmacology data reported in Table 6 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_001.csv">jm0c00828_si_001.csv (4.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_002.pdf">jm0c00828_si_002.pdf (2.28 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00828" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1169-2180" title="Orcid link">http://orcid.org/0000-0003-1169-2180</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9dfeeff4eee9f4f3fcb3fafceff9f8f1f1f4ddfceee9effce7f8f3f8fefcb3fef2f0"><span class="__cf_email__" data-cfemail="bcdfced5cfc8d5d2dd92dbddced8d9d0d0d5fcddcfc8ceddc6d9d2d9dfdd92dfd3d1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Cooper</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span>Present Address:
                        M.C. and H.W.: Sygnature Discovery Ltd., BioCity, Pennyfoot Street, Nottingham, U.K</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Llinas</span> - <span class="hlFld-Affiliation affiliation">DMPK Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4620-9363" title="Orcid link">http://orcid.org/0000-0003-4620-9363</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Hansen</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moya Caffrey</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Asim Ray</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stina Sjödin</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical
Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Igor Shamovsky</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2881-9531" title="Orcid link">http://orcid.org/0000-0002-2881-9531</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroki Wada</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span>Present Address:
                        M.C. and H.W.: Sygnature Discovery Ltd., BioCity, Pennyfoot Street, Nottingham, U.K</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tina Jellesmark Jensen</span> - <span class="hlFld-Affiliation affiliation">Early
Clinical Development, Research and Early Development, Respiratory,
Inflammation and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Sivars</span> - <span class="hlFld-Affiliation affiliation">Bioscience Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leif Hultin</span> - <span class="hlFld-Affiliation affiliation">In
Vivo Imaging Sciences, Clinical Pharmacology & Safety Sciences,
R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulf Andersson</span> - <span class="hlFld-Affiliation affiliation">Clinical
Pharmacology & Safety Sciences, R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara Lundqvist</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Gedda</span> - <span class="hlFld-Affiliation affiliation">Precision
Medicine, Oncology R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Jinton</span> - <span class="hlFld-Affiliation affiliation">Bioscience Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Krutrök</span> - <span class="hlFld-Affiliation affiliation">Bioscience Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Lewis</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9404-8520" title="Orcid link">http://orcid.org/0000-0001-9404-8520</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Jansson</span> - <span class="hlFld-Affiliation affiliation">Projects Department, , , and , Research and Early Development, Respiratory, Inflammation
and Autoimmune (RIA), BioPharmaceuticals R&D, AstraZeneca, Mölndal SE-43183, Sweden</span>; 
    <span>Present Address:
                        P.J.: Volvo Penta, Gothenburg, Sweden</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions from M.C., C.G., A.L., P.H., M.C., I.S., T.J.J., L.H., S.L., L.J., and R.L. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Bioduro chemists for their work in the synthesis and purification of several of the reported compounds. We thank our colleagues at AstraZeneca R&D and Pharmaron whose testing of the compounds in log <i>D</i>, Caco, PPB, metabolic stability, and PK studies provided the results which are described. We thank the purification and analytical teams at AstraZeneca.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">Boc<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl dicarbonate</p></td></tr><tr><td class="NLM_term">Caco-2</td><td class="NLM_def"><p class="first last">colorectal adenocarcinoma cell-2</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabiciclo[5.4.0]undec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">hexafluorophosphate azabenzotriazole tetramethyluronium</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">hexafluorophosphate benzotriazole tetramethyluronium</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectroscopy</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">IVIV</td><td class="NLM_def"><p class="first last">in vitro–in vivo correlation</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">MTBE</td><td class="NLM_def"><p class="first last">methyl <i>tert</i>-butyl ether</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">TBDMSOTf</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyldimethylsilyl triflate</p></td></tr><tr><td class="NLM_term">TMSCl</td><td class="NLM_def"><p class="first last">trimethylsilyl chloride</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(01)00633-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2FS0196-9781%2801%2900633-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=11836003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=531-536&author=I.+Sakataauthor=K.+Nakamuraauthor=M.+Yamazakiauthor=M.+Matsubaraauthor=Y.+Hayashiauthor=K.+Kangawaauthor=T.+Sakai&title=Ghrelin-producing+cells+exist+as+two+types+of+cells%2C+closed-+and+opened-type+cells%2C+in+the+rat+gastrointestinal+tract&doi=10.1016%2FS0196-9781%2801%2900633-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span></div><div class="casAuthors">Sakata, Ichiro; Nakamura, Kazuaki; Yamazaki, Mami; Matsubara, Maki; Hayashi, Yuijiro; Kangawa, Kenji; Sakai, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Ghrelin was recently isolated from the rat stomach as an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R) and is known to exist in the gastrointestinal tract and hypothalamus.  In this study, the authors investigated in detail the distribution and morphol. characteristics of ghrelin-contg. cells (ghrelin cells) in the gastrointestinal tract by immunohistochem. and in situ hybridization.  Ghrelin cells were found to be localized in the mucous membrane of the stomach, duodenum, ileum, cecum and colon but not in myenteric plexus, and they can be classified into open- and closed-type cells.  The greatest no. of ghrelin cells was found in the stomach, and it was found that the no. of the opened-type cells gradually increased in the direction from stomach to the lower gastrointestinal tract.  These results suggest that the two types of ghrelin cells may be distinctly regulated and play different physiol. roles in various regions of the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPBfgaJT_67Vg90H21EOLACvtfcHk0li_WPNbdmFqiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D&md5=1624e2c509d4cc8f7711834a18c09877</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900633-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900633-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakata%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMatsubara%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DGhrelin-producing%2520cells%2520exist%2520as%2520two%2520types%2520of%2520cells%252C%2520closed-%2520and%2520opened-type%2520cells%252C%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D531%26epage%3D536%26doi%3D10.1016%2FS0196-9781%2801%2900633-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span> <span> </span><span class="NLM_article-title">The homeostatic force of ghrelin</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.cmet.2018.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=29576534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=786-804&issue=4&author=S.+Yanagiauthor=T.+Satoauthor=K.+Kangawaauthor=M.+Nakazato&title=The+homeostatic+force+of+ghrelin&doi=10.1016%2Fj.cmet.2018.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Homeostatic Force of Ghrelin</span></div><div class="casAuthors">Yanagi, Shigehisa; Sato, Takahiro; Kangawa, Kenji; Nakazato, Masamitsu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">786-804</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ghrelin, a gastric-derived acylated peptide, regulates energy homeostasis by transmitting information about peripheral nutritional status to the brain, and is essential for protecting organisms against famine.  Ghrelin operates brain circuits to regulate homeostatic and hedonic feeding.  Recent research advances have shed new light on ghrelin's multifaceted roles in cellular homeostasis, which could maintain the internal environment and overcome metaflammation in metabolic organs.  Here, we highlight our current understanding of the regulatory mechanisms of the ghrelin system in energy metab. and cellular homeostasis and its clin. trials.  Future studies of ghrelin will further elucidate how the stomach regulates systemic homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7OKGdGduDnLVg90H21EOLACvtfcHk0lgJThW1EjeBnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOhu7c%253D&md5=04b47ab4be17c8751d6d7e5d67a6ef86</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DNakazato%26aufirst%3DM.%26atitle%3DThe%2520homeostatic%2520force%2520of%2520ghrelin%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26issue%3D4%26spage%3D786%26epage%3D804%26doi%3D10.1016%2Fj.cmet.2018.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueiras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andermann, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anker, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batterham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanueva, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depoortere, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geliebter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diéguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grill, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habegger, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heppner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbonits, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferrère, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRoux, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Tilve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfluger, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Lely, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Ploeg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zigman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span> <span> </span><span class="NLM_article-title">Ghrelin</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2015.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.molmet.2015.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=26042199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFemtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=437-460&issue=6&author=T.+D.+M%C3%BCllerauthor=R.+Nogueirasauthor=M.+L.+Andermannauthor=Z.+B.+Andrewsauthor=S.+D.+Ankerauthor=J.+Argenteauthor=R.+L.+Batterhamauthor=S.+C.+Benoitauthor=C.+Y.+Bowersauthor=F.+Broglioauthor=F.+F.+Casanuevaauthor=D.+D%E2%80%99Alessioauthor=I.+Depoortereauthor=A.+Geliebterauthor=E.+Ghigoauthor=P.+A.+Coleauthor=M.+Cowleyauthor=D.+E.+Cummingsauthor=A.+Dagherauthor=S.+Dianoauthor=S.+L.+Dicksonauthor=C.+Di%C3%A9guezauthor=R.+Granataauthor=H.+J.+Grillauthor=K.+Groveauthor=K.+M.+Habeggerauthor=K.+Heppnerauthor=M.+L.+Heimanauthor=L.+Holsenauthor=B.+Holstauthor=A.+Inuiauthor=J.+O.+Janssonauthor=H.+Kirchnerauthor=M.+Korbonitsauthor=B.+Laferr%C3%A8reauthor=C.+W.+LeRouxauthor=M.+Lopezauthor=S.+Morinauthor=M.+Nakazatoauthor=R.+Nassauthor=D.+Perez-Tilveauthor=P.+T.+Pflugerauthor=T.+W.+Schwartzauthor=R.+J.+Seeleyauthor=M.+Sleemanauthor=Y.+Sunauthor=L.+Susselauthor=J.+Tongauthor=M.+O.+Thornerauthor=A.+J.+van+der%0ALelyauthor=L.+H.+van+der+Ploegauthor=J.+M.+Zigmanauthor=M.+Kojimaauthor=K.+Kangawaauthor=R.+G.+Smithauthor=T.+Horvathauthor=M.+H.+Tsch%C3%B6p&title=Ghrelin&doi=10.1016%2Fj.molmet.2015.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin</span></div><div class="casAuthors">Mueller, T. D.; Nogueiras, R.; Andermann, M. L.; Andrews, Z. B.; Anker, S. D.; Argente, J.; Batterham, R.; Benoit, S. C.; Bowers, C. Y.; Broglio, F.; Casanueva, F. F.; D'Alessio, D.; Depoortere, I.; Geliebter, A.; Ghigo, E.; Cole, P. A.; Cowley, M.; Cummings, D. E.; Dagher, A.; Diano, S.; Dickson, S. L.; Dieguez, C.; Granata, R.; Grill, H. J.; Grove, K.; Habegger, K. M.; Heppner, K.; Heiman, M. L.; Holsen, L.; Holst, B.; Inui, A.; Jansson, J. O.; Kirchner, H.; Korbonits, M.; Laferrere, B.; LeRoux, C. W.; Lopez, M.; Morin, S.; Nakazato, M.; Nass, R.; Perez-Tilve, D.; Pfluger, P. T.; Schwartz, T. W.; Seeley, R. J.; Sleeman, M.; Sun, Y.; Sussel, L.; Tong, J.; Thorner, M. O.; van der Lely, A. J.; van der Ploeg, L. H. T.; Zigman, J. M.; Kojima, M.; Kangawa, K.; Smith, R. G.; Horvath, T.; Tschoep, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-460</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the endogenous ligand of the growth hormone secretagogue receptor.  Increasing evidence supports more complicated and nuanced roles for the hormone, which go beyond the regulation of systemic energy metab.  In this review, we discuss the diverse biol. functions of ghrelin, the regulation of its secretion, and address questions that still remain 15 years after its discovery.  In recent years, ghrelin has been found to have a plethora of central and peripheral actions in distinct areas including learning and memory, gut motility and gastric acid secretion, sleep/wake rhythm, reward seeking behavior, taste sensation and glucose metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw5XYL0bEstLVg90H21EOLACvtfcHk0lgJThW1EjeBnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFemtrc%253D&md5=1e20daf703c9bdcc87d6b3f86813d371</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2015.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2015.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DNogueiras%26aufirst%3DR.%26aulast%3DAndermann%26aufirst%3DM.%2BL.%26aulast%3DAndrews%26aufirst%3DZ.%2BB.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DArgente%26aufirst%3DJ.%26aulast%3DBatterham%26aufirst%3DR.%2BL.%26aulast%3DBenoit%26aufirst%3DS.%2BC.%26aulast%3DBowers%26aufirst%3DC.%2BY.%26aulast%3DBroglio%26aufirst%3DF.%26aulast%3DCasanueva%26aufirst%3DF.%2BF.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DD.%26aulast%3DDepoortere%26aufirst%3DI.%26aulast%3DGeliebter%26aufirst%3DA.%26aulast%3DGhigo%26aufirst%3DE.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCowley%26aufirst%3DM.%26aulast%3DCummings%26aufirst%3DD.%2BE.%26aulast%3DDagher%26aufirst%3DA.%26aulast%3DDiano%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DS.%2BL.%26aulast%3DDi%25C3%25A9guez%26aufirst%3DC.%26aulast%3DGranata%26aufirst%3DR.%26aulast%3DGrill%26aufirst%3DH.%2BJ.%26aulast%3DGrove%26aufirst%3DK.%26aulast%3DHabegger%26aufirst%3DK.%2BM.%26aulast%3DHeppner%26aufirst%3DK.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DHolsen%26aufirst%3DL.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DJansson%26aufirst%3DJ.%2BO.%26aulast%3DKirchner%26aufirst%3DH.%26aulast%3DKorbonits%26aufirst%3DM.%26aulast%3DLaferr%25C3%25A8re%26aufirst%3DB.%26aulast%3DLeRoux%26aufirst%3DC.%2BW.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DNass%26aufirst%3DR.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%2BT.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DSleeman%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSussel%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DThorner%26aufirst%3DM.%2BO.%26aulast%3Dvan%2Bder%2BLely%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26aulast%3DZigman%26aufirst%3DJ.%2BM.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DHorvath%26aufirst%3DT.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DGhrelin%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26issue%3D6%26spage%3D437%26epage%3D460%26doi%3D10.1016%2Fj.molmet.2015.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abegg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernasconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riediger, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1111/dom.13020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1111%2Fdom.13020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=28544245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1740-1750&author=K.+Abeggauthor=L.+Bernasconiauthor=M.+Hutterauthor=L.+Whitingauthor=C.+Pietraauthor=C.+Giulianoauthor=T.+A.+Lutzauthor=T.+Riediger&title=Ghrelin+receptor+inverse+agonists+as+a+novel+therapeutic+approach+against+obesity-related+metabolic+disease&doi=10.1111%2Fdom.13020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease</span></div><div class="casAuthors">Abegg, Kathrin; Bernasconi, Lara; Hutter, Melanie; Whiting, Lynda; Pietra, Claudio; Giuliano, Claudio; Lutz, Thomas A.; Riediger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1740-1750</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ghrelin is implicated in the control of energy balance and glucose homeostasis.  The ghrelin receptor exhibits ligand-independent constitutive activity, which can be pharmacol. exploited to induce inverse ghrelin actions.  Because ghrelin receptor inverse agonists (GHSR-IA) might be effective for the treatment of obesity-related metabolic disease, we tested 2 novel synthetic compds. GHSR-IA1 and GHSR-IA2.  In functional cell assays, electrophysiogical and immunohistochem. expts., we demonstrated inverse agonist activity for GHSR-IA1 and GHSR-IA2.  We used healthy mice, Zucker diabetic fatty (ZDF) rats and diet-induced obese (DIO) mice to explore effects on food intake (FI), body wt. (BW), conditioned taste aversion (CTA), oral glucose tolerance (OGT), pancreatic islet morphol., hepatic steatosis (HS), and blood lipids.  Both compds. acutely reduced FI in mice without inducing CTA.  Chronic GHSR-IA1 increased metabolic rate in chow-fed mice, suppressed FI, and improved OGT in ZDF rats.  Moreover, the progression of islet hyperplasia to fibrosis in ZDF rats slowed down.  GHSR-IA2 reduced FI and BW in DIO mice, and reduced fasting and stimulated glucose levels compared with pair-fed and vehicle-treated mice.  GHSR-IA2-treated DIO mice showed decreased blood lipids.  GHSR-IA1 treatment markedly decreased HS in DIO mice.  Our study demonstrates therapeutic actions of novel ghrelin receptor inverse agonists, suggesting a potential to treat obesity-related metabolic disorders including diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKxlWZb8nH87Vg90H21EOLACvtfcHk0ljQpceXJn3scQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvL&md5=cfc0cd992fdb060af83e4f48128e6ddf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fdom.13020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13020%26sid%3Dliteratum%253Aachs%26aulast%3DAbegg%26aufirst%3DK.%26aulast%3DBernasconi%26aufirst%3DL.%26aulast%3DHutter%26aufirst%3DM.%26aulast%3DWhiting%26aufirst%3DL.%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DLutz%26aufirst%3DT.%2BA.%26aulast%3DRiediger%26aufirst%3DT.%26atitle%3DGhrelin%2520receptor%2520inverse%2520agonists%2520as%2520a%2520novel%2520therapeutic%2520approach%2520against%2520obesity-related%2520metabolic%2520disease%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2017%26volume%3D19%26spage%3D1740%26epage%3D1750%26doi%3D10.1111%2Fdom.13020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guainazzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Rubio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span> <span> </span><span class="NLM_article-title">Rational design, synthesis, and pharmacological characterization of novel ghrelin receptor inverse agonists as potential treatment against obesity-related metabolic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00794</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00794" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVantLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11039-11060&issue=24&author=A.+Dainaauthor=C.+Giulianoauthor=C.+Pietraauthor=J.+Wangauthor=Y.+Chiauthor=Z.+Zouauthor=F.+Liauthor=Z.+Yanauthor=Y.+Zhouauthor=A.+Guainazziauthor=S.+Garcia+Rubioauthor=V.+Zoete&title=Rational+design%2C+synthesis%2C+and+pharmacological+characterization+of+novel+ghrelin+receptor+inverse+agonists+as+potential+treatment+against+obesity-related+metabolic+diseases&doi=10.1021%2Facs.jmedchem.8b00794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases</span></div><div class="casAuthors">Daina, Antoine; Giuliano, Claudio; Pietra, Claudio; Wang, Junbo; Chi, Yushi; Zou, Zack; Li, Fugang; Yan, Zhonghua; Zhou, Yifan; Guainazzi, Angelo; Garcia Rubio, Silvina; Zoete, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new chemotype of ghrelin inverse agonists was discovered through chimeric design based on mol. scaffolds known as growth-hormone secretagogue receptor (GHSR) modulators but with divergent pharmacodynamic and pharmacokinetic properties.  The structure-activities/properties exploration led to compd. I, which displayed potent human GHSR antagonism and inverse agonism in cellular assays (IC50 = 68 nM, EC50 = 29 nM), moderate oral bioavailability, and notable brain penetration in rat (F = 27%, B/P ratio = 1.9).  First in vivo studies demonstrated effective redn. of food intake after oral or parenteral administration to mouse (78% at 1 h and 38% at 8 h, resp.).  Further preclin. studies are needed to evaluate the most suited mode of administration with the aim of promoting a first central-acting ghrelin inverse agonist mol. to development, which would represent a significant step toward therapeutic agents to treat metabolic disorders related to obesity, such as type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ1xJll3Qu0LVg90H21EOLACvtfcHk0ljQpceXJn3scQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVantLfI&md5=83f3dd140db3f999eeed0158a5dcc9f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00794%26sid%3Dliteratum%253Aachs%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuainazzi%26aufirst%3DA.%26aulast%3DGarcia%2BRubio%26aufirst%3DS.%26aulast%3DZoete%26aufirst%3DV.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520ghrelin%2520receptor%2520inverse%2520agonists%2520as%2520potential%2520treatment%2520against%2520obesity-related%2520metabolic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D24%26spage%3D11039%26epage%3D11060%26doi%3D10.1021%2Facs.jmedchem.8b00794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeglin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demange, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M’Kadmi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J.-A.</span></span> <span> </span><span class="NLM_article-title">The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1355-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1007%2Fs00726-012-1355-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=22798076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=301-314&issue=2&author=A.+Moulinauthor=L.+Brunelauthor=D.+Boeglinauthor=L.+Demangeauthor=J.+Ryanauthor=C.+M%E2%80%99Kadmiauthor=S.+Denoyelleauthor=J.+Martinezauthor=J.-A.+Fehrentz&title=The+1%2C2%2C4-triazole+as+a+scaffold+for+the+design+of+ghrelin+receptor+ligands%3A+development+of+JMV+2959%2C+a+potent+antagonist&doi=10.1007%2Fs00726-012-1355-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist</span></div><div class="casAuthors">Moulin, Aline; Brunel, Luc; Boeglin, Damien; Demange, Luc; Ryan, Johanne; M'Kadmi, Celine; Denoyelle, Severine; Martinez, Jean; Fehrentz, Jean-Alain</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-314</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Ghrelin is a 28-residue peptide acylated with an n-octanoyl group on the Ser 3 residue, predominantly produced by the stomach.  Ghrelin displays strong growth hormone (GH) releasing activity, which is mediated by the activation of the so-called GH secretagogue receptor type 1a (GHS-R1a).  Given the wide spectrum of biol. activities of Ghrelin in neuroendocrine and metabolic pathways, many research groups, including our group, developed synthetic peptide, and nonpeptide GHS-R1a ligands, acting as agonists, partial agonists, antagonists, or inverse agonists.  In this highlight article, we will focus on the discovery of a GHS-R1a antagonist compd., JMV 2959, which has been extensively studied in different in vitro and in vivo models.  We will first describe the peptidomimetic approach that led us to discover this compd.  Then we will review the results obtained with this compd. in different studies in the fields of food intake and obesity, addictive behaviors, hyperactivity and retinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKjw0hKGX9sbVg90H21EOLACvtfcHk0lh_SUmAAvTpkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyhs78%253D&md5=d7b25a98b0ac00ef6e8b6ef00d312bab</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1355-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1355-2%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DBoeglin%26aufirst%3DD.%26aulast%3DDemange%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DM%25E2%2580%2599Kadmi%26aufirst%3DC.%26aulast%3DDenoyelle%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DFehrentz%26aufirst%3DJ.-A.%26atitle%3DThe%25201%252C2%252C4-triazole%2520as%2520a%2520scaffold%2520for%2520the%2520design%2520of%2520ghrelin%2520receptor%2520ligands%253A%2520development%2520of%2520JMV%25202959%252C%2520a%2520potent%2520antagonist%26jtitle%3DAmino%2520Acids%26date%3D2013%26volume%3D44%26issue%3D2%26spage%3D301%26epage%3D314%26doi%3D10.1007%2Fs00726-012-1355-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Treatment of cachexia with ghrelin in patients with COPD</span>. <i>Chest</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1378/chest.128.3.1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1378%2Fchest.128.3.1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=16162705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1187-1193&issue=3&author=N.+Nagayaauthor=T.+Itohauthor=S.+Murakamiauthor=H.+Oyaauthor=M.+Uematsuauthor=K.+Miyatakeauthor=K.+Kangawa&title=Treatment+of+cachexia+with+ghrelin+in+patients+with+COPD&doi=10.1378%2Fchest.128.3.1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cachexia with ghrelin in patients with COPD</span></div><div class="casAuthors">Nagaya, Noritoshi; Itoh, Takefumi; Murakami, Shinsuke; Oya, Hideo; Uematsu, Masaaki; Miyatake, Kunio; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Chest</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">CHETBF</span>;
        ISSN:<span class="NLM_cas:issn">0012-3692</span>.
    
            (<span class="NLM_cas:orgname">American College of Chest Physicians</span>)
        </div><div class="casAbstract">Study objectives: Ghrelin is a novel growth hormone (GH)-releasing peptide that also induces a pos. energy balance by decreasing fat utility and stimulating feeding through GH-independent mechanisms.  We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD.  Methods: This is an open-label pilot study.  Human ghrelin (2 μg/kg bid) was IV administered to seven cachectic patients with COPD for 3 wk.  Food intake, body compn., muscle strength, exercise capacity, pulmonary function, and sympathetic nerve activity were examd. before and after ghrelin therapy.  Results: A single administration of ghrelin markedly increased serum GH (21-fold).  Three-week treatment with ghrelin resulted in a significant increase in mean (± SEM) body wt. (49.3 ± 3.6 to 50.3 ± 3.8 kg; p < 0.05).  Food intake was significantly increased during ghrelin therapy.  Ghrelin increased lean body mass and peripheral and respiratory muscle strength.  Ghrelin significantly increased Karnofsky performance status score and the distance walked in 6 min (370 ± 30 to 432 ± 35 m; p < 0.05), although it did not significantly alter pulmonary function.  Ghrelin attenuated the exaggerated sympathetic nerve activity, as indicated by a marked decrease in plasma norepinephrine level (889 ± 123 to 597 ± 116 pg/mL; p < 0.05).  Conclusions: These preliminary results suggest that repeated administration of ghrelin improves body compn., muscle wasting, functional capacity, and sympathetic augmentation in cachectic patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH00rMa5X4DbVg90H21EOLACvtfcHk0lh_SUmAAvTpkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D&md5=5b4232ebb551a421f3111d0492521bef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1378%2Fchest.128.3.1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1378%252Fchest.128.3.1187%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DMiyatake%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520cachexia%2520with%2520ghrelin%2520in%2520patients%2520with%2520COPD%26jtitle%3DChest%26date%3D2005%26volume%3D128%26issue%3D3%26spage%3D1187%26epage%3D1193%26doi%3D10.1378%2Fchest.128.3.1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertner, J.</span></span> <span> </span><span class="NLM_article-title">Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease</span>. <i>e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e171</span>– <span class="NLM_lpage">e175</span>, <span class="refDoi"> DOI: 10.1016/j.clnme.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.clnme.2012.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e171-e175&author=B.+Levinsonauthor=J.+Gertner&title=Randomized+study+of+the+efficacy+and+safety+of+SUN11031+%28synthetic+human+ghrelin%29+in+cachexia+associated+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.clnme.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.clnme.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnme.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DB.%26aulast%3DGertner%26aufirst%3DJ.%26atitle%3DRandomized%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520SUN11031%2520%2528synthetic%2520human%2520ghrelin%2529%2520in%2520cachexia%2520associated%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3De-SPEN%252C%2520the%2520European%2520e-Journal%2520of%2520Clinical%2520Nutrition%2520and%2520Metabolism%26date%3D2012%26volume%3D7%26spage%3De171%26epage%3De175%26doi%3D10.1016%2Fj.clnme.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tholander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivars, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanganee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidvik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydén
Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span> <span> </span><span class="NLM_article-title">Identification and pharmacological profile of an indane based series of ghrelin receptor full agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5974</span>– <span class="NLM_lpage">5987</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00322</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00322" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5974-5987&issue=14&author=C.+Gardelliauthor=H.+Wadaauthor=A.+Rayauthor=M.+Caffreyauthor=A.+Llinasauthor=I.+Shamovskyauthor=J.+Tholanderauthor=J.+Larssonauthor=U.+Sivarsauthor=L.+Hultinauthor=U.+Anderssonauthor=H.+J.+Sanganeeauthor=K.+Stenvallauthor=B.+Leidvikauthor=K.+Geddaauthor=L.+Jintonauthor=M.+Ryd%C3%A9n%0ALandergrenauthor=K.+Karabelas&title=Identification+and+pharmacological+profile+of+an+indane+based+series+of+ghrelin+receptor+full+agonists&doi=10.1021%2Facs.jmedchem.8b00322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and pharmacological profile of an indane-based series of Ghrelin receptor full agonists</span></div><div class="casAuthors">Gardelli, Cristina; Wada, Hiroki; Ray, Asim; Caffrey, Moya; Llinas, Antonio; Shamovsky, Igor; Tholander, Joakim; Larsson, Joakim; Sivars, Ulf; Hultin, Leif; Andersson, Ulf; Sanganee, Hitesh J.; Stenvall, Kristina; Leidvik, Brith; Gedda, Karin; Jinton, Lisa; Ryden Landergren, Marie; Karabelas, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5974-5987</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases.  Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels.  The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity.  Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions.  We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqWM9RhtTE3LVg90H21EOLACvtfcHk0ljaKbYxTmQTOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsrrL&md5=c64386fe2b23f10f89b7513cd6ae7351</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00322%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DTholander%26aufirst%3DJ.%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DSivars%26aufirst%3DU.%26aulast%3DHultin%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DSanganee%26aufirst%3DH.%2BJ.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DLeidvik%26aufirst%3DB.%26aulast%3DGedda%26aufirst%3DK.%26aulast%3DJinton%26aufirst%3DL.%26aulast%3DRyd%25C3%25A9n%2BLandergren%26aufirst%3DM.%26aulast%3DKarabelas%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520pharmacological%2520profile%2520of%2520an%2520indane%2520based%2520series%2520of%2520ghrelin%2520receptor%2520full%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D14%26spage%3D5974%26epage%3D5987%26doi%3D10.1021%2Facs.jmedchem.8b00322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinnerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenhan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of a new helix-forming β-amino acid: <i>trans</i>-4-aminopiperidine-3-carboxylic acid</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1002%2Fejoc.200390112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=721-726&author=M.+Schinnerlauthor=J.+K.+Murrayauthor=J.+M.+Langenhanauthor=S.+H.+Gellman&title=Asymmetric+synthesis+of+a+new+helix-forming+%CE%B2-amino+acid%3A+trans-4-aminopiperidine-3-carboxylic+acid&doi=10.1002%2Fejoc.200390112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200390112%26sid%3Dliteratum%253Aachs%26aulast%3DSchinnerl%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%2BK.%26aulast%3DLangenhan%26aufirst%3DJ.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAsymmetric%2520synthesis%2520of%2520a%2520new%2520helix-forming%2520%25CE%25B2-amino%2520acid%253A%2520trans-4-aminopiperidine-3-carboxylic%2520acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26volume%3D2003%26spage%3D721%26epage%3D726%26doi%3D10.1002%2Fejoc.200390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchmore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giranda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laver, W. G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1021/jm000468c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000468c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1192-1201&author=G.+T.+Wangauthor=Y.+Chenauthor=S.+Wangauthor=R.+Gentlesauthor=T.+Sowinauthor=W.+Katiauthor=S.+Muchmoreauthor=V.+Girandaauthor=K.+Stewartauthor=H.+Shamauthor=D.+Kempfauthor=W.+G.+Laver&title=Design%2C+synthesis%2C+and+structural+analysis+of+influenza+neuraminidase+inhibitors+containing+pyrrolidine+cores&doi=10.1021%2Fjm000468c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structural Analysis of Influenza Neuraminidase Inhibitors Containing Pyrrolidine Cores</span></div><div class="casAuthors">Wang, Gary T.; Chen, Yuanwei; Wang, Sheldon; Gentles, Robert; Sowin, Thomas; Kati, Warren; Muchmore, Steve; Giranda, Vincent; Stewart, Kent; Sham, Hing; Kempf, Dale; Laver, W. Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1192-1201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of (±)-(2S,3R,4R)-2-(trifluoroacetamido)methyl-3-amino-1-(N'-ethyl-N'-isopropylcarbamyl)pyrrolidine-4-carboxylic acid (A-192558) as a potent inhibitor of influenza neuraminidase (NA) is described.  Efficient syntheses of two core structures, cis-3-(allyloxycarbonyl)amino-1-(9'-fluorenylmethoxycarbonyl)pyrrolidine-4-carboxylic acid and tert-Bu(±)-(2S,3R,4R)-2-aminomethyl-3-bis(tert-butyloxycarbonyl)amino-1-(N'-ethyl-N'-isopropylcarbamyl)pyrrolidine-4-carboxylate were developed.  Starting with these core structures and using available structural information of the NA active site as the guide, analogs were synthesized in both the tri- and tetrasubstituted pyrrolidine series by high-throughput parallel synthesis in solid or soln. phase for expeditious SAR.  These studies accelerated the identification of A-192558 as the most potent NA inhibitor in this series (IC50 = 0.2 μM against NA A and 8 μM against NA B).  The x-ray crystallog. structure of A-192558 bound to NA revealed the predicted interaction of the carboxylic group with the pos. charged pocket (Arg118, Arg292, Arg371) and interaction of the trifluoroacetamino residue with the hydrophobic pocket (Ile222, Trp178) of the enzyme active site. Surprisingly, the Et and iso-Pr groups of the urea functionality induced a conformational change of Glu276, turning the Glu276/Glu277 hydrophilic pocket, which normally accommodates the triglycerol side chain of substrate sialic acid, into an induced hydrophobic pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNqTbHyyc32rVg90H21EOLACvtfcHk0ljaKbYxTmQTOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvFaqurg%253D&md5=dfd0b3a8e687ea313c651dd15ed9973a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm000468c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000468c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGentles%26aufirst%3DR.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DMuchmore%26aufirst%3DS.%26aulast%3DGiranda%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DSham%26aufirst%3DH.%26aulast%3DKempf%26aufirst%3DD.%26aulast%3DLaver%26aufirst%3DW.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structural%2520analysis%2520of%2520influenza%2520neuraminidase%2520inhibitors%2520containing%2520pyrrolidine%2520cores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1192%26epage%3D1201%26doi%3D10.1021%2Fjm000468c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. E.</span>; <span class="NLM_string-name">Anderson, D. D.</span>; <span class="NLM_string-name">Bosse, T. D.</span>; <span class="NLM_string-name">Cooper, C. S.</span>; <span class="NLM_string-name">Klein, L. L.</span>; <span class="NLM_string-name">Krueger, A. C.</span>; <span class="NLM_string-name">Larson, D. P.</span>; <span class="NLM_string-name">Liu, D.</span>; <span class="NLM_string-name">McDaniel, K. F.</span>; <span class="NLM_string-name">Motter, C. E.</span>; <span class="NLM_string-name">Pratt, J. K.</span>; <span class="NLM_string-name">Rockway, T. W.</span>; <span class="NLM_string-name">Rosenberg, T. A.</span>; <span class="NLM_string-name">Yeung, M. C.</span>; <span class="NLM_string-name">Chen, H.-J.</span>; <span class="NLM_string-name">Shanley, J. P.</span></span> <span> </span><span class="NLM_article-title">HCV Protease Inhibitors and Uses Thereof</span>. Patent <span class="NLM_patent">WO074035</span>, June 19, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+E.+Green&author=D.+D.+Anderson&author=T.+D.+Bosse&author=C.+S.+Cooper&author=L.+L.+Klein&author=A.+C.+Krueger&author=D.+P.+Larson&author=D.+Liu&author=K.+F.+McDaniel&author=C.+E.+Motter&author=J.+K.+Pratt&author=T.+W.+Rockway&author=T.+A.+Rosenberg&author=M.+C.+Yeung&author=H.-J.+Chen&author=J.+P.+Shanley&title=HCV+Protease+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DB.%2BE.%26atitle%3DHCV%2520Protease%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span>; <span class="NLM_string-name">Bayard, R. H.</span></span>. <span> </span><span class="NLM_article-title">Oligomers and Polymers of Di-Substituted Cyclic Imino Carboxylic Acids</span>. U.S. Patent <span class="NLM_patent">0032334</span>, Mar 14, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.+H.+Gellman&author=R.+H.+Bayard&title=Oligomers+and+Polymers+of+Di-Substituted+Cyclic+Imino+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DOligomers%2520and%2520Polymers%2520of%2520Di-Substituted%2520Cyclic%2520Imino%2520Carboxylic%2520Acids%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">12-Helix formation in aqueous solution with short β-peptides containing pyrrolidine-based residues</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4821</span>– <span class="NLM_lpage">4822</span>, <span class="refDoi"> DOI: 10.1021/ja000093k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja000093k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVWhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=4821-4822&issue=19&author=X.+Wangauthor=J.+F.+Espinosaauthor=S.+H.+Gellman&title=12-Helix+formation+in+aqueous+solution+with+short+%CE%B2-peptides+containing+pyrrolidine-based+residues&doi=10.1021%2Fja000093k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">12-Helix formation in aqueous solution with short β-peptides containing pyrrolidine-based residues</span></div><div class="casAuthors">Wang, Xifang; Espinosa, Juan F.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4821-4822</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis and conformational anal. of a set of β-amino acid oligomers ("β-peptides") I (n = 1-3; TFA = trifluoroacetate) were presented.  One of the β-amino acids, protected 3-aminopyrrolidine-4-carboxylate II, was synthesized in an enantiopure form from β-ketoester III.  I was synthesized from the β-amino acids II and (R,R)-2-aminocyclopentanecarboxylate using solid-phase methodol. with Rink amide resin, Fmoc/Boc protection and PyBoP as the coupling agent; after HPLC purifications, I was isolated as a trifluoroacetate salt.  Using NMR and CD, detailed conformational anal. of I (n=2) was provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7w_ZRVOxoyrVg90H21EOLACvtfcHk0li55mqkWnxGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVWhsb8%253D&md5=d6c182815e2033ff57a9d0dc26538424</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja000093k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000093k%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DEspinosa%26aufirst%3DJ.%2BF.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3D12-Helix%2520formation%2520in%2520aqueous%2520solution%2520with%2520short%2520%25CE%25B2-peptides%2520containing%2520pyrrolidine-based%2520residues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26issue%3D19%26spage%3D4821%26epage%3D4822%26doi%3D10.1021%2Fja000093k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuzuriha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niijima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, M.</span></span> <span> </span><span class="NLM_article-title">Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1053/gast.2001.22158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1053%2Fgast.2001.22158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=11159873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2001&pages=337-345&author=A.+Asakawaauthor=A.+Inuiauthor=T.+Kagaauthor=H.+Yuzurihaauthor=T.+Nagataauthor=N.+Uenoauthor=S.+Makinoauthor=M.+Fujimiyaauthor=A.+Niijimaauthor=M.+A.+Fujinoauthor=M.+Kasuga&title=Ghrelin+is+an+appetite-stimulatory+signal+from+stomach+with+structural+resemblance+to+motilin&doi=10.1053%2Fgast.2001.22158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin</span></div><div class="casAuthors">Asakawa, Akihiro; Inui, Akio; Kaga, Toshihiro; Yuzuriha, Hideki; Nagata, Toshiaki; Ueno, Naohiko; Makino, Susumu; Fujimiya, Mineko; Niijima, Akira; Fujino, Masayuki A.; Kasuga, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Ghrelin, an endogenous ligand for growth hormone secretagogue receptor, was recently identified in the rat stomach.  The authors examd. the effects of the gastric peptide ghrelin on energy balance in assocn. with leptin and vagal nerve activity.  Food intake, oxygen consumption, gastric emptying, and hypothalamic neuropeptide Y (NPY) mRNA expression were measured after intra-third cerebroventricular or i.p. injections of ghrelin in mice.  The gastric vagal nerve activity was recorded after i.v. administration in rats.  Gastric ghrelin gene expression was assessed by Northern blot anal.  Repeated coadministration of ghrelin and interleukin (IL)-1β was continued for 5 days.  Ghrelin exhibited gastroprokinetic activity with structural resemblance to motilin and potent orexigenic activity through action on the hypothalamic neuropeptide Y (NPY) and Y1 receptor, which was lost after vagotomy.  Ghrelin decreased gastric vagal afferent discharge in contrast to other anorexigenic peptides that increased the activity.  Ghrelin gene expression in the stomach was increased by fasting and in ob/ob mice, and was decreased by administration of leptin and IL-1β.  Peripherally administered ghrelin blocked IL-1β-induced anorexia and produced pos. energy balance by promoting food intake and decreasing energy expenditure.  Ghrelin, which is neg. regulated by leptin and IL-1β, is secreted by the stomach and increases arcuate NPY expression, which in turn acts through Y1 receptors to increase food intake and decrease energy expenditure.  Gastric peptide ghrelin may thus function as part of the orexigenic pathway downstream from leptin and is a potential therapeutic target not only for obesity but also for anorexia and cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vDv5f8zG0bVg90H21EOLACvtfcHk0li55mqkWnxGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKlt7Y%253D&md5=3e6dbec9dd369f82b4ebe7e287c1896d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1053%2Fgast.2001.22158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2001.22158%26sid%3Dliteratum%253Aachs%26aulast%3DAsakawa%26aufirst%3DA.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DKaga%26aufirst%3DT.%26aulast%3DYuzuriha%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DN.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DFujimiya%26aufirst%3DM.%26aulast%3DNiijima%26aufirst%3DA.%26aulast%3DFujino%26aufirst%3DM.%2BA.%26aulast%3DKasuga%26aufirst%3DM.%26atitle%3DGhrelin%2520is%2520an%2520appetite-stimulatory%2520signal%2520from%2520stomach%2520with%2520structural%2520resemblance%2520to%2520motilin%26jtitle%3DGastroenterology%26date%3D2001%26volume%3D120%26spage%3D337%26epage%3D345%26doi%3D10.1053%2Fgast.2001.22158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geary, N.</span></span> <span> </span><span class="NLM_article-title">Gut vagal afferents are not necessary for the eating-stimulatory injected ghrelin in the rat</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">11052</span>– <span class="NLM_lpage">11060</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2606-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1523%2FJNEUROSCI.2606-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17065447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFymsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=11052-11060&author=M.+Arnoldauthor=A.+Muraauthor=W.+Langhansauthor=N.+Geary&title=Gut+vagal+afferents+are+not+necessary+for+the+eating-stimulatory+injected+ghrelin+in+the+rat&doi=10.1523%2FJNEUROSCI.2606-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat</span></div><div class="casAuthors">Arnold, Myrtha; Mura, Anna; Langhans, Wolfgang; Geary, Nori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">11052-11060</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ghrelin is unique among gut peptides in that its plasma level increases during fasts and its administration stimulates eating.  Although ghrelin physiol. has been intensively studied, whether its eating-stimulatory effect arises from endocrine-neural signal transduction at peripheral or central sites remains unresolved.  To address this issue, we tested the effects of subdiaphragmatic vagal deafferentation (SDA), the most complete and selective vagal deafferentation method available, on ghrelin-induced eating.  SDA was verified with a cholecystokinin satiation test, retrograde labeling of vagal motor neurons in the dorsal motor nucleus of the vagus with fluorogold, and anterograde labeling of vagal afferents in the nucleus tractus solitarius with wheat germ agglutinin-horseradish peroxidase.  I.p. injections of 10-40 μg/kg ghrelin stimulated eating as robustly in rats with verified complete SDA as in sham-operated controls.  Ghrelin also stimulated eating in rats with total subdiaphragmatic vagotomies.  We also recorded the electrophysiol. responses of gastric load-sensitive vagal afferent neurons to i.v. ghrelin.  Ghrelin (10 nmol) phasically (0-30 s) increased activity in two of seven gastric load-sensitive fibers in the absence of gastric loads and tonically (5-30 min) increased activity in only one fiber.  Ghrelin did not affect any of the eight fibers tested in the presence of 1-3 mL gastric loads.  We conclude that although phasic increases in plasma ghrelin may affect the activity of a fraction of gastric load-sensitive vagal afferents, the acute eating-stimulatory effect of i.p. ghrelin does not require vagal afferent signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeSP-QxfD2bVg90H21EOLACvtfcHk0li55mqkWnxGsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFymsLnN&md5=a4a4c2494e8b8229f3013d62773568d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2606-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2606-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DA.%26aulast%3DLanghans%26aufirst%3DW.%26aulast%3DGeary%26aufirst%3DN.%26atitle%3DGut%2520vagal%2520afferents%2520are%2520not%2520necessary%2520for%2520the%2520eating-stimulatory%2520injected%2520ghrelin%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D11052%26epage%3D11060%26doi%3D10.1523%2FJNEUROSCI.2606-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nogueiras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieguez, C.</span></span> <span> </span><span class="NLM_article-title">Ghrelin: new molecular pathways modulating appetite and adiposity</span>. <i>Obes. Facts</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1159/000321265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1159%2F000321265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=20975294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=285-292&author=R.+Nogueirasauthor=L.+M.+Williamsauthor=C.+Dieguez&title=Ghrelin%3A+new+molecular+pathways+modulating+appetite+and+adiposity&doi=10.1159%2F000321265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin: New Molecular Pathways Modulating Appetite and Adiposity</span></div><div class="casAuthors">Nogueiras, Ruben; Williams, Lynda M.; Dieguez, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Obesity Facts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">OFBABR</span>;
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    
            (<span class="NLM_cas:orgname">S. Karger Verlag fuer Medizin und Naturwissenschaften GmbH</span>)
        </div><div class="casAbstract">A review.  Ghrelin is a unique endogenous peptidic hormone regulating both hunger and adiposity.  Many of the actions of ghrelin are modulated specifically by the central nervous system.  A no. of mol. events triggered via the activation of the ghrelin receptor (GHS-R1a), leading to increased levels of neuropeptide Y (NPY) and agouti-related peptide (AgRP) and ultimately responsible for the orexigenic effect of ghrelin have been characterized.  Moreover, the discovery of ghrelin O-acyltransferase (GOAT), the enzyme responsible for the octanoylation of ghrelin, provides a mechanism allowing specific targeting of the ghrelin/GHS-R1a system without affecting the role of des-acyl-ghrelin in other pathways involved in the regulation of energy balance.  This review aims to summarize novel roles of ghrelin in energy balance, focusing particularly on both the newly identified neuronal pathways mediating the effects of ghrelin and on peripheral mechanisms leading to increased adiposity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNsx4MIbzhAbVg90H21EOLACvtfcHk0liz3iqZppw_kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqu7fM&md5=7125cf6d16589f5236f5ba918be404af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1159%2F000321265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000321265%26sid%3Dliteratum%253Aachs%26aulast%3DNogueiras%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DL.%2BM.%26aulast%3DDieguez%26aufirst%3DC.%26atitle%3DGhrelin%253A%2520new%2520molecular%2520pathways%2520modulating%2520appetite%2520and%2520adiposity%26jtitle%3DObes.%2520Facts%26date%3D2010%26volume%3D3%26spage%3D285%26epage%3D292%26doi%3D10.1159%2F000321265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piirainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanekar, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span> <span> </span><span class="NLM_article-title">Structural features of adenosine receptors: from crystal to function</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1808</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2010.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.bbamem.2010.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=20595055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1233-1244&issue=5&author=H.+Piirainenauthor=Y.+Ashokauthor=R.+T.+Nanekarauthor=V.-P.+Jaakola&title=Structural+features+of+adenosine+receptors%3A+from+crystal+to+function&doi=10.1016%2Fj.bbamem.2010.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of adenosine receptors: From crystal to function</span></div><div class="casAuthors">Piirainen, Henni; Ashok, Yashwanth; Nanekar, Rahul T.; Jaakola, Veli-Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1233-1244</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The important role that extracellular adenosine plays in many physiol. processes is mediated by the adenosine class of G protein-coupled receptors, a class of receptors that also responds to the antagonist caffeine, the most widely used pharmacol. agent in the world.  The crystallog. model of the human adenosine A2A receptor was recently solved to 2.6 Å in complex with the antagonist ZM 241385, which is also referred to as "super-caffeine" because of its strong antagonistic effect on adenosine receptors.  The crystallog. model revealed some unexpected and unusual features of the adenosine A2A receptor structure that have led to new studies on the receptor and the re-examn. of pre-existing data.  Compared to other known GPCR structures, the adenosine A2A receptor has a unique ligand binding pocket that is nearly perpendicular to the membrane plane.  The ligand binding site highlights the integral role of the helical core together with the extracellular loops and the four disulfide bridges in the extracellular domain, in ligand recognition by the adenosine class of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlHy63somyAbVg90H21EOLACvtfcHk0liz3iqZppw_kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSku7g%253D&md5=f27c2b1d7e9044e5b61b60988e39f452</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DPiirainen%26aufirst%3DH.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DNanekar%26aufirst%3DR.%2BT.%26aulast%3DJaakola%26aufirst%3DV.-P.%26atitle%3DStructural%2520features%2520of%2520adenosine%2520receptors%253A%2520from%2520crystal%2520to%2520function%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26issue%3D5%26spage%3D1233%26epage%3D1244%26doi%3D10.1016%2Fj.bbamem.2010.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">The chimera that curbs appetite</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11037</span>– <span class="NLM_lpage">11038</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKjurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11037-11038&author=L.+G.+Luyt&title=The+chimera+that+curbs+appetite&doi=10.1021%2Facs.jmedchem.8b01809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Chimera That Curbs Appetite</span></div><div class="casAuthors">Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11037-11038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chimeric drug design approach, merging the structure of an antagonist and an inverse agonist, results in a new mol. scaffold for targeting the ghrelin receptor (GHSR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXAGEiWVKaQLVg90H21EOLACvtfcHk0liz3iqZppw_kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKjurzE&md5=41e5a9a54a99fb355344c100a3828cfe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01809%26sid%3Dliteratum%253Aachs%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DThe%2520chimera%2520that%2520curbs%2520appetite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11037%26epage%3D11038%26doi%3D10.1021%2Facs.jmedchem.8b01809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&issue=6&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+signaling-competent+neurotensin+receptor+1+obtained+by+directed+evolution+in+Escherichia+coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0liz3iqZppw_kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520signaling-competent%2520neurotensin%2520receptor%25201%2520obtained%2520by%2520directed%2520evolution%2520in%2520Escherichia%2520coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D6%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejmech.2016.07.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=27541265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=822-833&author=J.+Houauthor=C.+L.+Charronauthor=M.+M.+Fowkesauthor=L.+G.+Luyt&title=Bridging+computational+modeling+with+amino+acid+replacements+to+investigate+GHS-R1a-peptidomimetic+recognition&doi=10.1016%2Fj.ejmech.2016.07.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span></div><div class="casAuthors">Hou, Jinqiang; Charron, Carlie L.; Fowkes, Milan M.; Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">822-833</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The ghrelin receptor, also referred to as the growth hormone secretagogue receptor 1a (GHS-R1a), is a G protein-coupled receptor (GPCR) primarily expressed in the brain and pituitary.  The wide spectrum of biol. functions of GHS-R1a has rendered it a target for therapeutic drugs and for mol. imaging agents, for a variety of diseases.  An improved understanding of the binding mechanism of a ligand to GHS-R1a would provide guidance on ligand design.  This study investigates the binding of G-7039, a peptidomimetic agonist, to the GHS-R1a.  A series of computational studies including homol. modeling, mol. docking, mol. dynamics (MD) simulations, and binding free energy calcns. were carried out in conjunction with amino acid replacements on G-7039.  The results suggest that the first three residues on the N-terminal segment of the peptidomimetic are bound to three hydrophobic sub-pockets in the receptor binding site, with the driving force for binding mainly from hydrophobic interactions.  It has been reported that a charge-charge interaction between the pos. charged terminal amine of the agonist and Glu124 on the receptor serves as an anchor point for binding.  However, our studies suggest that this interaction is not strong enough to anchor a ligand to the ghrelin receptor in the absence of hydrophobic interactions.  The resulting computational model provides insight into structure activity relationship anal. for the ghrelin receptor and will assist in future ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6ZSlrS_AL7Vg90H21EOLACvtfcHk0liX445Zqtkqvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM&md5=f96e7229ff7b1416f8039adae7bfb7a8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.078%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCharron%26aufirst%3DC.%2BL.%26aulast%3DFowkes%26aufirst%3DM.%2BM.%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DBridging%2520computational%2520modeling%2520with%2520amino%2520acid%2520replacements%2520to%2520investigate%2520GHS-R1a-peptidomimetic%2520recognition%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D822%26epage%3D833%26doi%3D10.1016%2Fj.ejmech.2016.07.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taddese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. A.</span></span> <span> </span><span class="NLM_article-title">Modeling active GPCR conformations</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>522</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-407865-9.00002-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2FB978-0-12-407865-9.00002-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=23374178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2013&pages=21-35&author=B.+Taddeseauthor=L.+M.+Simpsonauthor=I.+D.+Wallauthor=F.+E.+Blaneyauthor=C.+A.+Reynolds&title=Modeling+active+GPCR+conformations&doi=10.1016%2FB978-0-12-407865-9.00002-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling active GPCR conformations</span></div><div class="casAuthors">Taddese, Bruck; Simpson, Lisa M.; Wall, Ian D.; Blaney, Frank E.; Reynolds, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">522</span>
        (<span class="NLM_cas:issue">G Protein Coupled Receptors</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The most significant advance in modeling GPCR active states has been the β2-adrenergic receptor-Gs complex as this essentially transforms active-state modeling into homol. modeling.  Various different mol. dynamics-based approaches for modeling active states are presented, and a no. of key applications discussed.  These simulations have given insights into the activation pathway, conformational changes, dimerization, hydration, the ionic lock, ligand binding, protonation, and sodium binding.  Crystallog. and simulations have shown that the presence of agonist alone is unlikely to be sufficient to form the active state and that restraints applied to the G protein-binding region are required.  The role of various microswitches in activation is discussed, including the controversial rotamer toggle switch.  The importance of explicitly simulating exptl. mol. probes to understand activation is highlighted, along with the need to ensure that such mols. are well parameterized.  Approaches to loop modeling are discussed.  We argue that the role of successful virtual screening against active models should not be overestimated as the main conformational changes on activation occur in the intracellular region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-GS5Ws7B5gbVg90H21EOLACvtfcHk0liX445Zqtkqvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSit7g%253D&md5=fa1f66ec0b5bb146b3c77968d1b9edef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407865-9.00002-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-407865-9.00002-9%26sid%3Dliteratum%253Aachs%26aulast%3DTaddese%26aufirst%3DB.%26aulast%3DSimpson%26aufirst%3DL.%2BM.%26aulast%3DWall%26aufirst%3DI.%2BD.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DReynolds%26aufirst%3DC.%2BA.%26atitle%3DModeling%2520active%2520GPCR%2520conformations%26jtitle%3DMethods%2520Enzymol.%26date%3D2013%26volume%3D522%26spage%3D21%26epage%3D35%26doi%3D10.1016%2FB978-0-12-407865-9.00002-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E. D.</span></span> <span> </span><span class="NLM_article-title">OPLS3e: Extending force field coverage for drug-like small molecules</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.8b01026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.8b01026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1863-1874&author=K.+Roosauthor=C.+Wuauthor=W.+Dammauthor=M.+Reboulauthor=J.+M.+Stevensonauthor=C.+Luauthor=M.+K.+Dahlgrenauthor=S.+Mondalauthor=W.+Chenauthor=L.+Wangauthor=R.+Abelauthor=R.+A.+Friesnerauthor=E.+D.+Harder&title=OPLS3e%3A+Extending+force+field+coverage+for+drug-like+small+molecules&doi=10.1021%2Facs.jctc.8b01026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules</span></div><div class="casAuthors">Roos, Katarina; Wu, Chuanjie; Damm, Wolfgang; Reboul, Mark; Stevenson, James M.; Lu, Chao; Dahlgren, Markus K.; Mondal, Sayan; Chen, Wei; Wang, Lingle; Abel, Robert; Friesner, Richard A.; Harder, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building upon the OPLS3 force field we report on an enhanced model, OPLS3e, that further extends its coverage of medicinally relevant chem. space by addressing limitations in chemotype transferability.  OPLS3e accomplishes this by incorporating new parameter types that recognize moieties with greater chem. specificity and integrating an on-the-fly parametrization approach to the assignment of partial charges.  As a consequence, OPLS3e leads to greater accuracy against performance benchmarks that assess small mol. conformational propensities, solvation, and protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWzxgqjMQBLLVg90H21EOLACvtfcHk0liX445Zqtkqvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFKlsrs%253D&md5=5c91547ddc0c975f9616cfba56a5454f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.8b01026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.8b01026%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DStevenson%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DHarder%26aufirst%3DE.%2BD.%26atitle%3DOPLS3e%253A%2520Extending%2520force%2520field%2520coverage%2520for%2520drug-like%2520small%2520molecules%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2019%26volume%3D15%26spage%3D1863%26epage%3D1874%26doi%3D10.1021%2Facs.jctc.8b01026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollinger, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span> <span> </span><span class="NLM_article-title">The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3014</span>, <span class="refDoi"> DOI: 10.1021/jp961992r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp961992r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADyaK2sXitFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1997&pages=3005-3014&author=D.+Qiuauthor=P.+S.+Shenkinauthor=F.+P.+Hollingerauthor=W.+C.+Still&title=The+GB%2FSA+continuum+model+for+solvation.+A+fast+analytical+method+for+the+calculation+of+approximate+Born+radii&doi=10.1021%2Fjp961992r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The GB/SA Continuum Model for Solvation. A Fast Analytical Method for the Calculation of Approximate Born Radii</span></div><div class="casAuthors">Qiu, Di; Shenkin, Peter S.; Hollinger, Frank P.; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3005-3014</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At. Born radii (α) are used in the generalized Born (GB) equation to calc. approxns. to the elec. polarization component (Gpol) of solvation free energy.  The authors present here a simple anal. formula for calcg. Born radii rapidly and with useful accuracy.  The new function is based on a at. pairwise rij-4 treatment and contains several empirically detd. parameters that were established by optimization against a data set of >10 000 accurate Born radii computed numerically using the Poisson equation on a diverse group of org. mols., mol. complexes, oligopeptides, and a small protein.  Coupling this new Born radius calcn. with the previously described GB/SA solvation treatment provides a fully anal. solvation model that is computationally efficient in comparison with traditional mol. solvent models and also affords first and second derivs.  Tests with the GB/SA model and Born radii calcd. with the authors' new anal. function and with the accurate but more time-consuming Poisson-Boltzmann methods indicate that comparable free energies of solvent-like dielec. polarization can be obtained using either method and that the resulting GB/SA solvation free energies compare well with the exptl. results on small mols. in water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8qRXR8qs07Vg90H21EOLACvtfcHk0ljwo8kMqgIbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFWgs7w%253D&md5=ac84707bd3f8024870483891334439d1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjp961992r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp961992r%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26aulast%3DHollinger%26aufirst%3DF.%2BP.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DThe%2520GB%252FSA%2520continuum%2520model%2520for%2520solvation.%2520A%2520fast%2520analytical%2520method%2520for%2520the%2520calculation%2520of%2520approximate%2520Born%2520radii%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1997%26volume%3D101%26spage%3D3005%26epage%3D3014%26doi%3D10.1021%2Fjp961992r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feighner, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palyha, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hreniuk, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Ploeg, L. H.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1210/mend.12.1.0051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1210%2Fmend.12.1.0051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=9440817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=137-141&issue=1&author=S.+D.+Feighnerauthor=A.+D.+Howardauthor=K.+Prendergastauthor=O.+C.+Palyhaauthor=D.+L.+Hreniukauthor=R.+Nargundauthor=D.+Underwoodauthor=J.+R.+Tataauthor=D.+C.+Deanauthor=C.+P.+Tanauthor=K.+K.+McKeeauthor=J.+W.+Woodsauthor=A.+A.+Patchettauthor=R.+G.+Smithauthor=L.+H.+Van+der%0APloeg&title=Structural+requirements+for+the+activation+of+the+human+growth+hormone+secretagogue+receptor+by+peptide+and+nonpeptide+secretagogues&doi=10.1210%2Fmend.12.1.0051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues</span></div><div class="casAuthors">Feighner, Scott D.; Howard, Andrew D.; Prendergast, Kristine; Palyha, Oksana C.; Hreniuk, Donna L.; Nargund, Ravi; Underwood, Dennis; Tata, James R.; Dean, Dennis C.; Tan, Carina P.; McKee, Karen Kulju; Woods, John W.; Patchett, Arthur A.; Smith, Roy G.; Van der Ploeg, Lex H. T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-145</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antibodies raised against an intracellular and extracellular domain of the GH secretagogue receptor (GHS-R) confirmed that its topol. orientation in the lipid bilayer is as predicted for G protein-coupled receptors with seven transmembrane domains.  A strategy for mapping the agonist-binding site of the human GHS-R was conceived based on our understanding of ligand binding in biogenic amine and peptide hormone G protein-coupled receptors.  Using site-directed mutagenesis and mol. modeling, we classified GHS peptide and nonpeptide agonist binding in the context of its receptor environment.  All peptide and nonpeptide ligand classes shared a common binding domain in transmembrane (TM) region 3 of the GHS-R.  This finding was based on TM-3 mutation E124Q, which eliminated the counter-ion to the shared basic N+ group of all GHSs and resulted in a nonfunctional receptor.  Restoration of function for the E124Q mutant was achieved by a complementary change in the MK-0677 ligand through modification of its amine side-chain to the corresponding alc.  Contacts in other TM domains [TM-2 (D99N), TM-5 (M213K, S117A), TM-6 (H280F), and extracellular loop 1 (C116A)] of the receptor revealed specificity for the different peptide, benzolactam, and spiroindolane GHSs.  GHS-R agonism, therefore, does not require identical disposition of all agonist classes at the ligand-binding site.  Our results support the hypothesis that the ligand-binding pocket in the GHS-R is spatially disposed similarly to the well characterized catechol-binding site in the β2-adrenergic receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetKI2LSRgu7Vg90H21EOLACvtfcHk0ljwo8kMqgIbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFaltA%253D%253D&md5=4e7350515438326d7ccb4fd7eb0f7c6f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.1.0051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.1.0051%26sid%3Dliteratum%253Aachs%26aulast%3DFeighner%26aufirst%3DS.%2BD.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DPrendergast%26aufirst%3DK.%26aulast%3DPalyha%26aufirst%3DO.%2BC.%26aulast%3DHreniuk%26aufirst%3DD.%2BL.%26aulast%3DNargund%26aufirst%3DR.%26aulast%3DUnderwood%26aufirst%3DD.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DDean%26aufirst%3DD.%2BC.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DMcKee%26aufirst%3DK.%2BK.%26aulast%3DWoods%26aufirst%3DJ.%2BW.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DVan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520requirements%2520for%2520the%2520activation%2520of%2520the%2520human%2520growth%2520hormone%2520secretagogue%2520receptor%2520by%2520peptide%2520and%2520nonpeptide%2520secretagogues%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26issue%3D1%26spage%3D137%26epage%3D141%26doi%3D10.1210%2Fmend.12.1.0051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">The growth hormone secretagogue receptor: its intracellular signaling and regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4855</span>, <span class="refDoi"> DOI: 10.3390/ijms15034837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.3390%2Fijms15034837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=24651458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1OqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=4837-4855&issue=3&author=Y.+Yinauthor=Y.+Liauthor=W.+Zhang&title=The+growth+hormone+secretagogue+receptor%3A+its+intracellular+signaling+and+regulation&doi=10.3390%2Fijms15034837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The growth hormone secretagogue receptor: its intracellular signaling and regulation</span></div><div class="casAuthors">Yin, Yue; Li, Yin; Zhang, Weizhen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">4837-4855, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor, is involved in mediating a wide variety of biol. effects of ghrelin, including: stimulation of growth hormone release, increase of food intake and body wt., modulation of glucose and lipid metab., regulation of gastrointestinal motility and secretion, protection of neuronal and cardiovascular cells, and regulation of immune function.  Dependent on the tissues and cells, activation of GHSR may trigger a diversity of signaling mechanisms and subsequent distinct physiol. responses.  Distinct regulation of GHSR occurs at levels of transcription, receptor interaction and internalization.  Here we review the current understanding on the intracellular signaling pathways of GHSR and its modulation.  An overview of the mol. structure of GHSR is presented first, followed by the discussion on its signaling mechanisms.  Finally, potential mechanisms regulating GHSR are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAZstvgKgicrVg90H21EOLACvtfcHk0ljwo8kMqgIbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1OqtLw%253D&md5=3efb2c601dd9e79c3265dfbd20d9ec50</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms15034837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15034837%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThe%2520growth%2520hormone%2520secretagogue%2520receptor%253A%2520its%2520intracellular%2520signaling%2520and%2520regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D3%26spage%3D4837%26epage%3D4855%26doi%3D10.3390%2Fijms15034837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullberg, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Overlapping binding site for endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1124%2Fmol.108.049189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=18923064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=44-59&author=B.+Holstauthor=T.+M.+Frimurerauthor=J.+Mokrosinskiauthor=T.+Halkjaerauthor=K.+B.+Cullbergauthor=C.+R.+Underwoodauthor=T.+W.+Schwartz&title=Overlapping+binding+site+for+endogenous+agonist%2C+small-molecule+agonists%2C+and+ago-allosteric+modulators+on+the+ghrelin+receptor&doi=10.1124%2Fmol.108.049189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span></div><div class="casAuthors">Holst, Birgitte; Frimurer, Thomas M.; Mokrosinski, Jacek; Halkjaer, Tine; Cullberg, Karina B.; Underwood, Christina R.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A library of robust ghrelin receptor mutants with single substitutions at 22 positions in the main ligand-binding pocket was employed to map binding sites for six different agonists: two peptides (the 28-amino-acid octanoylated endogenous ligand ghrelin and the hexapeptide growth hormone secretagogue GHRP-6) plus four nonpeptide agonists-the original benzolactam L-692,429, the spiroindoline sulfonamide MK-677, and two novel oxindole derivs., SM-130686 and SM-157740.  The strongest mutational effect with respect to decrease in potency for stimulation of inositol phosphate turnover was for all six agonists the GluIII:09-to-Gln substitution in the extracellular segment of TM-III.  Likewise, all six agonists were affected by substitutions of PheVI:16, ArgVI:20, and PheVI:23 on the opposing face of transmembrane domain (TM) VI.  Each of the agonists was also affected selectively by specific mutations.  The mutational map of the ability of L-692,429 and GHRP-6 to act as allosteric modulators by increasing ghrelin's maximal efficacy overlapped with the common mutational map for agonism but it was not identical with the map for the agonist property of these small-mol. ligands.  In mol. models, built over the inactive conformation of rhodopsin, low energy conformations of the nonpeptide agonists could be docked to satisfy many of their mutational hits.  It is concluded that although each of the ligands in addn. exploits other parts of the receptor, a large, common binding site for both small-mol. agonists-including ago-allosteric modulators-and the endogenous agonist is found on the opposing faces of TM-III and -VI of the ghrelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vPmuuW-QabVg90H21EOLACvtfcHk0lgpwXs-7WegXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D&md5=565858dd8c6657fda2938e10ab30fed1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049189%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DHalkjaer%26aufirst%3DT.%26aulast%3DCullberg%26aufirst%3DK.%2BB.%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DOverlapping%2520binding%2520site%2520for%2520endogenous%2520agonist%252C%2520small-molecule%2520agonists%252C%2520and%2520ago-allosteric%2520modulators%2520on%2520the%2520ghrelin%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D44%26epage%3D59%26doi%3D10.1124%2Fmol.108.049189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15799</span>– <span class="NLM_lpage">15811</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism&doi=10.1074%2Fjbc.M609796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0lgpwXs-7WegXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811%26doi%3D10.1074%2Fjbc.M609796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vortmeier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernicke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huster, D.</span></span> <span> </span><span class="NLM_article-title">Structural model of ghrelin bound to its G protein-coupled receptor</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.str.2018.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.str.2018.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=30686667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=537-544&author=B.+J.+Benderauthor=G.+Vortmeierauthor=S.+Ernickeauthor=M.+Bosseauthor=A.+Kaiserauthor=S.+Els-Heindlauthor=U.+Krugauthor=A.+Beck-Sickingerauthor=J.+Meilerauthor=D.+Huster&title=Structural+model+of+ghrelin+bound+to+its+G+protein-coupled+receptor&doi=10.1016%2Fj.str.2018.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor</span></div><div class="casAuthors">Bender, Brian Joseph; Vortmeier, Gerrit; Ernicke, Stefan; Bosse, Mathias; Kaiser, Anette; Els-Heindl, Sylvia; Krug, Ulrike; Beck-Sickinger, Annette; Meiler, Jens; Huster, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-544.e4</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The peptide ghrelin targets the growth hormone secretagogue receptor 1a (GHSR) to signal changes in cell metab. and is a sought-after therapeutic target, although no structure is known to date.  To investigate the structural basis of ghrelin binding to GHSR, we used solid-state NMR (NMR) spectroscopy, site-directed mutagenesis, and Rosetta modeling.  The use of satn. transfer difference NMR identified key residues in the peptide for receptor binding beyond the known motif.  This information combined with assignment of the secondary structure of ghrelin in its receptor-bound state was incorporated into Rosetta using an approach that accounts for flexible binding partners.  The NMR data and models revealed an extended binding surface that was confirmed via mutagenesis.  Our results agree with a growing evidence of peptides interacting via two sites at G protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJVWAM5_EcyrVg90H21EOLACvtfcHk0lgpwXs-7WegXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSltrw%253D&md5=169f718765ba8c38e22729d02063575f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2018.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2018.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DVortmeier%26aufirst%3DG.%26aulast%3DErnicke%26aufirst%3DS.%26aulast%3DBosse%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DHuster%26aufirst%3DD.%26atitle%3DStructural%2520model%2520of%2520ghrelin%2520bound%2520to%2520its%2520G%2520protein-coupled%2520receptor%26jtitle%3DStructure%26date%3D2019%26volume%3D27%26spage%3D537%26epage%3D544%26doi%3D10.1016%2Fj.str.2018.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bladh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Heuvel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josefsson, B.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristoffersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnanen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisius, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Männikkö, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosendahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrinjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span> <span> </span><span class="NLM_article-title">Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7706</span>– <span class="NLM_lpage">7723</span>, <span class="refDoi"> DOI: 10.1021/jm900713y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900713y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7706-7723&author=I.+Shamovskyauthor=C.+de+Graafauthor=L.+Alderinauthor=M.+Bengtssonauthor=H.+Bladhauthor=L.+B%C3%B6rjessonauthor=S.+Connollyauthor=H.+J.+Dykeauthor=M.+van+den+Heuvelauthor=H.+Johanssonauthor=B.-G.+Josefssonauthor=A.+Kristofferssonauthor=T.+Linnanenauthor=A.+Lisiusauthor=R.+M%C3%A4nnikk%C3%B6author=B.+Nord%C3%A9nauthor=S.+Priceauthor=L.+Ripaauthor=D.+Rognanauthor=A.+Rosendahlauthor=M.+Skrinjarauthor=K.+Urbahns&title=Increasing+selectivity+of+CC+chemokine+receptor+8+antagonists+by+engineering+nondesolvation+related+interactions+with+the+intended+and+off-target+binding+sites&doi=10.1021%2Fjm900713y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related Interactions with the Intended and Off-Target Binding Sites</span></div><div class="casAuthors">Shamovsky, Igor; de Graaf, Chris; Alderin, Lisa; Bengtsson, Malena; Bladh, Hakan; Borjesson, Lena; Connolly, Stephen; Dyke, Hazel J.; van den Heuvel, Marco; Johansson, Henrik; Josefsson, Bo-Goran; Kristoffersson, Anna; Linnanen, Tero; Lisius, Annea; Mannikko, Roope; Norden, Bo; Price, Steve; Ripa, Lena; Rognan, Didier; Rosendahl, Alexander; Skrinjar, Marco; Urbahns, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7706-7723</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERG ion channel and cytochrome Cyp2D6 are studied by principal component anal.  It is demonstrated that an efficient way of increasing metabolic stability and selectivity of this series is to decrease compd. lipophilicity by engineering nondesolvation related attractive interactions with CCR8, as rationalized by three-dimensional receptor models.  Although such polar interactions led to increased compd. selectivity, such a strategy could also jeopardize the DMPK profile of compds.  However, once increased potency is found, the lipophilicity can be readjusted by engineering hydrophobic substituents that fit to CCR8 but do not fit to hERG.  Several such lipophilic fragments are identified by two-dimensional fragment-based QSAR anal.  Electrophysiol. measurements and site-directed mutagenesis studies indicated that the repulsive interactions of these fragments with hERG are caused by steric hindrances with residue F656.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnucSk9AFKrVg90H21EOLACvtfcHk0lhfu1eoOiEfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsLc%253D&md5=5c2c3fba29d17ae235e77c88d0aaf8ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900713y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900713y%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DAlderin%26aufirst%3DL.%26aulast%3DBengtsson%26aufirst%3DM.%26aulast%3DBladh%26aufirst%3DH.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DL.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DJosefsson%26aufirst%3DB.-G.%26aulast%3DKristoffersson%26aufirst%3DA.%26aulast%3DLinnanen%26aufirst%3DT.%26aulast%3DLisius%26aufirst%3DA.%26aulast%3DM%25C3%25A4nnikk%25C3%25B6%26aufirst%3DR.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRosendahl%26aufirst%3DA.%26aulast%3DSkrinjar%26aufirst%3DM.%26aulast%3DUrbahns%26aufirst%3DK.%26atitle%3DIncreasing%2520selectivity%2520of%2520CC%2520chemokine%2520receptor%25208%2520antagonists%2520by%2520engineering%2520nondesolvation%2520related%2520interactions%2520with%2520the%2520intended%2520and%2520off-target%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7706%26epage%3D7723%26doi%3D10.1021%2Fjm900713y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhfu1eoOiEfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Molecular
Operating Environment, Chemical Computing Group (CCG). <a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular%0AOperating+Environment%2C+Chemical+Computing+Group+%28CCG%29.+www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coish, P. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickens, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomquist, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claus, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khire, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenleber, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelekhin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakalopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardell, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, W. H.</span></span> <span> </span><span class="NLM_article-title">Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5202</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1021/jm070071+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070071%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGqt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5202-5216&issue=21&author=J.+Rudolphauthor=W.+P.+Eslerauthor=S.+O%E2%80%99Connorauthor=P.+D.+G.+Coishauthor=P.+L.+Wickensauthor=M.+Brandsauthor=D.+E.+Biererauthor=B.+T.+Bloomquistauthor=G.+Bondarauthor=L.+Chenauthor=C.-Y.+Chuangauthor=T.+H.+Clausauthor=Z.+Fathiauthor=W.+Fuauthor=U.+R.+Khireauthor=J.+A.+Kristieauthor=X.-G.+Liuauthor=D.+B.+Loweauthor=A.+C.+McClureauthor=M.+Michelsauthor=A.+A.+Ortizauthor=P.+D.+Ramsdenauthor=R.+W.+Schoenleberauthor=T.+E.+Shelekhinauthor=A.+Vakalopoulosauthor=W.+Tangauthor=L.+Wangauthor=L.+Yiauthor=S.+J.+Gardellauthor=J.+N.+Livingstonauthor=L.+J.+Sweetauthor=W.+H.+Bullock&title=Quinazolinone+derivatives+as+orally+available+ghrelin+receptor+antagonists+for+the+treatment+of+diabetes+and+obesity&doi=10.1021%2Fjm070071%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity</span></div><div class="casAuthors">Rudolph, Joachim; Esler, William P.; O'Connor, Stephen; Coish, Philip D. G.; Wickens, Philip L.; Brands, Michael; Bierer, Donald E.; Bloomquist, Brian T.; Bondar, Georgiy; Chen, Libing; Chuang, Chih-Yuan; Claus, Thomas H.; Fathi, Zahra; Fu, Wenlang; Khire, Uday R.; Kristie, James A.; Liu, Xiao-Gao; Lowe, Derek B.; McClure, Andrea C.; Michels, Martin; Ortiz, Astrid A.; Ramsden, Philip D.; Schoenleber, Robert W.; Shelekhin, Tatiana E.; Vakalopoulos, Alexandros; Tang, Weifeng; Wang, Lei; Yi, Lin; Gardell, Stephen J.; Livingston, James N.; Sweet, Laurel J.; Bullock, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5202-5216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peptide hormone ghrelin is the endogenous ligand for the type 1a growth hormone secretagogue receptor (GHS-R1a) and the only currently known circulating appetite stimulant.  GHS-R1a antagonism has therefore been proposed as a potential approach for obesity treatment.  More recently, ghrelin has been recognized to also play a role in controlling glucose-induced insulin secretion, which suggests another possible benefit for a GHS-R1a antagonist, namely, the role as an insulin secretagogue with potential value for diabetes treatment.  In our labs., piperidine-substituted quinazolinone derivs. were identified as a new class of small-mol. GHS-R1a antagonists.  Starting from an agonist with poor oral bioavailability, optimization led to potent, selective, and orally bioavailable antagonists.  In vivo efficacy evaluation of selected compds. revealed suppression of food intake and body wt. redn. as well as glucose-lowering effects mediated by glucose-dependent insulin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrdFtfyC6CSrVg90H21EOLACvtfcHk0lhfu1eoOiEfqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGqt7vK&md5=ebaa1f1db240b5834d8975a55a6a8f71</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070071%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070071%252B%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DEsler%26aufirst%3DW.%2BP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26aulast%3DCoish%26aufirst%3DP.%2BD.%2BG.%26aulast%3DWickens%26aufirst%3DP.%2BL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBierer%26aufirst%3DD.%2BE.%26aulast%3DBloomquist%26aufirst%3DB.%2BT.%26aulast%3DBondar%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChuang%26aufirst%3DC.-Y.%26aulast%3DClaus%26aufirst%3DT.%2BH.%26aulast%3DFathi%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DKhire%26aufirst%3DU.%2BR.%26aulast%3DKristie%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DX.-G.%26aulast%3DLowe%26aufirst%3DD.%2BB.%26aulast%3DMcClure%26aufirst%3DA.%2BC.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DOrtiz%26aufirst%3DA.%2BA.%26aulast%3DRamsden%26aufirst%3DP.%2BD.%26aulast%3DSchoenleber%26aufirst%3DR.%2BW.%26aulast%3DShelekhin%26aufirst%3DT.%2BE.%26aulast%3DVakalopoulos%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DJ.%2BN.%26aulast%3DSweet%26aufirst%3DL.%2BJ.%26aulast%3DBullock%26aufirst%3DW.%2BH.%26atitle%3DQuinazolinone%2520derivatives%2520as%2520orally%2520available%2520ghrelin%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D21%26spage%3D5202%26epage%3D5216%26doi%3D10.1021%2Fjm070071%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claesson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2010.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.cbi.2010.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=21074519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVyiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=65-71&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=R.+Weaverauthor=L.+Weidolfauthor=I.+Wilsonauthor=A.+Claessonauthor=K.+Pageauthor=H.+Dolgosauthor=J.+G.+Kenna&title=Risk+assessment+and+mitigation+strategies+for+reactive+metabolites+in+drug+discovery+and+development&doi=10.1016%2Fj.cbi.2010.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weaver, Richard; Weidolf, Lars; Wilson, Ian; Claesson, Alf; Page, Ken; Dolgos, Hugues; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-71</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug toxicity is a leading cause of attrition of candidate drugs during drug development as well as of withdrawal of drugs post-licensing due to adverse drug reactions in man.  These adverse drug reactions cause a broad range of clin. severe conditions including both highly reproducible and dose dependent toxicities as well as relatively infrequent and idiosyncratic adverse events.  The underlying risk factors can be split into two groups: (1) drug-related and (2) patient-related.  The drug-related risk factors include metabolic factors that det. the propensity of a mol. to form toxic reactive metabolites (RMs), and the RM and non-RM mediated mechanisms which cause cell and tissue injury.  Patient related risk factors may vary markedly between individuals, and encompass genetic and non-genetic processes, e.g. environmental, that influence the disposition of drugs and their metabolites, the nature of the adverse responses elicited and the resulting biol. consequences.  We describe a new strategy, which builds upon the strategies used currently within numerous pharmaceutical companies to avoid and minimize RM formation during drug discovery, and that is intended to reduce the likelihood that candidate drugs will cause toxicity in the human population.  The new strategy addresses drug-related safety hazards, but not patient-related risk factors.  A common target organ of toxicity is the liver and to decrease the likelihood that candidate drugs will cause liver toxicity (both non-idiosyncratic and idiosyncratic), we propose use of an in vitro Hepatic Liability Panel alongside in vitro methods for the detection of RMs.  This will enable design and selection of compds. in discovery that have reduced propensity to cause liver toxicity.  In vitro Hepatic Liability is assessed using toxicity assays that quantify: CYP 450 dependent and CYP 450 independent cell toxicity; mitochondrial impairment; and inhibition of the Bile Salt Export Pump.  Prior to progression into development, a Hepatotoxicity Hazard Matrix combines data from the Hepatic Liability Panel with the Estd. RM Body Burden.  The latter is defined as the level of covalent binding of radiolabeled drug to human hepatocyte proteins in vitro adjusted for the predicted human dose.  We exemplify the potential value of this approach by consideration of the thiazolidinedione class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAv1YMcAPyUrVg90H21EOLACvtfcHk0lgKHUoTIRvUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVyiu7c%253D&md5=54ef4b6d98e18d3b7d3ae75ad0d6c114</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DClaesson%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DRisk%2520assessment%2520and%2520mitigation%2520strategies%2520for%2520reactive%2520metabolites%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D192%26spage%3D65%26epage%3D71%26doi%3D10.1016%2Fj.cbi.2010.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easterwood, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, G. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism and bioactivation of 3-methylindole by human liver microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">140</span>, <span class="refDoi"> DOI: 10.1021/tx060239e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx060239e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=140&issue=1&author=Z.+Yanauthor=L.+M.+Easterwoodauthor=N.+Maherauthor=R.+Torresauthor=N.+Huebertauthor=G.+S.+Yost&title=Metabolism+and+bioactivation+of+3-methylindole+by+human+liver+microsomes&doi=10.1021%2Ftx060239e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Bioactivation of 3-Methylindole by Human Liver Microsomes</span></div><div class="casAuthors">Yan, Zhengyin; Easterwood, LaHoma M.; Maher, Noureddine; Torres, Rhoda; Huebert, Norman; Yost, Garold S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metab. and bioactivation of 3-methylindole (3MI) were investigated in human liver microsomes.  The metab. of two deuterium-labeled analogs of 3MI permitted a relatively unambiguous identification of multiple metabolites and glutathione (GSH) adducts of reactive intermediates.  A total of eight oxidized metabolites were detected, five of which were assigned as previously identified 3-methyloxindole, 3-hydroxy-3-methylindolenine, 3-hydroxy-3-methyloxindole, 5-hydroxy-3-methylindole, and 6-hydroxy-3-methylindole.  Among the three new metabolites, one was either 4- or 7-OH-3-methylindole, and the other two were derived from addnl. oxidn. on the Ph ring of 3-methyloxindole.  When GSH was added to the microsomal incubations, seven conjugates that had mol. ions corresponding to the incorporation of GSH and an atom of oxygen at m/z 453 (group I) were produced, and two addnl. conjugates had mol. ions at m/z 437 that corresponded to the incorporation of GSH with no addnl. oxygen (group II).  Two conjugates in group I (m/z 453) were apparently derived by GSH addn. to the 5,6-epoxide metabolite of 3-methyloxindole.  These two GSH adducts were tentatively identified as 5-(glutathione-S-yl)-3-methyloxindole and 6-(glutathione-S-yl)-3-methyloxindole.  The most abundant conjugate in group I was identified as 3-(glutathione-S-yl)-3-methyloxindole, which substantiated the presence of the putative 2,3-epoxy-3-methylindole intermediate.  The remaining four adducts in group I were likely formed by conjugation of GSH at different positions of the Ph ring, possibly via oxidn. of 5-hydroxy-3-methylindole and 6-hydroxy-3-methylindole to two very interesting new electrophilic benzoquinone imine intermediates.  For the group II conjugates (m/z 437), two isomers were identified as 2-(glutathione-S-yl)-3-methylindole and 3-(glutathione-S-yl-methyl)-indole.  The former adduct was primarily derived from the 2,3-epoxide intermediate by thiol conjugation followed by dehydration.  The latter adduct was consistent with the authors' previously published work on the dehydrogenation of 3MI.  In those studies, the authors showed that the reactive intermediate, 3-methylenenindolenine, was formed by hydrogen abstraction at the Me group and was trapped with GSH.  The putative dehydrogenation bioactivation mechanism is also substantiated by the finding that CYP2E1 selectively generated 2-(glutathione-S-yl)-3-methylindole but did not produce 3-(glutathione-S-yl-methyl)-indole.  In summary, the results not only confirmed the formation of 2,3-epoxide-3-methylindole in human liver microsomes but also suggested that the phenolic metabolites of 3-methylindole were dehydrogenated to previously uncharacterized reactive intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo100nHRgVS8bVg90H21EOLACvtfcHk0lgKHUoTIRvUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCit7rO&md5=e6348f323b09b598ba2d098079f5c056</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx060239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx060239e%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DEasterwood%26aufirst%3DL.%2BM.%26aulast%3DMaher%26aufirst%3DN.%26aulast%3DTorres%26aufirst%3DR.%26aulast%3DHuebert%26aufirst%3DN.%26aulast%3DYost%26aufirst%3DG.%2BS.%26atitle%3DMetabolism%2520and%2520bioactivation%2520of%25203-methylindole%2520by%2520human%2520liver%2520microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26issue%3D1%26spage%3D140%26doi%3D10.1021%2Ftx060239e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alelyunas, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi-Kilby, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span> <span> </span><span class="NLM_article-title">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2009.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejps.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=19429424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=172-182&issue=2&author=Y.+W.+Alelyunasauthor=R.+Liuauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Application+of+a+dried-DMSO+rapid+throughput+24-h+equilibrium+solubility+in+advancing+discovery+candidates&doi=10.1016%2Fj.ejps.2009.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span></div><div class="casAuthors">Alelyunas, Yun W.; Liu, Ruifeng; Pelosi-Kilby, Luciana; Shen, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-182</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A rapid throughput equil. soly. measurement is described.  The method utilizes central liq. storage where compds. are stored as 10 mM soln. in DMSO.  The DMSO is subsequently removed to generate solid like material used for soly. measurement.  A full range of available technologies is used including automated liq. handling, automated data collection using both HPLC/UV and LC/MS/MS.  The method is fully validated and has been used to measure soly. for over 20,000 compds. across all phases of drug discovery.  A detailed discussion on data interpretation and comparison to traditional soly. measurement using solid material is presented.  An inhouse soly. predictive model has been developed from the vast data set and has been employed successfully as part of compd. design resulting in over 30% redn. in the no. of poorly sol. compd. synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUrCZlVKS_bVg90H21EOLACvtfcHk0lgKHUoTIRvUZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D&md5=6ee437462b50cc0c4acfd6d2f27b6405</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DApplication%2520of%2520a%2520dried-DMSO%2520rapid%2520throughput%252024-h%2520equilibrium%2520solubility%2520in%2520advancing%2520discovery%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D37%26issue%3D2%26spage%3D172%26epage%3D182%26doi%3D10.1016%2Fj.ejps.2009.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span> <span> </span><span class="NLM_article-title">Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1715</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1002/rcm.5026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1002%2Frcm.5026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=21598331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtlagu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1715-1724&author=Y.+Zhangauthor=N.+Liauthor=P.+W.+Brownauthor=J.+S.+Ozerauthor=Y.+Lai&title=Liquid+chromatography%2Ftandem+mass+spectrometry+based+targeted+proteomics+quantification+of+P-glycoprotein+in+various+biological+samples&doi=10.1002%2Frcm.5026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples</span></div><div class="casAuthors">Zhang, Yiqun; Li, Na; Brown, Paul W.; Ozer, Josef S.; Lai, Yurong</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1715-1724</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">P-Glycoprotein (P-gp/ABCB1) is expressed in membrane barriers to exclude pharmacol. substrates from cells, and therefore influences the ADME/Tox properties and efficacy of therapeutics.  In the present study, a liq. chromatog./tandem mass spectrometry (LC/MS/MS)-mediated targeted proteomics was developed to quantitate P-gp protein.  With the aid of in silico predictive tools, a unique 9-mer tryptic peptide of P-gp protein was synthesized (with the stable isotope labeled (SIL) peptide as internal std.) and applied for quant. LC/MS/MS method development.  For LC/MS/MS quantification, the N-glycosylation of the peptide, polymorphism and transmembrane region was intended to be excluded during the peptide selection.  The lower limit of quantification was established to be 0.025 nM with the linearity of the std. curve ranging to 20 nM of P-gp signature peptides in the matrix digested surrogate bovine serum albumin.  The digestion efficiency, both the accuracy (relative error) and the precision (coeff. of variation) of the method, was verified by using the synthetic quantification peptide and the synthetic surrogate substrate peptide that mimics the sequence of tryptic peptide and assocd. flanking tryptic cleavage sites at the N- and C-terminals.  By applying the method developed, the abs. amts. of human, dog and mouse P-gp (Mdr1a) were quantified in various biol. samples.  LC/MS/MS-mediated P-gp quantification was achieved as a highly sensitive, selective and reproducible assay and could be directly applicable to many current research needs related to P-gp.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrryW5IZccQR7Vg90H21EOLACvtfcHk0lgT2ThES38_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtlagu7c%253D&md5=a3538519f54b61e55916d995dbe9f6f0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Frcm.5026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.5026%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DBrown%26aufirst%3DP.%2BW.%26aulast%3DOzer%26aufirst%3DJ.%2BS.%26aulast%3DLai%26aufirst%3DY.%26atitle%3DLiquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%2520based%2520targeted%2520proteomics%2520quantification%2520of%2520P-glycoprotein%2520in%2520various%2520biological%2520samples%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2011%26volume%3D25%26spage%3D1715%26epage%3D1724%26doi%3D10.1002%2Frcm.5026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjöberg, Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannergren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungell, A.-L.</span></span> <span> </span><span class="NLM_article-title">Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2012.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejps.2012.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=23103351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fos1Srsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=166-180&author=%C3%85.+Sj%C3%B6bergauthor=M.+Lutzauthor=C.+Tannergrenauthor=C.+Wingolfauthor=A.+Bordeauthor=A.-L.+Ungell&title=Comprehensive+study+on+regional+human+intestinal+permeability+and+prediction+of+fraction+absorbed+of+drugs+using+the+Ussing+chamber+technique&doi=10.1016%2Fj.ejps.2012.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique</span></div><div class="casAuthors">Sjoberg ¡ÑÜAsa; Lutz Mareike; Tannergren Christer; Wingolf Caroline; Borde Anders; Ungell Anna-Lena</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">166-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this study was to evaluate the use of human intestinal tissue in Ussing chamber to predict oral and colonic drug absorption and intestinal metabolism.  Data on viability, correlation between apparent permeability coefficients (P(app)) and fraction absorbed (f(a)) after oral and colonic administration, regional permeability, active uptake and efflux of drugs as well as intestinal metabolism were compiled from experiments using 159 human donors.  Permeability coefficients for up to 28 drugs were determined using one or several of four intestinal regions: duodenum, jejunum, ileum and colon and 10 drugs were studied bidirectionally.  Viability was monitored simultaneously with transport experiments by recording potential difference (PD), short-circuit current (SCC) and the resistance (TER).  Intestinal metabolism was studied using testosterone and midazolam as probe substrates.  There was a steep sigmoidal correlation between P(app) in the Ussing chamber, using jejunal segments, and oral f(a) in humans, for a set of 25 drugs (R(2): 0.85, p<0.01).  A clear sigmoidal relationship was also obtained between P(app) in colonic segments and f(a) after colonic administration in humans for a set of 10 drugs (R(2): 0.93, p<0.05).  Regional permeability data showed a tendency for highly permeable compounds to have higher or similar P(app) in colon as in the small intestinal segments, while the colonic regions showed a lower P(app) for more polar compounds as well as for d-glucose and l-leucine.  Bidirectional transport (mucosa to serosa and serosa to mucosa direction) in jejunum showed well functioning efflux- and uptake asymmetry.  Intestinal metabolic extraction during transport across jejunum segments was found for both testosterone and midazolam.  In conclusion, viable excised human intestine mounted in the Ussing chamber, is a powerful technique for predicting regional fraction absorbed (f(a)), transporter-mediated uptake or efflux as well as intestinal metabolism of drug candidates in man.  Furthermore, a sigmoidal relationship of P(app) vs. f(a) was obtained when permeability data from the present study were merged with data from 2 other independent laboratories (R(2): 0.83, p<0.01).  The correlation curve reported can be used by any laboratory for predictions of human permeability and f(a)(.) In addition, for the first time a correlation curve between colonic P(app) and human colonic f(a) is reported, which demonstrates the usefulness of this methodology in early assessment of the colonic absorption potential of extended release formulation candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-JxodOyNmjxpyrDyM_m9cfW6udTcc2eY6ji3dt1UEpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fos1Srsg%253D%253D&md5=03bdd068c6297471a2086e0f7f2cc0a2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2012.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2012.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6berg%26aufirst%3D%25C3%2585.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3DTannergren%26aufirst%3DC.%26aulast%3DWingolf%26aufirst%3DC.%26aulast%3DBorde%26aufirst%3DA.%26aulast%3DUngell%26aufirst%3DA.-L.%26atitle%3DComprehensive%2520study%2520on%2520regional%2520human%2520intestinal%2520permeability%2520and%2520prediction%2520of%2520fraction%2520absorbed%2520of%2520drugs%2520using%2520the%2520Ussing%2520chamber%2520technique%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D48%26spage%3D166%26epage%3D180%26doi%3D10.1016%2Fj.ejps.2012.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.</span></span> <span> </span><span class="NLM_article-title">Adenosine is not a direct GHSR agonist-artificial cross-talk between GHSR and adenosine receptor pathways</span>. <i>Acta Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-201X.2007.01691.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1111%2Fj.1365-201X.2007.01691.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17428235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2007&pages=77-86&author=N.+O.+Hermanssonauthor=D.+G.+Morganauthor=T.+Drmotaauthor=N.+Larsson&title=Adenosine+is+not+a+direct+GHSR+agonist-artificial+cross-talk+between+GHSR+and+adenosine+receptor+pathways&doi=10.1111%2Fj.1365-201X.2007.01691.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine is not a direct GHSR agonist - artificial cross-talk between GHSR and adenosine receptor pathways</span></div><div class="casAuthors">Hermansson, N.-O.; Morgan, D. G. A.; Drmota, T.; Larsson, N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aim: To assess if adenosine is a direct growth hormone secretagogue receptor (GHSR) agonist by investigating the mechanism behind adenosine induced calcium release in human embryonic kidney 293s (HEK) cells expressing GHSR.  Methods: Calcium mobilization, cAMP (cAMP) and IP3 expts. were performed using HEK cells stably expressing GHSR and/or adenosine A2B receptor (A2BR).  Results: Adenosine has been widely reported as a GHSR agonist.  In our hands, adenosine and forskolin stimulated calcium release from IP3 controlled stores in HEK-GHSR cells but not in non-transfected HEK cells.  This release was not accompanied by increased IP3 levels.  The calcium release was both cholera toxin and U73122 sensitive, indicating the involvement of both Gαs/adenylyl cyclase and Gαq/11/phospholipase C pathways.  Importantly, the GHSR inverse agonist [D-Arg1 D-Phe5 D-Trp7,9 Leu11]-Substance P (SP-analog) blocked the adenosine stimulated calcium release, demonstrating that GHSR is involved.  Assessment of the GHSR-dependent calcium release using adenosine receptor agonists and antagonists resulted in a rank order of potencies resembling the profile of A2BR.  A2BR over-expression in HEK-GHSR cells enhanced potency and efficacy of the adenosine induced calcium release without increasing IP3 prodn.  Moreover, A2BR over-expression in HEK cells potentiated NECA-induced cAMP prodn.  However, GHSR expression had no effect on intracellular cAMP prodn.  Conclusion: In HEK-GHSR cells adenosine activates endogenously expressed A2BR resulting in calcium mobilization.  We hypothesize that the responsible mechanism is cAMP-dependent sensitization of IP3 receptors for the high basal level of IP3 caused by GHSR constitutive activity.  Altogether, our results demonstrate that adenosine is not a direct GHSR agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xsD9OHtxHLVg90H21EOLACvtfcHk0lgT2ThES38_YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D&md5=70f0cb61ba1421cb2d30c51ef4044a43</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-201X.2007.01691.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-201X.2007.01691.x%26sid%3Dliteratum%253Aachs%26aulast%3DHermansson%26aufirst%3DN.%2BO.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DN.%26atitle%3DAdenosine%2520is%2520not%2520a%2520direct%2520GHSR%2520agonist-artificial%2520cross-talk%2520between%2520GHSR%2520and%2520adenosine%2520receptor%2520pathways%26jtitle%3DActa%2520Physiol.%26date%3D2007%26volume%3D190%26spage%3D77%26epage%3D86%26doi%3D10.1111%2Fj.1365-201X.2007.01691.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourrier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansanay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhaire, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernout, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrétien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapleur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">D-myo-inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ab.2006.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=16965760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=126-135&author=E.+Trinquetauthor=M.+Finkauthor=H.+Bazinauthor=F.+Grilletauthor=F.+Maurinauthor=E.+Bourrierauthor=H.+Ansanayauthor=C.+Leroyauthor=A.+Michaudauthor=T.+Durrouxauthor=D.+Maurelauthor=F.+Malhaireauthor=C.+Goudetauthor=J.+P.+Pinauthor=M.+Navalauthor=O.+Hernoutauthor=F.+Chr%C3%A9tienauthor=Y.+Chapleurauthor=G.+Mathis&title=D-myo-inositol+1-phosphate+as+a+surrogate+of+d-myo-inositol+1%2C4%2C5-tris+phosphate+to+monitor+G+protein-coupled+receptor+activation&doi=10.1016%2Fj.ab.2006.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">D-myo-Inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span></div><div class="casAuthors">Trinquet, Eric; Fink, Michel; Bazin, Herve; Grillet, Florence; Maurin, Fabrice; Bourrier, Emmanuel; Ansanay, Herve; Leroy, Cedric; Michaud, Audrey; Durroux, Thierry; Maurel, Damien; Malhaire, Fanny; Goudet, Cyril; Pin, Jean-Philippe; Naval, Magali; Hernout, Olivier; Chretien, Francoise; Chapleur, Yves; Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-135</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phospholipase C β (PLC-β)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-β hydrolysis product, or by measuring the prodn. of inositol phosphate using cumbersome radioactive assays.  A specific detection of IP3 prodn. was also established using IP3 binding proteins.  The short lifetime of IP3 makes this detection very challenging in measuring GPCR responses.  Indeed, this IP3 rapidly enters the metabolic inositol phosphate cascade.  It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.  We show here that IP1 can be used as a surrogate of IP3 to monitor GPCR activation.  We developed a novel homogeneous time-resolved fluorescence (HTRF) assay that correlates perfectly with existing methods and is easily amenable to high-throughput screening.  The IP-One assay was validated on various GPCR models.  It has the advantage over the traditional Ca2+ assay of allowing the measurement of inverse agonist activity as well as the anal. of PLC-β activity in any nontransfected primary cultures.  Finally, the high assay specificity for D-myo-inositol 1 monophosphate (IP1(1)) opens new possibilities in developing selective assays to study the functional roles of the various isoforms of inositol phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFlTq9szK1LVg90H21EOLACvtfcHk0lhN631U1Vwbdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ&md5=fce292860fb4d99a590a9118772d9f58</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DFink%26aufirst%3DM.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DGrillet%26aufirst%3DF.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMaurel%26aufirst%3DD.%26aulast%3DMalhaire%26aufirst%3DF.%26aulast%3DGoudet%26aufirst%3DC.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DNaval%26aufirst%3DM.%26aulast%3DHernout%26aufirst%3DO.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DF.%26aulast%3DChapleur%26aufirst%3DY.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DD-myo-inositol%25201-phosphate%2520as%2520a%2520surrogate%2520of%2520d-myo-inositol%25201%252C4%252C5-tris%2520phosphate%2520to%2520monitor%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D126%26epage%3D135%26doi%3D10.1016%2Fj.ab.2006.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergsdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp-Goerkis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaehler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parczyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">A one-day, dispense-only IP-one HTRF assay for high-throughput screening of Gaq protein-coupled receptors: towards cells as reagents</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1089/adt.2007.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1089%2Fadt.2007.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=18315499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=39-53&author=C.+Bergsdorfauthor=C.+Kropp-Goerkisauthor=I.+Kaehlerauthor=L.+Ketscherauthor=U.+Boemerauthor=K.+Parczykauthor=B.+Bader&title=A+one-day%2C+dispense-only+IP-one+HTRF+assay+for+high-throughput+screening+of+Gaq+protein-coupled+receptors%3A+towards+cells+as+reagents&doi=10.1089%2Fadt.2007.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A One-Day, Dispense-Only IP-One HTRF Assay for High-Throughput Screening of Gαq Protein-Coupled Receptors: Towards Cells as Reagents</span></div><div class="casAuthors">Bergsdorf, Christian; Kropp-Goerkis, Carmen; Kaehler, Irene; Ketscher, Lars; Boemer, Ulf; Parczyk, Karsten; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-53</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Compared to biochem. high-throughput screening (HTS) assays, cell-based functional assays are generally thought to be more time consuming and complex because of addnl. efforts for running continuous cell cultures as well as the numerous assay steps when transferring media and compds.  A common strategy to compensate the anticipated redn. in overall throughput is to implement highly automated cell culture and screening systems.  However, such systems require substantial investments in sophisticated hardware and highly specialized personnel.  In trying to set up alternatives to increasing throughput in functional cell-based screening, the authors combined several approaches.  By using cryopreserved cell aliquots instead of continuous cell culture, cells in suspension instead of adherent cells, and "ready-to-screen" assay plates with nanoliter aliquots of test compds., an assay procedure was developed that very much resembles a std. biochem., enzymic assay comprising only a few dispense steps.  Chinese hamster ovary cells stably overexpressing a Gαq-coupled receptor were used as a model system to measure receptor activation by detection of intracellular D-myo-inositol 1-phosphate with the help of homogeneous time-resolved fluorescence (HTRF, CISbio International, Bagnols-sur-Ceze, France).  Initially established in 384-well adherent cell format, the assay was successfully transferred to 1536-well format.  The assay quality was sufficient to run HTS campaigns in both formats with good Z'-factors and excellent reproducibility of antagonists.  Subsequently, the assay procedure was optimized for usage of suspension cells.  The influences of cell culture media, plate type, cell no., and incubation time were assessed.  Finally, the suspension cell assay was applied to pharmacol. characterization of a small mol. antagonist by Schild plot anal.  The authors' data demonstrate not only the application of the IP-One HTRF assay (CISbio International) for HTS in a high-d. format, but furthermore the successful use of cryopreserved and suspension cells in a one-day functional cell-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5f7PM16SSl7Vg90H21EOLACvtfcHk0lhN631U1Vwbdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtb8%253D&md5=4966cfdf7e3c87080a7993e623b3f6de</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.108%26sid%3Dliteratum%253Aachs%26aulast%3DBergsdorf%26aufirst%3DC.%26aulast%3DKropp-Goerkis%26aufirst%3DC.%26aulast%3DKaehler%26aufirst%3DI.%26aulast%3DKetscher%26aufirst%3DL.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DParczyk%26aufirst%3DK.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DA%2520one-day%252C%2520dispense-only%2520IP-one%2520HTRF%2520assay%2520for%2520high-throughput%2520screening%2520of%2520Gaq%2520protein-coupled%2520receptors%253A%2520towards%2520cells%2520as%2520reagents%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D39%26epage%3D53%26doi%3D10.1089%2Fadt.2007.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lamiaa  Ouchakour</span>, <span class="hlFld-ContribAuthor ">Melinda  Nonn</span>, <span class="hlFld-ContribAuthor ">Attila M.  Remete</span>, <span class="hlFld-ContribAuthor ">Loránd  Kiss</span>. </span><span class="cited-content_cbyCitation_article-title">An Improved Stereocontrolled Access Route to Piperidine or Azepane β‐Amino Esters and Azabicyclic β‐ and γ‐Lactams; Synthesis of Novel Functionalized Azaheterocyles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (28)
                                     , 3874-3885. <a href="https://doi.org/10.1002/ejoc.202100540" title="DOI URL">https://doi.org/10.1002/ejoc.202100540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100540%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAn%252BImproved%252BStereocontrolled%252BAccess%252BRoute%252Bto%252BPiperidine%252Bor%252BAzepane%252B%2525CE%2525B2%2525E2%252580%252590Amino%252BEsters%252Band%252BAzabicyclic%252B%2525CE%2525B2%2525E2%252580%252590%252Band%252B%2525CE%2525B3%2525E2%252580%252590Lactams%25253B%252BSynthesis%252Bof%252BNovel%252BFunctionalized%252BAzaheterocyles%26aulast%3DOuchakour%26aufirst%3DLamiaa%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D28%26spage%3D3874%26epage%3D3885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Jia</span>, <span class="hlFld-ContribAuthor ">Gongruixue  Zeng</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>, <span class="hlFld-ContribAuthor ">Linghui  Zeng</span>, <span class="hlFld-ContribAuthor ">Wenya  Zheng</span>, <span class="hlFld-ContribAuthor ">Siyao  Li</span>, <span class="hlFld-ContribAuthor ">Keyi  Wu</span>, <span class="hlFld-ContribAuthor ">Jiaan  Shao</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">The reaction of prop-2-ynylsulfonium salts and sulfonyl-protected β-amino ketones to epoxide-fused 2-methylenepyrrolidines and S-containing pyrroles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (21)
                                     , 2657-2660. <a href="https://doi.org/10.1039/D0CC07745C" title="DOI URL">https://doi.org/10.1039/D0CC07745C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC07745C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC07745C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DThe%252Breaction%252Bof%252Bprop-2-ynylsulfonium%252Bsalts%252Band%252Bsulfonyl-protected%252B%2525CE%2525B2-amino%252Bketones%252Bto%252Bepoxide-fused%252B2-methylenepyrrolidines%252Band%252BS-containing%252Bpyrroles%26aulast%3DJia%26aufirst%3DTingting%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D21%26spage%3D2657%26epage%3D2660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported indane compound <b>1</b>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> related pyrrolidine and piperidine compounds <b>2a</b> and <b>3a</b>, and optimized compound <b>12j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrrolidine Stereoisomers <b>2a</b>, <b>4</b>, and <b>rac-5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, rt, 16 h; (b) (i) TMSCl, EtOH; (ii) benzenesulfonyl chloride, pyridine, DCM, 4 h; (c) (i) LiOH, THF, MeOH, H<sub>2</sub>O, rt, 3 h; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, 20 °C, 16 h; (d) chiral HPLC.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the Piperidine Enantiomers <b>3a</b>, <b>6</b>, and <b>rac-7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzenesulfonyl chloride, Et<sub>3</sub>N, DCM, 4 h; (b) (i) TFA, DCM, 10 min.; (ii) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, rt, 16 h; (c) (i) LiOH, THF, H<sub>2</sub>O, 35 °C, 1 h; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, rt, 16 h; (d) chiral SFC chromatography; (e) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HBTU, Et<sub>3</sub>N, MeCN, rt, 0.5 h; (f) TFA, DCM; (g) NaOH 1M, THF, 40 °C, 4 h; (h) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, DMSO, 0.5 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Piperidine Derivatives <b>3b</b>–<b>e</b> and <b>3g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CbzCl, NaHCO<sub>3</sub>, DCM, 0 °C, then rt overnight; (b) TFA, DCM; (c) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, DIPEA, DMF, 20 °C, overnight; (d) LiOH, MeCN, H<sub>2</sub>O, 35 °C, 1 h; (e) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, DIPEA, DMF, 20 °C, 16 h; (f) H<sub>2</sub>, 5% Pd/C, MeOH; (g) R<sub>1</sub>SO<sub>2</sub>Cl or nicotinoyl chloride, Et<sub>3</sub>N, MeCN, rt, 2 h; (h) chiral SFC chromatography.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Piperidine Derivatives <b>11a</b>,<b>b</b> and <b>3f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) RSO<sub>2</sub>Cl, Et<sub>3</sub>N, DCM; (b) NaOH 1N, THF, H<sub>2</sub>O, 35 °C, 1 h; (c) (<i>S</i>)-1-methylpiperidin-3-amine or <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, DMSO; (d) (<i>S</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate, HBTU, Et<sub>3</sub>N, DCM, closed vial, 45 min; (e) TFA, DCM, 0.5 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of the Alternative Piperidine Regioisomers <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzenesulfonyl chloride, Et<sub>3</sub>N, DCM, 16 h; (b) NH<sub>4</sub>OAc, EtOH, 50 °C, 1.5 h; (c) NaBH(OAc)<sub>3</sub>, AcOH, MeCN, 1 h; (d) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HBTU, Et<sub>3</sub>N, DCM, 20 °C, 1 h; (e) (i) NaOH, H<sub>2</sub>O, THF; (ii) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HBTU, Et<sub>3</sub>N, MeCN, 20 °C, 1 h; (f) RP preparative HPLC.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Pyrrolidine Common Intermediate <b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (<i>S</i>)-α-methylbenzylamine, MeOH, AcOH;<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> (b) NaBH<sub>4</sub>, AcOH, MeCN, 0–5 °C, 20 h; (c) (i) DBU (0.2 equiv), MeOH, 50 °C, 4 h; (ii) HCl, 1,4-dioxane, EtOAc, 0–3 °C, 1 h; (d) H<sub>2</sub> 4 bar, 10% Pd/C, EtOH, rt, 20 h.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Methods A and B for Synthesis of Final Compounds <b>2a</b>–<b>g</b> and <b>10a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, NMM, DMF, 20 °C, 16 h; (b) LiOH, H<sub>2</sub>O, THF; (c) <i>N</i><sub>1</sub>,<i>N</i><sub>1</sub>-dimethylethane-1,2-diamine, HATU, Et<sub>3</sub>N, DCM–DMF, 20 °C, 16 h; (d) TMSCl, MeOH; (e) benzenesulfonyl chloride, pyridine, DCM, rt, 16 h; (f) mono Boc-protected diamine or <i>N</i>-Me diamine, HATU, Et<sub>3</sub>N, DMF, 20 °C, 16 h.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Method C: Synthesis of Final Compounds <b>12a</b>–<b>m</b>, <b>16b</b>, and <b>16d</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, DCM; (b) benzenesulfonyl chloride, pyridine, DCM, 16 h; (c) LiOH, H<sub>2</sub>O, MeOH, THF, 1 h; (d) mono Boc-protected diamine, HATU, NMM, DMF, 20 °C, 16 h; (e) H<sub>2</sub>, Pd(OH)<sub>2</sub>, EtOH; (f) aromatic carboxylic acid, HATU, NMM, DMF, 20 °C, 16 h; (g) HCO<sub>2</sub>H, 60 °C, 30 min; (h) HCHO, HCO<sub>2</sub>H, 90 °C, 30 min; (i) HCO<sub>2</sub>Et, reflux, 1.5 h; (j) Ac<sub>2</sub>O, NaHCO<sub>3</sub>, MeTHF.</p></p></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of N-Methylated Compounds<b>16a</b> and <b>16c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HCHO, HCO<sub>2</sub>H, 90 °C, 15 min; (b) H<sub>2</sub> 4 bar, 10% Pd/C, MeOH, 20 °C, 3 h; (c) 5-(2-chlorophenyl)isoxazole-3-carboxylic acid, HATU, NMM, DMF, 20 °C, 1 h; (d) H<sub>2</sub>SO<sub>4</sub>, H<sub>2</sub>O, THF, 70 °C, 16 h; (e) <i>tert-</i>butyl (3<i>S</i>)-3-aminopiperidine-1-carboxylate or <i>tert-</i>butyl (3<i>S</i>)-3-(methylamino)piperidine-1-carboxylate, HATU, NMM, DMF, 20 °C, 1 h; (f) HCO<sub>2</sub>H, 60 °C, 30 min.</p></p></figure><figure data-id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0017.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of the α-Methyl Compound <b>13b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) TFA, toluene 0 °C, 0.5 h, 49%; (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, MeOH, 20 °C, 24 h; (c) PhSO<sub>2</sub>Cl, NaHCO<sub>3</sub> (aq), MeTHF, 20 °C, 18 h, then 40 °C, 3 h, 72%; (d) NaOH<sub>(aq)</sub>, THF, MeOH, 0–10 °C, 3 h, then 20 °C, 20 h, 82% (crude); (e) diphenyl phosphorazidate, Et<sub>3</sub>N, toluene, 8 h, BnOH, 1 h, 53% (crude); (f) NaOH, THF, MeOH, 15 min; (g) <i>tert</i>-butyl (3<i>S</i>)-3-aminopiperidine-1-carboxylate, HATU, Et<sub>3</sub>N, DMF, 20 °C, 0.5 h; (h) H<sub>2</sub>, Pd(OH)<sub>2</sub>, EtOH, 20 °C, 3 days; (i) 5-methyl-1<i>H</i>-indole-2-carboxylic acid, HATU, Et<sub>3</sub>N, DMF, 20 °C, 0.5 h; (j) HCO<sub>2</sub>H, 60 °C, 0.5 h.</p></p></figure><figure data-id="fig2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overlay of putative binding modes of compounds <b>1</b> (orange carbons) and <b>2a</b> (turquoise carbons) in human ghrelin receptor homology model obtained by molecular mechanical energy minimization using MacroModel (Schrodinger LLC). This homology model was built using the program MOE (Chemical Computing Group)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the X-ray crystallographic structure of the agonist-bound rat neurotensine receptor 1 as a template (PDB access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Energy minimization included high-quality all-atom OPLS3e force field<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and GB/SA effective solvation model<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> as incorporated into MacroModel and involved the bound ligand and nearby amino acid side chains of ghrelin receptor located closer than 7 Å from ligand. Nonpolar hydrogens are omitted for clarity. The area of structural differences between indanes and pyrrolidines (piperidines) is highlighted by the red circle. Ligand–receptor H-bonds are shown by red dashed lines. New H-bonding interactions with the new cores are likely made by residue S123. Residues F119 and S123 are known to constitute the efficacy switch region.<a onclick="showRef(event, 'ref21 ref28'); return false;" href="javascript:void(0);" class="ref ref21 ref28">(21,28)</a> Approximate direction of the long axis of the homology model and the rigid indole–carboxamide moiety of bound molecules toward the extracellular loops is indicated by the green arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0003.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of putative binding modes of <b>2a</b> (turquoise carbons) and <b>12j</b> (pink carbons) in human ghrelin receptor homology model obtained by molecular mechanical energy minimization using MacroModel (Schrodinger LLC). The homology model was built using the program MOE (Chemical Computing Group)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the X-ray crystallographic structure of the agonist-bound rat neurotensine receptor 1 as a template (PDB access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Nonpolar hydrogens are omitted for clarity. The conformational out-of-plane effect of 2-chloro-substituent within the biaryl moiety of <b>12j</b> leads to the attractive cation−π interaction with the side chain of R199.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0004.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dog PK/PD data for <b>12j</b>: IGF-1 increase from baseline (left) and plasma concentration (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0005.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Fabs in different species of compounds <b>12d</b> and <b>12j</b>: pink dot, female; yellow triangle, male; blue diamond and gray diamond, undefinied.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0006.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ussing chamber permeability (<i>P</i><sub>app</sub>) of compounds <b>12j</b> and <b>12d</b> in rat (green) and human (purple) jejunum tissue: AtB = apical to basal; BtA = basal to apical permeability.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/medium/jm0c00828_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0007.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Pharmacokinetics of <b>16d</b> in male HW rats, dose 1 mg/kg (iv), 2.8 mg/kg (oral): blue dot, parent <b>16d</b>; orange dot, metabolite <b>12j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00828/20200903/images/large/jm0c00828_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00828&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span>, <span class="refDoi"> DOI: 10.1016/S0196-9781(01)00633-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2FS0196-9781%2801%2900633-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=11836003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=531-536&author=I.+Sakataauthor=K.+Nakamuraauthor=M.+Yamazakiauthor=M.+Matsubaraauthor=Y.+Hayashiauthor=K.+Kangawaauthor=T.+Sakai&title=Ghrelin-producing+cells+exist+as+two+types+of+cells%2C+closed-+and+opened-type+cells%2C+in+the+rat+gastrointestinal+tract&doi=10.1016%2FS0196-9781%2801%2900633-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin-producing cells exist as two types of cells, closed- and opened-type cells, in the rat gastrointestinal tract</span></div><div class="casAuthors">Sakata, Ichiro; Nakamura, Kazuaki; Yamazaki, Mami; Matsubara, Maki; Hayashi, Yuijiro; Kangawa, Kenji; Sakai, Takafumi</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Ghrelin was recently isolated from the rat stomach as an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R) and is known to exist in the gastrointestinal tract and hypothalamus.  In this study, the authors investigated in detail the distribution and morphol. characteristics of ghrelin-contg. cells (ghrelin cells) in the gastrointestinal tract by immunohistochem. and in situ hybridization.  Ghrelin cells were found to be localized in the mucous membrane of the stomach, duodenum, ileum, cecum and colon but not in myenteric plexus, and they can be classified into open- and closed-type cells.  The greatest no. of ghrelin cells was found in the stomach, and it was found that the no. of the opened-type cells gradually increased in the direction from stomach to the lower gastrointestinal tract.  These results suggest that the two types of ghrelin cells may be distinctly regulated and play different physiol. roles in various regions of the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPBfgaJT_67Vg90H21EOLACvtfcHk0lgUs5NRbpN62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVKrsb8%253D&md5=1624e2c509d4cc8f7711834a18c09877</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2801%2900633-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252801%252900633-7%26sid%3Dliteratum%253Aachs%26aulast%3DSakata%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DM.%26aulast%3DMatsubara%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DT.%26atitle%3DGhrelin-producing%2520cells%2520exist%2520as%2520two%2520types%2520of%2520cells%252C%2520closed-%2520and%2520opened-type%2520cells%252C%2520in%2520the%2520rat%2520gastrointestinal%2520tract%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D531%26epage%3D536%26doi%3D10.1016%2FS0196-9781%2801%2900633-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span> <span> </span><span class="NLM_article-title">The homeostatic force of ghrelin</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.cmet.2018.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=29576534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOhu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=786-804&issue=4&author=S.+Yanagiauthor=T.+Satoauthor=K.+Kangawaauthor=M.+Nakazato&title=The+homeostatic+force+of+ghrelin&doi=10.1016%2Fj.cmet.2018.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Homeostatic Force of Ghrelin</span></div><div class="casAuthors">Yanagi, Shigehisa; Sato, Takahiro; Kangawa, Kenji; Nakazato, Masamitsu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">786-804</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Ghrelin, a gastric-derived acylated peptide, regulates energy homeostasis by transmitting information about peripheral nutritional status to the brain, and is essential for protecting organisms against famine.  Ghrelin operates brain circuits to regulate homeostatic and hedonic feeding.  Recent research advances have shed new light on ghrelin's multifaceted roles in cellular homeostasis, which could maintain the internal environment and overcome metaflammation in metabolic organs.  Here, we highlight our current understanding of the regulatory mechanisms of the ghrelin system in energy metab. and cellular homeostasis and its clin. trials.  Future studies of ghrelin will further elucidate how the stomach regulates systemic homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7OKGdGduDnLVg90H21EOLACvtfcHk0lgUs5NRbpN62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOhu7c%253D&md5=04b47ab4be17c8751d6d7e5d67a6ef86</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DNakazato%26aufirst%3DM.%26atitle%3DThe%2520homeostatic%2520force%2520of%2520ghrelin%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26issue%3D4%26spage%3D786%26epage%3D804%26doi%3D10.1016%2Fj.cmet.2018.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueiras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andermann, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anker, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batterham, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benoit, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broglio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanueva, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Alessio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depoortere, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geliebter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghigo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diéguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granata, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grill, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grove, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habegger, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heppner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korbonits, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laferrère, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeRoux, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Tilve, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfluger, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorner, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Lely, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Ploeg, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zigman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschöp, M. H.</span></span> <span> </span><span class="NLM_article-title">Ghrelin</span>. <i>Mol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">460</span>, <span class="refDoi"> DOI: 10.1016/j.molmet.2015.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.molmet.2015.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=26042199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFemtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=437-460&issue=6&author=T.+D.+M%C3%BCllerauthor=R.+Nogueirasauthor=M.+L.+Andermannauthor=Z.+B.+Andrewsauthor=S.+D.+Ankerauthor=J.+Argenteauthor=R.+L.+Batterhamauthor=S.+C.+Benoitauthor=C.+Y.+Bowersauthor=F.+Broglioauthor=F.+F.+Casanuevaauthor=D.+D%E2%80%99Alessioauthor=I.+Depoortereauthor=A.+Geliebterauthor=E.+Ghigoauthor=P.+A.+Coleauthor=M.+Cowleyauthor=D.+E.+Cummingsauthor=A.+Dagherauthor=S.+Dianoauthor=S.+L.+Dicksonauthor=C.+Di%C3%A9guezauthor=R.+Granataauthor=H.+J.+Grillauthor=K.+Groveauthor=K.+M.+Habeggerauthor=K.+Heppnerauthor=M.+L.+Heimanauthor=L.+Holsenauthor=B.+Holstauthor=A.+Inuiauthor=J.+O.+Janssonauthor=H.+Kirchnerauthor=M.+Korbonitsauthor=B.+Laferr%C3%A8reauthor=C.+W.+LeRouxauthor=M.+Lopezauthor=S.+Morinauthor=M.+Nakazatoauthor=R.+Nassauthor=D.+Perez-Tilveauthor=P.+T.+Pflugerauthor=T.+W.+Schwartzauthor=R.+J.+Seeleyauthor=M.+Sleemanauthor=Y.+Sunauthor=L.+Susselauthor=J.+Tongauthor=M.+O.+Thornerauthor=A.+J.+van+der%0ALelyauthor=L.+H.+van+der+Ploegauthor=J.+M.+Zigmanauthor=M.+Kojimaauthor=K.+Kangawaauthor=R.+G.+Smithauthor=T.+Horvathauthor=M.+H.+Tsch%C3%B6p&title=Ghrelin&doi=10.1016%2Fj.molmet.2015.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin</span></div><div class="casAuthors">Mueller, T. D.; Nogueiras, R.; Andermann, M. L.; Andrews, Z. B.; Anker, S. D.; Argente, J.; Batterham, R.; Benoit, S. C.; Bowers, C. Y.; Broglio, F.; Casanueva, F. F.; D'Alessio, D.; Depoortere, I.; Geliebter, A.; Ghigo, E.; Cole, P. A.; Cowley, M.; Cummings, D. E.; Dagher, A.; Diano, S.; Dickson, S. L.; Dieguez, C.; Granata, R.; Grill, H. J.; Grove, K.; Habegger, K. M.; Heppner, K.; Heiman, M. L.; Holsen, L.; Holst, B.; Inui, A.; Jansson, J. O.; Kirchner, H.; Korbonits, M.; Laferrere, B.; LeRoux, C. W.; Lopez, M.; Morin, S.; Nakazato, M.; Nass, R.; Perez-Tilve, D.; Pfluger, P. T.; Schwartz, T. W.; Seeley, R. J.; Sleeman, M.; Sun, Y.; Sussel, L.; Tong, J.; Thorner, M. O.; van der Lely, A. J.; van der Ploeg, L. H. T.; Zigman, J. M.; Kojima, M.; Kangawa, K.; Smith, R. G.; Horvath, T.; Tschoep, M. H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-460</span>CODEN:
                <span class="NLM_cas:coden">MMOEAS</span>;
        ISSN:<span class="NLM_cas:issn">2212-8778</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">The gastrointestinal peptide hormone ghrelin was discovered in 1999 as the endogenous ligand of the growth hormone secretagogue receptor.  Increasing evidence supports more complicated and nuanced roles for the hormone, which go beyond the regulation of systemic energy metab.  In this review, we discuss the diverse biol. functions of ghrelin, the regulation of its secretion, and address questions that still remain 15 years after its discovery.  In recent years, ghrelin has been found to have a plethora of central and peripheral actions in distinct areas including learning and memory, gut motility and gastric acid secretion, sleep/wake rhythm, reward seeking behavior, taste sensation and glucose metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw5XYL0bEstLVg90H21EOLACvtfcHk0lgVVG_JDUrkKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFemtrc%253D&md5=1e20daf703c9bdcc87d6b3f86813d371</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molmet.2015.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmet.2015.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%2BD.%26aulast%3DNogueiras%26aufirst%3DR.%26aulast%3DAndermann%26aufirst%3DM.%2BL.%26aulast%3DAndrews%26aufirst%3DZ.%2BB.%26aulast%3DAnker%26aufirst%3DS.%2BD.%26aulast%3DArgente%26aufirst%3DJ.%26aulast%3DBatterham%26aufirst%3DR.%2BL.%26aulast%3DBenoit%26aufirst%3DS.%2BC.%26aulast%3DBowers%26aufirst%3DC.%2BY.%26aulast%3DBroglio%26aufirst%3DF.%26aulast%3DCasanueva%26aufirst%3DF.%2BF.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DD.%26aulast%3DDepoortere%26aufirst%3DI.%26aulast%3DGeliebter%26aufirst%3DA.%26aulast%3DGhigo%26aufirst%3DE.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DCowley%26aufirst%3DM.%26aulast%3DCummings%26aufirst%3DD.%2BE.%26aulast%3DDagher%26aufirst%3DA.%26aulast%3DDiano%26aufirst%3DS.%26aulast%3DDickson%26aufirst%3DS.%2BL.%26aulast%3DDi%25C3%25A9guez%26aufirst%3DC.%26aulast%3DGranata%26aufirst%3DR.%26aulast%3DGrill%26aufirst%3DH.%2BJ.%26aulast%3DGrove%26aufirst%3DK.%26aulast%3DHabegger%26aufirst%3DK.%2BM.%26aulast%3DHeppner%26aufirst%3DK.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DHolsen%26aufirst%3DL.%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DJansson%26aufirst%3DJ.%2BO.%26aulast%3DKirchner%26aufirst%3DH.%26aulast%3DKorbonits%26aufirst%3DM.%26aulast%3DLaferr%25C3%25A8re%26aufirst%3DB.%26aulast%3DLeRoux%26aufirst%3DC.%2BW.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DNakazato%26aufirst%3DM.%26aulast%3DNass%26aufirst%3DR.%26aulast%3DPerez-Tilve%26aufirst%3DD.%26aulast%3DPfluger%26aufirst%3DP.%2BT.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DSeeley%26aufirst%3DR.%2BJ.%26aulast%3DSleeman%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSussel%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DJ.%26aulast%3DThorner%26aufirst%3DM.%2BO.%26aulast%3Dvan%2Bder%2BLely%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26aulast%3DZigman%26aufirst%3DJ.%2BM.%26aulast%3DKojima%26aufirst%3DM.%26aulast%3DKangawa%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DHorvath%26aufirst%3DT.%26aulast%3DTsch%25C3%25B6p%26aufirst%3DM.%2BH.%26atitle%3DGhrelin%26jtitle%3DMol.%2520Metab.%26date%3D2015%26volume%3D4%26issue%3D6%26spage%3D437%26epage%3D460%26doi%3D10.1016%2Fj.molmet.2015.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abegg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernasconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riediger, T.</span></span> <span> </span><span class="NLM_article-title">Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1740</span>– <span class="NLM_lpage">1750</span>, <span class="refDoi"> DOI: 10.1111/dom.13020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1111%2Fdom.13020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=28544245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1740-1750&author=K.+Abeggauthor=L.+Bernasconiauthor=M.+Hutterauthor=L.+Whitingauthor=C.+Pietraauthor=C.+Giulianoauthor=T.+A.+Lutzauthor=T.+Riediger&title=Ghrelin+receptor+inverse+agonists+as+a+novel+therapeutic+approach+against+obesity-related+metabolic+disease&doi=10.1111%2Fdom.13020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease</span></div><div class="casAuthors">Abegg, Kathrin; Bernasconi, Lara; Hutter, Melanie; Whiting, Lynda; Pietra, Claudio; Giuliano, Claudio; Lutz, Thomas A.; Riediger, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1740-1750</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Ghrelin is implicated in the control of energy balance and glucose homeostasis.  The ghrelin receptor exhibits ligand-independent constitutive activity, which can be pharmacol. exploited to induce inverse ghrelin actions.  Because ghrelin receptor inverse agonists (GHSR-IA) might be effective for the treatment of obesity-related metabolic disease, we tested 2 novel synthetic compds. GHSR-IA1 and GHSR-IA2.  In functional cell assays, electrophysiogical and immunohistochem. expts., we demonstrated inverse agonist activity for GHSR-IA1 and GHSR-IA2.  We used healthy mice, Zucker diabetic fatty (ZDF) rats and diet-induced obese (DIO) mice to explore effects on food intake (FI), body wt. (BW), conditioned taste aversion (CTA), oral glucose tolerance (OGT), pancreatic islet morphol., hepatic steatosis (HS), and blood lipids.  Both compds. acutely reduced FI in mice without inducing CTA.  Chronic GHSR-IA1 increased metabolic rate in chow-fed mice, suppressed FI, and improved OGT in ZDF rats.  Moreover, the progression of islet hyperplasia to fibrosis in ZDF rats slowed down.  GHSR-IA2 reduced FI and BW in DIO mice, and reduced fasting and stimulated glucose levels compared with pair-fed and vehicle-treated mice.  GHSR-IA2-treated DIO mice showed decreased blood lipids.  GHSR-IA1 treatment markedly decreased HS in DIO mice.  Our study demonstrates therapeutic actions of novel ghrelin receptor inverse agonists, suggesting a potential to treat obesity-related metabolic disorders including diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKxlWZb8nH87Vg90H21EOLACvtfcHk0lie-QZtygd3Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvL&md5=cfc0cd992fdb060af83e4f48128e6ddf</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fdom.13020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13020%26sid%3Dliteratum%253Aachs%26aulast%3DAbegg%26aufirst%3DK.%26aulast%3DBernasconi%26aufirst%3DL.%26aulast%3DHutter%26aufirst%3DM.%26aulast%3DWhiting%26aufirst%3DL.%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DLutz%26aufirst%3DT.%2BA.%26aulast%3DRiediger%26aufirst%3DT.%26atitle%3DGhrelin%2520receptor%2520inverse%2520agonists%2520as%2520a%2520novel%2520therapeutic%2520approach%2520against%2520obesity-related%2520metabolic%2520disease%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2017%26volume%3D19%26spage%3D1740%26epage%3D1750%26doi%3D10.1111%2Fdom.13020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guainazzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia Rubio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoete, V.</span></span> <span> </span><span class="NLM_article-title">Rational design, synthesis, and pharmacological characterization of novel ghrelin receptor inverse agonists as potential treatment against obesity-related metabolic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00794</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00794" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVantLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11039-11060&issue=24&author=A.+Dainaauthor=C.+Giulianoauthor=C.+Pietraauthor=J.+Wangauthor=Y.+Chiauthor=Z.+Zouauthor=F.+Liauthor=Z.+Yanauthor=Y.+Zhouauthor=A.+Guainazziauthor=S.+Garcia+Rubioauthor=V.+Zoete&title=Rational+design%2C+synthesis%2C+and+pharmacological+characterization+of+novel+ghrelin+receptor+inverse+agonists+as+potential+treatment+against+obesity-related+metabolic+diseases&doi=10.1021%2Facs.jmedchem.8b00794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases</span></div><div class="casAuthors">Daina, Antoine; Giuliano, Claudio; Pietra, Claudio; Wang, Junbo; Chi, Yushi; Zou, Zack; Li, Fugang; Yan, Zhonghua; Zhou, Yifan; Guainazzi, Angelo; Garcia Rubio, Silvina; Zoete, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new chemotype of ghrelin inverse agonists was discovered through chimeric design based on mol. scaffolds known as growth-hormone secretagogue receptor (GHSR) modulators but with divergent pharmacodynamic and pharmacokinetic properties.  The structure-activities/properties exploration led to compd. I, which displayed potent human GHSR antagonism and inverse agonism in cellular assays (IC50 = 68 nM, EC50 = 29 nM), moderate oral bioavailability, and notable brain penetration in rat (F = 27%, B/P ratio = 1.9).  First in vivo studies demonstrated effective redn. of food intake after oral or parenteral administration to mouse (78% at 1 h and 38% at 8 h, resp.).  Further preclin. studies are needed to evaluate the most suited mode of administration with the aim of promoting a first central-acting ghrelin inverse agonist mol. to development, which would represent a significant step toward therapeutic agents to treat metabolic disorders related to obesity, such as type 2 diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ1xJll3Qu0LVg90H21EOLACvtfcHk0lie-QZtygd3Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVantLfI&md5=83f3dd140db3f999eeed0158a5dcc9f6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00794%26sid%3Dliteratum%253Aachs%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DPietra%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChi%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuainazzi%26aufirst%3DA.%26aulast%3DGarcia%2BRubio%26aufirst%3DS.%26aulast%3DZoete%26aufirst%3DV.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520novel%2520ghrelin%2520receptor%2520inverse%2520agonists%2520as%2520potential%2520treatment%2520against%2520obesity-related%2520metabolic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D24%26spage%3D11039%26epage%3D11060%26doi%3D10.1021%2Facs.jmedchem.8b00794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeglin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demange, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">M’Kadmi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denoyelle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J.-A.</span></span> <span> </span><span class="NLM_article-title">The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1355-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1007%2Fs00726-012-1355-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=22798076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=301-314&issue=2&author=A.+Moulinauthor=L.+Brunelauthor=D.+Boeglinauthor=L.+Demangeauthor=J.+Ryanauthor=C.+M%E2%80%99Kadmiauthor=S.+Denoyelleauthor=J.+Martinezauthor=J.-A.+Fehrentz&title=The+1%2C2%2C4-triazole+as+a+scaffold+for+the+design+of+ghrelin+receptor+ligands%3A+development+of+JMV+2959%2C+a+potent+antagonist&doi=10.1007%2Fs00726-012-1355-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist</span></div><div class="casAuthors">Moulin, Aline; Brunel, Luc; Boeglin, Damien; Demange, Luc; Ryan, Johanne; M'Kadmi, Celine; Denoyelle, Severine; Martinez, Jean; Fehrentz, Jean-Alain</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-314</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">SpringerWienNewYork</span>)
        </div><div class="casAbstract">Ghrelin is a 28-residue peptide acylated with an n-octanoyl group on the Ser 3 residue, predominantly produced by the stomach.  Ghrelin displays strong growth hormone (GH) releasing activity, which is mediated by the activation of the so-called GH secretagogue receptor type 1a (GHS-R1a).  Given the wide spectrum of biol. activities of Ghrelin in neuroendocrine and metabolic pathways, many research groups, including our group, developed synthetic peptide, and nonpeptide GHS-R1a ligands, acting as agonists, partial agonists, antagonists, or inverse agonists.  In this highlight article, we will focus on the discovery of a GHS-R1a antagonist compd., JMV 2959, which has been extensively studied in different in vitro and in vivo models.  We will first describe the peptidomimetic approach that led us to discover this compd.  Then we will review the results obtained with this compd. in different studies in the fields of food intake and obesity, addictive behaviors, hyperactivity and retinopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKjw0hKGX9sbVg90H21EOLACvtfcHk0lhMqPuyw3KvhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyhs78%253D&md5=d7b25a98b0ac00ef6e8b6ef00d312bab</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1355-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1355-2%26sid%3Dliteratum%253Aachs%26aulast%3DMoulin%26aufirst%3DA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DBoeglin%26aufirst%3DD.%26aulast%3DDemange%26aufirst%3DL.%26aulast%3DRyan%26aufirst%3DJ.%26aulast%3DM%25E2%2580%2599Kadmi%26aufirst%3DC.%26aulast%3DDenoyelle%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DFehrentz%26aufirst%3DJ.-A.%26atitle%3DThe%25201%252C2%252C4-triazole%2520as%2520a%2520scaffold%2520for%2520the%2520design%2520of%2520ghrelin%2520receptor%2520ligands%253A%2520development%2520of%2520JMV%25202959%252C%2520a%2520potent%2520antagonist%26jtitle%3DAmino%2520Acids%26date%3D2013%26volume%3D44%26issue%3D2%26spage%3D301%26epage%3D314%26doi%3D10.1007%2Fs00726-012-1355-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kangawa, K.</span></span> <span> </span><span class="NLM_article-title">Treatment of cachexia with ghrelin in patients with COPD</span>. <i>Chest</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1193</span>, <span class="refDoi"> DOI: 10.1378/chest.128.3.1187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1378%2Fchest.128.3.1187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=16162705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1187-1193&issue=3&author=N.+Nagayaauthor=T.+Itohauthor=S.+Murakamiauthor=H.+Oyaauthor=M.+Uematsuauthor=K.+Miyatakeauthor=K.+Kangawa&title=Treatment+of+cachexia+with+ghrelin+in+patients+with+COPD&doi=10.1378%2Fchest.128.3.1187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of cachexia with ghrelin in patients with COPD</span></div><div class="casAuthors">Nagaya, Noritoshi; Itoh, Takefumi; Murakami, Shinsuke; Oya, Hideo; Uematsu, Masaaki; Miyatake, Kunio; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Chest</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1187-1193</span>CODEN:
                <span class="NLM_cas:coden">CHETBF</span>;
        ISSN:<span class="NLM_cas:issn">0012-3692</span>.
    
            (<span class="NLM_cas:orgname">American College of Chest Physicians</span>)
        </div><div class="casAbstract">Study objectives: Ghrelin is a novel growth hormone (GH)-releasing peptide that also induces a pos. energy balance by decreasing fat utility and stimulating feeding through GH-independent mechanisms.  We investigated whether ghrelin improves cachexia and functional capacity in patients with COPD.  Methods: This is an open-label pilot study.  Human ghrelin (2 μg/kg bid) was IV administered to seven cachectic patients with COPD for 3 wk.  Food intake, body compn., muscle strength, exercise capacity, pulmonary function, and sympathetic nerve activity were examd. before and after ghrelin therapy.  Results: A single administration of ghrelin markedly increased serum GH (21-fold).  Three-week treatment with ghrelin resulted in a significant increase in mean (± SEM) body wt. (49.3 ± 3.6 to 50.3 ± 3.8 kg; p < 0.05).  Food intake was significantly increased during ghrelin therapy.  Ghrelin increased lean body mass and peripheral and respiratory muscle strength.  Ghrelin significantly increased Karnofsky performance status score and the distance walked in 6 min (370 ± 30 to 432 ± 35 m; p < 0.05), although it did not significantly alter pulmonary function.  Ghrelin attenuated the exaggerated sympathetic nerve activity, as indicated by a marked decrease in plasma norepinephrine level (889 ± 123 to 597 ± 116 pg/mL; p < 0.05).  Conclusions: These preliminary results suggest that repeated administration of ghrelin improves body compn., muscle wasting, functional capacity, and sympathetic augmentation in cachectic patients with COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH00rMa5X4DbVg90H21EOLACvtfcHk0lhMqPuyw3KvhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVWjtw%253D%253D&md5=5b4232ebb551a421f3111d0492521bef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1378%2Fchest.128.3.1187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1378%252Fchest.128.3.1187%26sid%3Dliteratum%253Aachs%26aulast%3DNagaya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DOya%26aufirst%3DH.%26aulast%3DUematsu%26aufirst%3DM.%26aulast%3DMiyatake%26aufirst%3DK.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520cachexia%2520with%2520ghrelin%2520in%2520patients%2520with%2520COPD%26jtitle%3DChest%26date%3D2005%26volume%3D128%26issue%3D3%26spage%3D1187%26epage%3D1193%26doi%3D10.1378%2Fchest.128.3.1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levinson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertner, J.</span></span> <span> </span><span class="NLM_article-title">Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease</span>. <i>e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e171</span>– <span class="NLM_lpage">e175</span>, <span class="refDoi"> DOI: 10.1016/j.clnme.2012.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.clnme.2012.07.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e171-e175&author=B.+Levinsonauthor=J.+Gertner&title=Randomized+study+of+the+efficacy+and+safety+of+SUN11031+%28synthetic+human+ghrelin%29+in+cachexia+associated+with+chronic+obstructive+pulmonary+disease&doi=10.1016%2Fj.clnme.2012.07.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.clnme.2012.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clnme.2012.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLevinson%26aufirst%3DB.%26aulast%3DGertner%26aufirst%3DJ.%26atitle%3DRandomized%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520SUN11031%2520%2528synthetic%2520human%2520ghrelin%2529%2520in%2520cachexia%2520associated%2520with%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3De-SPEN%252C%2520the%2520European%2520e-Journal%2520of%2520Clinical%2520Nutrition%2520and%2520Metabolism%26date%3D2012%26volume%3D7%26spage%3De171%26epage%3De175%26doi%3D10.1016%2Fj.clnme.2012.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caffrey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tholander, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivars, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hultin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanganee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leidvik, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydén
Landergren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karabelas, K.</span></span> <span> </span><span class="NLM_article-title">Identification and pharmacological profile of an indane based series of ghrelin receptor full agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">5974</span>– <span class="NLM_lpage">5987</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00322</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00322" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5974-5987&issue=14&author=C.+Gardelliauthor=H.+Wadaauthor=A.+Rayauthor=M.+Caffreyauthor=A.+Llinasauthor=I.+Shamovskyauthor=J.+Tholanderauthor=J.+Larssonauthor=U.+Sivarsauthor=L.+Hultinauthor=U.+Anderssonauthor=H.+J.+Sanganeeauthor=K.+Stenvallauthor=B.+Leidvikauthor=K.+Geddaauthor=L.+Jintonauthor=M.+Ryd%C3%A9n%0ALandergrenauthor=K.+Karabelas&title=Identification+and+pharmacological+profile+of+an+indane+based+series+of+ghrelin+receptor+full+agonists&doi=10.1021%2Facs.jmedchem.8b00322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and pharmacological profile of an indane-based series of Ghrelin receptor full agonists</span></div><div class="casAuthors">Gardelli, Cristina; Wada, Hiroki; Ray, Asim; Caffrey, Moya; Llinas, Antonio; Shamovsky, Igor; Tholander, Joakim; Larsson, Joakim; Sivars, Ulf; Hultin, Leif; Andersson, Ulf; Sanganee, Hitesh J.; Stenvall, Kristina; Leidvik, Brith; Gedda, Karin; Jinton, Lisa; Ryden Landergren, Marie; Karabelas, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5974-5987</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases.  Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels.  The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity.  Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions.  We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqWM9RhtTE3LVg90H21EOLACvtfcHk0lhMqPuyw3KvhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmsrrL&md5=c64386fe2b23f10f89b7513cd6ae7351</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00322%26sid%3Dliteratum%253Aachs%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DWada%26aufirst%3DH.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaffrey%26aufirst%3DM.%26aulast%3DLlinas%26aufirst%3DA.%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DTholander%26aufirst%3DJ.%26aulast%3DLarsson%26aufirst%3DJ.%26aulast%3DSivars%26aufirst%3DU.%26aulast%3DHultin%26aufirst%3DL.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DSanganee%26aufirst%3DH.%2BJ.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DLeidvik%26aufirst%3DB.%26aulast%3DGedda%26aufirst%3DK.%26aulast%3DJinton%26aufirst%3DL.%26aulast%3DRyd%25C3%25A9n%2BLandergren%26aufirst%3DM.%26aulast%3DKarabelas%26aufirst%3DK.%26atitle%3DIdentification%2520and%2520pharmacological%2520profile%2520of%2520an%2520indane%2520based%2520series%2520of%2520ghrelin%2520receptor%2520full%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D14%26spage%3D5974%26epage%3D5987%26doi%3D10.1021%2Facs.jmedchem.8b00322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinnerl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langenhan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of a new helix-forming β-amino acid: <i>trans</i>-4-aminopiperidine-3-carboxylic acid</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2003</i></span>,  <span class="NLM_fpage">721</span>– <span class="NLM_lpage">726</span>, <span class="refDoi"> DOI: 10.1002/ejoc.200390112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1002%2Fejoc.200390112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=721-726&author=M.+Schinnerlauthor=J.+K.+Murrayauthor=J.+M.+Langenhanauthor=S.+H.+Gellman&title=Asymmetric+synthesis+of+a+new+helix-forming+%CE%B2-amino+acid%3A+trans-4-aminopiperidine-3-carboxylic+acid&doi=10.1002%2Fejoc.200390112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fejoc.200390112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.200390112%26sid%3Dliteratum%253Aachs%26aulast%3DSchinnerl%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%2BK.%26aulast%3DLangenhan%26aufirst%3DJ.%2BM.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DAsymmetric%2520synthesis%2520of%2520a%2520new%2520helix-forming%2520%25CE%25B2-amino%2520acid%253A%2520trans-4-aminopiperidine-3-carboxylic%2520acid%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2003%26volume%3D2003%26spage%3D721%26epage%3D726%26doi%3D10.1002%2Fejoc.200390112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentles, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sowin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muchmore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giranda, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempf, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laver, W. G.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1192</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1021/jm000468c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000468c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhvFaqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1192-1201&author=G.+T.+Wangauthor=Y.+Chenauthor=S.+Wangauthor=R.+Gentlesauthor=T.+Sowinauthor=W.+Katiauthor=S.+Muchmoreauthor=V.+Girandaauthor=K.+Stewartauthor=H.+Shamauthor=D.+Kempfauthor=W.+G.+Laver&title=Design%2C+synthesis%2C+and+structural+analysis+of+influenza+neuraminidase+inhibitors+containing+pyrrolidine+cores&doi=10.1021%2Fjm000468c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structural Analysis of Influenza Neuraminidase Inhibitors Containing Pyrrolidine Cores</span></div><div class="casAuthors">Wang, Gary T.; Chen, Yuanwei; Wang, Sheldon; Gentles, Robert; Sowin, Thomas; Kati, Warren; Muchmore, Steve; Giranda, Vincent; Stewart, Kent; Sham, Hing; Kempf, Dale; Laver, W. Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1192-1201</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of (±)-(2S,3R,4R)-2-(trifluoroacetamido)methyl-3-amino-1-(N'-ethyl-N'-isopropylcarbamyl)pyrrolidine-4-carboxylic acid (A-192558) as a potent inhibitor of influenza neuraminidase (NA) is described.  Efficient syntheses of two core structures, cis-3-(allyloxycarbonyl)amino-1-(9'-fluorenylmethoxycarbonyl)pyrrolidine-4-carboxylic acid and tert-Bu(±)-(2S,3R,4R)-2-aminomethyl-3-bis(tert-butyloxycarbonyl)amino-1-(N'-ethyl-N'-isopropylcarbamyl)pyrrolidine-4-carboxylate were developed.  Starting with these core structures and using available structural information of the NA active site as the guide, analogs were synthesized in both the tri- and tetrasubstituted pyrrolidine series by high-throughput parallel synthesis in solid or soln. phase for expeditious SAR.  These studies accelerated the identification of A-192558 as the most potent NA inhibitor in this series (IC50 = 0.2 μM against NA A and 8 μM against NA B).  The x-ray crystallog. structure of A-192558 bound to NA revealed the predicted interaction of the carboxylic group with the pos. charged pocket (Arg118, Arg292, Arg371) and interaction of the trifluoroacetamino residue with the hydrophobic pocket (Ile222, Trp178) of the enzyme active site. Surprisingly, the Et and iso-Pr groups of the urea functionality induced a conformational change of Glu276, turning the Glu276/Glu277 hydrophilic pocket, which normally accommodates the triglycerol side chain of substrate sialic acid, into an induced hydrophobic pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNqTbHyyc32rVg90H21EOLACvtfcHk0lgUXXE97pOrTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhvFaqurg%253D&md5=dfd0b3a8e687ea313c651dd15ed9973a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm000468c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000468c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DGentles%26aufirst%3DR.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DKati%26aufirst%3DW.%26aulast%3DMuchmore%26aufirst%3DS.%26aulast%3DGiranda%26aufirst%3DV.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DSham%26aufirst%3DH.%26aulast%3DKempf%26aufirst%3DD.%26aulast%3DLaver%26aufirst%3DW.%2BG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structural%2520analysis%2520of%2520influenza%2520neuraminidase%2520inhibitors%2520containing%2520pyrrolidine%2520cores%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1192%26epage%3D1201%26doi%3D10.1021%2Fjm000468c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. E.</span>; <span class="NLM_string-name">Anderson, D. D.</span>; <span class="NLM_string-name">Bosse, T. D.</span>; <span class="NLM_string-name">Cooper, C. S.</span>; <span class="NLM_string-name">Klein, L. L.</span>; <span class="NLM_string-name">Krueger, A. C.</span>; <span class="NLM_string-name">Larson, D. P.</span>; <span class="NLM_string-name">Liu, D.</span>; <span class="NLM_string-name">McDaniel, K. F.</span>; <span class="NLM_string-name">Motter, C. E.</span>; <span class="NLM_string-name">Pratt, J. K.</span>; <span class="NLM_string-name">Rockway, T. W.</span>; <span class="NLM_string-name">Rosenberg, T. A.</span>; <span class="NLM_string-name">Yeung, M. C.</span>; <span class="NLM_string-name">Chen, H.-J.</span>; <span class="NLM_string-name">Shanley, J. P.</span></span> <span> </span><span class="NLM_article-title">HCV Protease Inhibitors and Uses Thereof</span>. Patent <span class="NLM_patent">WO074035</span>, June 19, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+E.+Green&author=D.+D.+Anderson&author=T.+D.+Bosse&author=C.+S.+Cooper&author=L.+L.+Klein&author=A.+C.+Krueger&author=D.+P.+Larson&author=D.+Liu&author=K.+F.+McDaniel&author=C.+E.+Motter&author=J.+K.+Pratt&author=T.+W.+Rockway&author=T.+A.+Rosenberg&author=M.+C.+Yeung&author=H.-J.+Chen&author=J.+P.+Shanley&title=HCV+Protease+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DB.%2BE.%26atitle%3DHCV%2520Protease%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span>; <span class="NLM_string-name">Bayard, R. H.</span></span>. <span> </span><span class="NLM_article-title">Oligomers and Polymers of Di-Substituted Cyclic Imino Carboxylic Acids</span>. U.S. Patent <span class="NLM_patent">0032334</span>, Mar 14, <span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.+H.+Gellman&author=R.+H.+Bayard&title=Oligomers+and+Polymers+of+Di-Substituted+Cyclic+Imino+Carboxylic+Acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3DOligomers%2520and%2520Polymers%2520of%2520Di-Substituted%2520Cyclic%2520Imino%2520Carboxylic%2520Acids%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espinosa, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellman, S. H.</span></span> <span> </span><span class="NLM_article-title">12-Helix formation in aqueous solution with short β-peptides containing pyrrolidine-based residues</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4821</span>– <span class="NLM_lpage">4822</span>, <span class="refDoi"> DOI: 10.1021/ja000093k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja000093k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVWhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=4821-4822&issue=19&author=X.+Wangauthor=J.+F.+Espinosaauthor=S.+H.+Gellman&title=12-Helix+formation+in+aqueous+solution+with+short+%CE%B2-peptides+containing+pyrrolidine-based+residues&doi=10.1021%2Fja000093k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">12-Helix formation in aqueous solution with short β-peptides containing pyrrolidine-based residues</span></div><div class="casAuthors">Wang, Xifang; Espinosa, Juan F.; Gellman, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4821-4822</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis and conformational anal. of a set of β-amino acid oligomers ("β-peptides") I (n = 1-3; TFA = trifluoroacetate) were presented.  One of the β-amino acids, protected 3-aminopyrrolidine-4-carboxylate II, was synthesized in an enantiopure form from β-ketoester III.  I was synthesized from the β-amino acids II and (R,R)-2-aminocyclopentanecarboxylate using solid-phase methodol. with Rink amide resin, Fmoc/Boc protection and PyBoP as the coupling agent; after HPLC purifications, I was isolated as a trifluoroacetate salt.  Using NMR and CD, detailed conformational anal. of I (n=2) was provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7w_ZRVOxoyrVg90H21EOLACvtfcHk0lgUXXE97pOrTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVWhsb8%253D&md5=d6c182815e2033ff57a9d0dc26538424</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja000093k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000093k%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DEspinosa%26aufirst%3DJ.%2BF.%26aulast%3DGellman%26aufirst%3DS.%2BH.%26atitle%3D12-Helix%2520formation%2520in%2520aqueous%2520solution%2520with%2520short%2520%25CE%25B2-peptides%2520containing%2520pyrrolidine-based%2520residues%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26issue%3D19%26spage%3D4821%26epage%3D4822%26doi%3D10.1021%2Fja000093k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asakawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuzuriha, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueno, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makino, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niijima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujino, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, M.</span></span> <span> </span><span class="NLM_article-title">Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1053/gast.2001.22158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1053%2Fgast.2001.22158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=11159873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlKlt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2001&pages=337-345&author=A.+Asakawaauthor=A.+Inuiauthor=T.+Kagaauthor=H.+Yuzurihaauthor=T.+Nagataauthor=N.+Uenoauthor=S.+Makinoauthor=M.+Fujimiyaauthor=A.+Niijimaauthor=M.+A.+Fujinoauthor=M.+Kasuga&title=Ghrelin+is+an+appetite-stimulatory+signal+from+stomach+with+structural+resemblance+to+motilin&doi=10.1053%2Fgast.2001.22158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin</span></div><div class="casAuthors">Asakawa, Akihiro; Inui, Akio; Kaga, Toshihiro; Yuzuriha, Hideki; Nagata, Toshiaki; Ueno, Naohiko; Makino, Susumu; Fujimiya, Mineko; Niijima, Akira; Fujino, Masayuki A.; Kasuga, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Ghrelin, an endogenous ligand for growth hormone secretagogue receptor, was recently identified in the rat stomach.  The authors examd. the effects of the gastric peptide ghrelin on energy balance in assocn. with leptin and vagal nerve activity.  Food intake, oxygen consumption, gastric emptying, and hypothalamic neuropeptide Y (NPY) mRNA expression were measured after intra-third cerebroventricular or i.p. injections of ghrelin in mice.  The gastric vagal nerve activity was recorded after i.v. administration in rats.  Gastric ghrelin gene expression was assessed by Northern blot anal.  Repeated coadministration of ghrelin and interleukin (IL)-1β was continued for 5 days.  Ghrelin exhibited gastroprokinetic activity with structural resemblance to motilin and potent orexigenic activity through action on the hypothalamic neuropeptide Y (NPY) and Y1 receptor, which was lost after vagotomy.  Ghrelin decreased gastric vagal afferent discharge in contrast to other anorexigenic peptides that increased the activity.  Ghrelin gene expression in the stomach was increased by fasting and in ob/ob mice, and was decreased by administration of leptin and IL-1β.  Peripherally administered ghrelin blocked IL-1β-induced anorexia and produced pos. energy balance by promoting food intake and decreasing energy expenditure.  Ghrelin, which is neg. regulated by leptin and IL-1β, is secreted by the stomach and increases arcuate NPY expression, which in turn acts through Y1 receptors to increase food intake and decrease energy expenditure.  Gastric peptide ghrelin may thus function as part of the orexigenic pathway downstream from leptin and is a potential therapeutic target not only for obesity but also for anorexia and cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vDv5f8zG0bVg90H21EOLACvtfcHk0lgOaq1phz3ykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlKlt7Y%253D&md5=3e6dbec9dd369f82b4ebe7e287c1896d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1053%2Fgast.2001.22158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fgast.2001.22158%26sid%3Dliteratum%253Aachs%26aulast%3DAsakawa%26aufirst%3DA.%26aulast%3DInui%26aufirst%3DA.%26aulast%3DKaga%26aufirst%3DT.%26aulast%3DYuzuriha%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DUeno%26aufirst%3DN.%26aulast%3DMakino%26aufirst%3DS.%26aulast%3DFujimiya%26aufirst%3DM.%26aulast%3DNiijima%26aufirst%3DA.%26aulast%3DFujino%26aufirst%3DM.%2BA.%26aulast%3DKasuga%26aufirst%3DM.%26atitle%3DGhrelin%2520is%2520an%2520appetite-stimulatory%2520signal%2520from%2520stomach%2520with%2520structural%2520resemblance%2520to%2520motilin%26jtitle%3DGastroenterology%26date%3D2001%26volume%3D120%26spage%3D337%26epage%3D345%26doi%3D10.1053%2Fgast.2001.22158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langhans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geary, N.</span></span> <span> </span><span class="NLM_article-title">Gut vagal afferents are not necessary for the eating-stimulatory injected ghrelin in the rat</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">11052</span>– <span class="NLM_lpage">11060</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2606-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1523%2FJNEUROSCI.2606-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17065447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFymsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=11052-11060&author=M.+Arnoldauthor=A.+Muraauthor=W.+Langhansauthor=N.+Geary&title=Gut+vagal+afferents+are+not+necessary+for+the+eating-stimulatory+injected+ghrelin+in+the+rat&doi=10.1523%2FJNEUROSCI.2606-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat</span></div><div class="casAuthors">Arnold, Myrtha; Mura, Anna; Langhans, Wolfgang; Geary, Nori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">11052-11060</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ghrelin is unique among gut peptides in that its plasma level increases during fasts and its administration stimulates eating.  Although ghrelin physiol. has been intensively studied, whether its eating-stimulatory effect arises from endocrine-neural signal transduction at peripheral or central sites remains unresolved.  To address this issue, we tested the effects of subdiaphragmatic vagal deafferentation (SDA), the most complete and selective vagal deafferentation method available, on ghrelin-induced eating.  SDA was verified with a cholecystokinin satiation test, retrograde labeling of vagal motor neurons in the dorsal motor nucleus of the vagus with fluorogold, and anterograde labeling of vagal afferents in the nucleus tractus solitarius with wheat germ agglutinin-horseradish peroxidase.  I.p. injections of 10-40 μg/kg ghrelin stimulated eating as robustly in rats with verified complete SDA as in sham-operated controls.  Ghrelin also stimulated eating in rats with total subdiaphragmatic vagotomies.  We also recorded the electrophysiol. responses of gastric load-sensitive vagal afferent neurons to i.v. ghrelin.  Ghrelin (10 nmol) phasically (0-30 s) increased activity in two of seven gastric load-sensitive fibers in the absence of gastric loads and tonically (5-30 min) increased activity in only one fiber.  Ghrelin did not affect any of the eight fibers tested in the presence of 1-3 mL gastric loads.  We conclude that although phasic increases in plasma ghrelin may affect the activity of a fraction of gastric load-sensitive vagal afferents, the acute eating-stimulatory effect of i.p. ghrelin does not require vagal afferent signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeSP-QxfD2bVg90H21EOLACvtfcHk0lgOaq1phz3ykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFymsLnN&md5=a4a4c2494e8b8229f3013d62773568d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2606-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2606-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DA.%26aulast%3DLanghans%26aufirst%3DW.%26aulast%3DGeary%26aufirst%3DN.%26atitle%3DGut%2520vagal%2520afferents%2520are%2520not%2520necessary%2520for%2520the%2520eating-stimulatory%2520injected%2520ghrelin%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D11052%26epage%3D11060%26doi%3D10.1523%2FJNEUROSCI.2606-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nogueiras, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieguez, C.</span></span> <span> </span><span class="NLM_article-title">Ghrelin: new molecular pathways modulating appetite and adiposity</span>. <i>Obes. Facts</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1159/000321265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1159%2F000321265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=20975294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=285-292&author=R.+Nogueirasauthor=L.+M.+Williamsauthor=C.+Dieguez&title=Ghrelin%3A+new+molecular+pathways+modulating+appetite+and+adiposity&doi=10.1159%2F000321265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ghrelin: New Molecular Pathways Modulating Appetite and Adiposity</span></div><div class="casAuthors">Nogueiras, Ruben; Williams, Lynda M.; Dieguez, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Obesity Facts</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">OFBABR</span>;
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    
            (<span class="NLM_cas:orgname">S. Karger Verlag fuer Medizin und Naturwissenschaften GmbH</span>)
        </div><div class="casAbstract">A review.  Ghrelin is a unique endogenous peptidic hormone regulating both hunger and adiposity.  Many of the actions of ghrelin are modulated specifically by the central nervous system.  A no. of mol. events triggered via the activation of the ghrelin receptor (GHS-R1a), leading to increased levels of neuropeptide Y (NPY) and agouti-related peptide (AgRP) and ultimately responsible for the orexigenic effect of ghrelin have been characterized.  Moreover, the discovery of ghrelin O-acyltransferase (GOAT), the enzyme responsible for the octanoylation of ghrelin, provides a mechanism allowing specific targeting of the ghrelin/GHS-R1a system without affecting the role of des-acyl-ghrelin in other pathways involved in the regulation of energy balance.  This review aims to summarize novel roles of ghrelin in energy balance, focusing particularly on both the newly identified neuronal pathways mediating the effects of ghrelin and on peripheral mechanisms leading to increased adiposity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNsx4MIbzhAbVg90H21EOLACvtfcHk0lgOaq1phz3ykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqu7fM&md5=7125cf6d16589f5236f5ba918be404af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1159%2F000321265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000321265%26sid%3Dliteratum%253Aachs%26aulast%3DNogueiras%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DL.%2BM.%26aulast%3DDieguez%26aufirst%3DC.%26atitle%3DGhrelin%253A%2520new%2520molecular%2520pathways%2520modulating%2520appetite%2520and%2520adiposity%26jtitle%3DObes.%2520Facts%26date%3D2010%26volume%3D3%26spage%3D285%26epage%3D292%26doi%3D10.1159%2F000321265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piirainen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanekar, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V.-P.</span></span> <span> </span><span class="NLM_article-title">Structural features of adenosine receptors: from crystal to function</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1808</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1233</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1016/j.bbamem.2010.05.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.bbamem.2010.05.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=20595055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1233-1244&issue=5&author=H.+Piirainenauthor=Y.+Ashokauthor=R.+T.+Nanekarauthor=V.-P.+Jaakola&title=Structural+features+of+adenosine+receptors%3A+from+crystal+to+function&doi=10.1016%2Fj.bbamem.2010.05.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of adenosine receptors: From crystal to function</span></div><div class="casAuthors">Piirainen, Henni; Ashok, Yashwanth; Nanekar, Rahul T.; Jaakola, Veli-Pekka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1233-1244</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The important role that extracellular adenosine plays in many physiol. processes is mediated by the adenosine class of G protein-coupled receptors, a class of receptors that also responds to the antagonist caffeine, the most widely used pharmacol. agent in the world.  The crystallog. model of the human adenosine A2A receptor was recently solved to 2.6 Å in complex with the antagonist ZM 241385, which is also referred to as "super-caffeine" because of its strong antagonistic effect on adenosine receptors.  The crystallog. model revealed some unexpected and unusual features of the adenosine A2A receptor structure that have led to new studies on the receptor and the re-examn. of pre-existing data.  Compared to other known GPCR structures, the adenosine A2A receptor has a unique ligand binding pocket that is nearly perpendicular to the membrane plane.  The ligand binding site highlights the integral role of the helical core together with the extracellular loops and the four disulfide bridges in the extracellular domain, in ligand recognition by the adenosine class of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlHy63somyAbVg90H21EOLACvtfcHk0lgOaq1phz3ykQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSku7g%253D&md5=f27c2b1d7e9044e5b61b60988e39f452</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.05.021%26sid%3Dliteratum%253Aachs%26aulast%3DPiirainen%26aufirst%3DH.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DNanekar%26aufirst%3DR.%2BT.%26aulast%3DJaakola%26aufirst%3DV.-P.%26atitle%3DStructural%2520features%2520of%2520adenosine%2520receptors%253A%2520from%2520crystal%2520to%2520function%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26issue%3D5%26spage%3D1233%26epage%3D1244%26doi%3D10.1016%2Fj.bbamem.2010.05.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">The chimera that curbs appetite</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">11037</span>– <span class="NLM_lpage">11038</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlKjurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=11037-11038&author=L.+G.+Luyt&title=The+chimera+that+curbs+appetite&doi=10.1021%2Facs.jmedchem.8b01809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The Chimera That Curbs Appetite</span></div><div class="casAuthors">Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11037-11038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A chimeric drug design approach, merging the structure of an antagonist and an inverse agonist, results in a new mol. scaffold for targeting the ghrelin receptor (GHSR).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXAGEiWVKaQLVg90H21EOLACvtfcHk0ljuStlwYnqkpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlKjurzE&md5=41e5a9a54a99fb355344c100a3828cfe</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01809%26sid%3Dliteratum%253Aachs%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DThe%2520chimera%2520that%2520curbs%2520appetite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D11037%26epage%3D11038%26doi%3D10.1021%2Facs.jmedchem.8b01809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&issue=6&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+signaling-competent+neurotensin+receptor+1+obtained+by+directed+evolution+in+Escherichia+coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0ljuStlwYnqkpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520signaling-competent%2520neurotensin%2520receptor%25201%2520obtained%2520by%2520directed%2520evolution%2520in%2520Escherichia%2520coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D6%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charron, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luyt, L. G.</span></span> <span> </span><span class="NLM_article-title">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">833</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.07.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejmech.2016.07.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=27541265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=822-833&author=J.+Houauthor=C.+L.+Charronauthor=M.+M.+Fowkesauthor=L.+G.+Luyt&title=Bridging+computational+modeling+with+amino+acid+replacements+to+investigate+GHS-R1a-peptidomimetic+recognition&doi=10.1016%2Fj.ejmech.2016.07.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bridging computational modeling with amino acid replacements to investigate GHS-R1a-peptidomimetic recognition</span></div><div class="casAuthors">Hou, Jinqiang; Charron, Carlie L.; Fowkes, Milan M.; Luyt, Leonard G.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">822-833</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The ghrelin receptor, also referred to as the growth hormone secretagogue receptor 1a (GHS-R1a), is a G protein-coupled receptor (GPCR) primarily expressed in the brain and pituitary.  The wide spectrum of biol. functions of GHS-R1a has rendered it a target for therapeutic drugs and for mol. imaging agents, for a variety of diseases.  An improved understanding of the binding mechanism of a ligand to GHS-R1a would provide guidance on ligand design.  This study investigates the binding of G-7039, a peptidomimetic agonist, to the GHS-R1a.  A series of computational studies including homol. modeling, mol. docking, mol. dynamics (MD) simulations, and binding free energy calcns. were carried out in conjunction with amino acid replacements on G-7039.  The results suggest that the first three residues on the N-terminal segment of the peptidomimetic are bound to three hydrophobic sub-pockets in the receptor binding site, with the driving force for binding mainly from hydrophobic interactions.  It has been reported that a charge-charge interaction between the pos. charged terminal amine of the agonist and Glu124 on the receptor serves as an anchor point for binding.  However, our studies suggest that this interaction is not strong enough to anchor a ligand to the ghrelin receptor in the absence of hydrophobic interactions.  The resulting computational model provides insight into structure activity relationship anal. for the ghrelin receptor and will assist in future ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos6ZSlrS_AL7Vg90H21EOLACvtfcHk0ljuStlwYnqkpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7jM&md5=f96e7229ff7b1416f8039adae7bfb7a8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.07.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.07.078%26sid%3Dliteratum%253Aachs%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DCharron%26aufirst%3DC.%2BL.%26aulast%3DFowkes%26aufirst%3DM.%2BM.%26aulast%3DLuyt%26aufirst%3DL.%2BG.%26atitle%3DBridging%2520computational%2520modeling%2520with%2520amino%2520acid%2520replacements%2520to%2520investigate%2520GHS-R1a-peptidomimetic%2520recognition%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D822%26epage%3D833%26doi%3D10.1016%2Fj.ejmech.2016.07.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taddese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpson, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. A.</span></span> <span> </span><span class="NLM_article-title">Modeling active GPCR conformations</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>522</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-407865-9.00002-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2FB978-0-12-407865-9.00002-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=23374178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFSit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=522&publication_year=2013&pages=21-35&author=B.+Taddeseauthor=L.+M.+Simpsonauthor=I.+D.+Wallauthor=F.+E.+Blaneyauthor=C.+A.+Reynolds&title=Modeling+active+GPCR+conformations&doi=10.1016%2FB978-0-12-407865-9.00002-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling active GPCR conformations</span></div><div class="casAuthors">Taddese, Bruck; Simpson, Lisa M.; Wall, Ian D.; Blaney, Frank E.; Reynolds, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">522</span>
        (<span class="NLM_cas:issue">G Protein Coupled Receptors</span>),
    <span class="NLM_cas:pages">21-35</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The most significant advance in modeling GPCR active states has been the β2-adrenergic receptor-Gs complex as this essentially transforms active-state modeling into homol. modeling.  Various different mol. dynamics-based approaches for modeling active states are presented, and a no. of key applications discussed.  These simulations have given insights into the activation pathway, conformational changes, dimerization, hydration, the ionic lock, ligand binding, protonation, and sodium binding.  Crystallog. and simulations have shown that the presence of agonist alone is unlikely to be sufficient to form the active state and that restraints applied to the G protein-binding region are required.  The role of various microswitches in activation is discussed, including the controversial rotamer toggle switch.  The importance of explicitly simulating exptl. mol. probes to understand activation is highlighted, along with the need to ensure that such mols. are well parameterized.  Approaches to loop modeling are discussed.  We argue that the role of successful virtual screening against active models should not be overestimated as the main conformational changes on activation occur in the intracellular region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-GS5Ws7B5gbVg90H21EOLACvtfcHk0li8Oyq9n2VftQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFSit7g%253D&md5=fa1f66ec0b5bb146b3c77968d1b9edef</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-407865-9.00002-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-407865-9.00002-9%26sid%3Dliteratum%253Aachs%26aulast%3DTaddese%26aufirst%3DB.%26aulast%3DSimpson%26aufirst%3DL.%2BM.%26aulast%3DWall%26aufirst%3DI.%2BD.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DReynolds%26aufirst%3DC.%2BA.%26atitle%3DModeling%2520active%2520GPCR%2520conformations%26jtitle%3DMethods%2520Enzymol.%26date%3D2013%26volume%3D522%26spage%3D21%26epage%3D35%26doi%3D10.1016%2FB978-0-12-407865-9.00002-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mondal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E. D.</span></span> <span> </span><span class="NLM_article-title">OPLS3e: Extending force field coverage for drug-like small molecules</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1863</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.8b01026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.8b01026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1863-1874&author=K.+Roosauthor=C.+Wuauthor=W.+Dammauthor=M.+Reboulauthor=J.+M.+Stevensonauthor=C.+Luauthor=M.+K.+Dahlgrenauthor=S.+Mondalauthor=W.+Chenauthor=L.+Wangauthor=R.+Abelauthor=R.+A.+Friesnerauthor=E.+D.+Harder&title=OPLS3e%3A+Extending+force+field+coverage+for+drug-like+small+molecules&doi=10.1021%2Facs.jctc.8b01026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules</span></div><div class="casAuthors">Roos, Katarina; Wu, Chuanjie; Damm, Wolfgang; Reboul, Mark; Stevenson, James M.; Lu, Chao; Dahlgren, Markus K.; Mondal, Sayan; Chen, Wei; Wang, Lingle; Abel, Robert; Friesner, Richard A.; Harder, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1863-1874</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building upon the OPLS3 force field we report on an enhanced model, OPLS3e, that further extends its coverage of medicinally relevant chem. space by addressing limitations in chemotype transferability.  OPLS3e accomplishes this by incorporating new parameter types that recognize moieties with greater chem. specificity and integrating an on-the-fly parametrization approach to the assignment of partial charges.  As a consequence, OPLS3e leads to greater accuracy against performance benchmarks that assess small mol. conformational propensities, solvation, and protein-ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWzxgqjMQBLLVg90H21EOLACvtfcHk0li8Oyq9n2VftQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFKlsrs%253D&md5=5c91547ddc0c975f9616cfba56a5454f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.8b01026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.8b01026%26sid%3Dliteratum%253Aachs%26aulast%3DRoos%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DStevenson%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DMondal%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DHarder%26aufirst%3DE.%2BD.%26atitle%3DOPLS3e%253A%2520Extending%2520force%2520field%2520coverage%2520for%2520drug-like%2520small%2520molecules%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2019%26volume%3D15%26spage%3D1863%26epage%3D1874%26doi%3D10.1021%2Facs.jctc.8b01026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollinger, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Still, W. C.</span></span> <span> </span><span class="NLM_article-title">The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii</span>. <i>J. Phys. Chem. A</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">3005</span>– <span class="NLM_lpage">3014</span>, <span class="refDoi"> DOI: 10.1021/jp961992r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp961992r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADyaK2sXitFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1997&pages=3005-3014&author=D.+Qiuauthor=P.+S.+Shenkinauthor=F.+P.+Hollingerauthor=W.+C.+Still&title=The+GB%2FSA+continuum+model+for+solvation.+A+fast+analytical+method+for+the+calculation+of+approximate+Born+radii&doi=10.1021%2Fjp961992r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The GB/SA Continuum Model for Solvation. A Fast Analytical Method for the Calculation of Approximate Born Radii</span></div><div class="casAuthors">Qiu, Di; Shenkin, Peter S.; Hollinger, Frank P.; Still, W. Clark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3005-3014</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At. Born radii (α) are used in the generalized Born (GB) equation to calc. approxns. to the elec. polarization component (Gpol) of solvation free energy.  The authors present here a simple anal. formula for calcg. Born radii rapidly and with useful accuracy.  The new function is based on a at. pairwise rij-4 treatment and contains several empirically detd. parameters that were established by optimization against a data set of >10 000 accurate Born radii computed numerically using the Poisson equation on a diverse group of org. mols., mol. complexes, oligopeptides, and a small protein.  Coupling this new Born radius calcn. with the previously described GB/SA solvation treatment provides a fully anal. solvation model that is computationally efficient in comparison with traditional mol. solvent models and also affords first and second derivs.  Tests with the GB/SA model and Born radii calcd. with the authors' new anal. function and with the accurate but more time-consuming Poisson-Boltzmann methods indicate that comparable free energies of solvent-like dielec. polarization can be obtained using either method and that the resulting GB/SA solvation free energies compare well with the exptl. results on small mols. in water.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU8qRXR8qs07Vg90H21EOLACvtfcHk0li8Oyq9n2VftQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitFWgs7w%253D&md5=ac84707bd3f8024870483891334439d1</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjp961992r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp961992r%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DD.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26aulast%3DHollinger%26aufirst%3DF.%2BP.%26aulast%3DStill%26aufirst%3DW.%2BC.%26atitle%3DThe%2520GB%252FSA%2520continuum%2520model%2520for%2520solvation.%2520A%2520fast%2520analytical%2520method%2520for%2520the%2520calculation%2520of%2520approximate%2520Born%2520radii%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1997%26volume%3D101%26spage%3D3005%26epage%3D3014%26doi%3D10.1021%2Fjp961992r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feighner, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prendergast, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palyha, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hreniuk, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nargund, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tata, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patchett, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der
Ploeg, L. H.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">141</span>, <span class="refDoi"> DOI: 10.1210/mend.12.1.0051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1210%2Fmend.12.1.0051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=9440817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=137-141&issue=1&author=S.+D.+Feighnerauthor=A.+D.+Howardauthor=K.+Prendergastauthor=O.+C.+Palyhaauthor=D.+L.+Hreniukauthor=R.+Nargundauthor=D.+Underwoodauthor=J.+R.+Tataauthor=D.+C.+Deanauthor=C.+P.+Tanauthor=K.+K.+McKeeauthor=J.+W.+Woodsauthor=A.+A.+Patchettauthor=R.+G.+Smithauthor=L.+H.+Van+der%0APloeg&title=Structural+requirements+for+the+activation+of+the+human+growth+hormone+secretagogue+receptor+by+peptide+and+nonpeptide+secretagogues&doi=10.1210%2Fmend.12.1.0051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues</span></div><div class="casAuthors">Feighner, Scott D.; Howard, Andrew D.; Prendergast, Kristine; Palyha, Oksana C.; Hreniuk, Donna L.; Nargund, Ravi; Underwood, Dennis; Tata, James R.; Dean, Dennis C.; Tan, Carina P.; McKee, Karen Kulju; Woods, John W.; Patchett, Arthur A.; Smith, Roy G.; Van der Ploeg, Lex H. T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-145</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Antibodies raised against an intracellular and extracellular domain of the GH secretagogue receptor (GHS-R) confirmed that its topol. orientation in the lipid bilayer is as predicted for G protein-coupled receptors with seven transmembrane domains.  A strategy for mapping the agonist-binding site of the human GHS-R was conceived based on our understanding of ligand binding in biogenic amine and peptide hormone G protein-coupled receptors.  Using site-directed mutagenesis and mol. modeling, we classified GHS peptide and nonpeptide agonist binding in the context of its receptor environment.  All peptide and nonpeptide ligand classes shared a common binding domain in transmembrane (TM) region 3 of the GHS-R.  This finding was based on TM-3 mutation E124Q, which eliminated the counter-ion to the shared basic N+ group of all GHSs and resulted in a nonfunctional receptor.  Restoration of function for the E124Q mutant was achieved by a complementary change in the MK-0677 ligand through modification of its amine side-chain to the corresponding alc.  Contacts in other TM domains [TM-2 (D99N), TM-5 (M213K, S117A), TM-6 (H280F), and extracellular loop 1 (C116A)] of the receptor revealed specificity for the different peptide, benzolactam, and spiroindolane GHSs.  GHS-R agonism, therefore, does not require identical disposition of all agonist classes at the ligand-binding site.  Our results support the hypothesis that the ligand-binding pocket in the GHS-R is spatially disposed similarly to the well characterized catechol-binding site in the β2-adrenergic receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetKI2LSRgu7Vg90H21EOLACvtfcHk0ljGu4nyBAxCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFaltA%253D%253D&md5=4e7350515438326d7ccb4fd7eb0f7c6f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1210%2Fmend.12.1.0051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.12.1.0051%26sid%3Dliteratum%253Aachs%26aulast%3DFeighner%26aufirst%3DS.%2BD.%26aulast%3DHoward%26aufirst%3DA.%2BD.%26aulast%3DPrendergast%26aufirst%3DK.%26aulast%3DPalyha%26aufirst%3DO.%2BC.%26aulast%3DHreniuk%26aufirst%3DD.%2BL.%26aulast%3DNargund%26aufirst%3DR.%26aulast%3DUnderwood%26aufirst%3DD.%26aulast%3DTata%26aufirst%3DJ.%2BR.%26aulast%3DDean%26aufirst%3DD.%2BC.%26aulast%3DTan%26aufirst%3DC.%2BP.%26aulast%3DMcKee%26aufirst%3DK.%2BK.%26aulast%3DWoods%26aufirst%3DJ.%2BW.%26aulast%3DPatchett%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DVan%2Bder%2BPloeg%26aufirst%3DL.%2BH.%26atitle%3DStructural%2520requirements%2520for%2520the%2520activation%2520of%2520the%2520human%2520growth%2520hormone%2520secretagogue%2520receptor%2520by%2520peptide%2520and%2520nonpeptide%2520secretagogues%26jtitle%3DMol.%2520Endocrinol.%26date%3D1998%26volume%3D12%26issue%3D1%26spage%3D137%26epage%3D141%26doi%3D10.1210%2Fmend.12.1.0051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">The growth hormone secretagogue receptor: its intracellular signaling and regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">4837</span>– <span class="NLM_lpage">4855</span>, <span class="refDoi"> DOI: 10.3390/ijms15034837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.3390%2Fijms15034837" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=24651458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC2cXos1OqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=4837-4855&issue=3&author=Y.+Yinauthor=Y.+Liauthor=W.+Zhang&title=The+growth+hormone+secretagogue+receptor%3A+its+intracellular+signaling+and+regulation&doi=10.3390%2Fijms15034837"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The growth hormone secretagogue receptor: its intracellular signaling and regulation</span></div><div class="casAuthors">Yin, Yue; Li, Yin; Zhang, Weizhen</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">4837-4855, 19 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  The growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor, is involved in mediating a wide variety of biol. effects of ghrelin, including: stimulation of growth hormone release, increase of food intake and body wt., modulation of glucose and lipid metab., regulation of gastrointestinal motility and secretion, protection of neuronal and cardiovascular cells, and regulation of immune function.  Dependent on the tissues and cells, activation of GHSR may trigger a diversity of signaling mechanisms and subsequent distinct physiol. responses.  Distinct regulation of GHSR occurs at levels of transcription, receptor interaction and internalization.  Here we review the current understanding on the intracellular signaling pathways of GHSR and its modulation.  An overview of the mol. structure of GHSR is presented first, followed by the discussion on its signaling mechanisms.  Finally, potential mechanisms regulating GHSR are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAZstvgKgicrVg90H21EOLACvtfcHk0ljGu4nyBAxCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXos1OqtLw%253D&md5=3efb2c601dd9e79c3265dfbd20d9ec50</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3390%2Fijms15034837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15034837%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DThe%2520growth%2520hormone%2520secretagogue%2520receptor%253A%2520its%2520intracellular%2520signaling%2520and%2520regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D3%26spage%3D4837%26epage%3D4855%26doi%3D10.3390%2Fijms15034837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkjaer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullberg, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Overlapping binding site for endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1124/mol.108.049189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1124%2Fmol.108.049189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=18923064" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2009&pages=44-59&author=B.+Holstauthor=T.+M.+Frimurerauthor=J.+Mokrosinskiauthor=T.+Halkjaerauthor=K.+B.+Cullbergauthor=C.+R.+Underwoodauthor=T.+W.+Schwartz&title=Overlapping+binding+site+for+endogenous+agonist%2C+small-molecule+agonists%2C+and+ago-allosteric+modulators+on+the+ghrelin+receptor&doi=10.1124%2Fmol.108.049189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor</span></div><div class="casAuthors">Holst, Birgitte; Frimurer, Thomas M.; Mokrosinski, Jacek; Halkjaer, Tine; Cullberg, Karina B.; Underwood, Christina R.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">44-59</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A library of robust ghrelin receptor mutants with single substitutions at 22 positions in the main ligand-binding pocket was employed to map binding sites for six different agonists: two peptides (the 28-amino-acid octanoylated endogenous ligand ghrelin and the hexapeptide growth hormone secretagogue GHRP-6) plus four nonpeptide agonists-the original benzolactam L-692,429, the spiroindoline sulfonamide MK-677, and two novel oxindole derivs., SM-130686 and SM-157740.  The strongest mutational effect with respect to decrease in potency for stimulation of inositol phosphate turnover was for all six agonists the GluIII:09-to-Gln substitution in the extracellular segment of TM-III.  Likewise, all six agonists were affected by substitutions of PheVI:16, ArgVI:20, and PheVI:23 on the opposing face of transmembrane domain (TM) VI.  Each of the agonists was also affected selectively by specific mutations.  The mutational map of the ability of L-692,429 and GHRP-6 to act as allosteric modulators by increasing ghrelin's maximal efficacy overlapped with the common mutational map for agonism but it was not identical with the map for the agonist property of these small-mol. ligands.  In mol. models, built over the inactive conformation of rhodopsin, low energy conformations of the nonpeptide agonists could be docked to satisfy many of their mutational hits.  It is concluded that although each of the ligands in addn. exploits other parts of the receptor, a large, common binding site for both small-mol. agonists-including ago-allosteric modulators-and the endogenous agonist is found on the opposing faces of TM-III and -VI of the ghrelin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7vPmuuW-QabVg90H21EOLACvtfcHk0ljGu4nyBAxCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOltw%253D%253D&md5=565858dd8c6657fda2938e10ab30fed1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049189%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DHalkjaer%26aufirst%3DT.%26aulast%3DCullberg%26aufirst%3DK.%2BB.%26aulast%3DUnderwood%26aufirst%3DC.%2BR.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DOverlapping%2520binding%2520site%2520for%2520endogenous%2520agonist%252C%2520small-molecule%2520agonists%252C%2520and%2520ago-allosteric%2520modulators%2520on%2520the%2520ghrelin%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2009%26volume%3D75%26spage%3D44%26epage%3D59%26doi%3D10.1124%2Fmol.108.049189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frimurer, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, T. W.</span></span> <span> </span><span class="NLM_article-title">Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">15799</span>– <span class="NLM_lpage">15811</span>, <span class="refDoi"> DOI: 10.1074/jbc.M609796200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1074%2Fjbc.M609796200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17371869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=15799-15811&author=B.+Holstauthor=J.+Mokrosinskiauthor=M.+Langauthor=E.+Brandtauthor=R.+Nygaardauthor=T.+M.+Frimurerauthor=A.+G.+Beck-Sickingerauthor=T.+W.+Schwartz&title=Identification+of+an+efficacy+switch+region+in+the+ghrelin+receptor+responsible+for+interchange+between+agonism+and+inverse+agonism&doi=10.1074%2Fjbc.M609796200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an Efficacy Switch Region in the Ghrelin Receptor Responsible for Interchange between Agonism and Inverse Agonism</span></div><div class="casAuthors">Holst, Birgitte; Mokrosinski, Jacek; Lang, Manja; Brandt, Erik; Nygaard, Rie; Frimurer, Thomas M.; Beck-Sickinger, Annette G.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">15799-15811</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The carboxyamidated wFwLL peptide was used as a core ligand to probe the structural basis for agonism vs. inverse agonism in the constitutively active ghrelin receptor.  In the ligand, an efficacy switch could be built at the N terminus, as exemplified by AwFwLL, which functioned as a high potency agonist, whereas KwFwLL was an equally high potency inverse agonist.  The wFw-contg. peptides, agonists as well as inverse agonists, were affected by receptor mutations covering the whole main ligand-binding pocket with key interaction sites being an arom. cluster in transmembrane (TM)-VI and -VII and residues on the opposing face of TM-III.  Gain-of-function in respect of either increased agonist or inverse agonist potency or swap between high potency versions of these properties was obtained by substitutions at a no. of positions covering a broad area of the binding pocket on TM-III, -IV, and -V.  However, in particular, space-generating substitutions at position III:04 shifted the efficacy of the ligands from inverse agonism toward agonism, whereas similar substitutions at position III: 08, one helical turn below, shifted the efficacy from agonism toward inverse agonism.  It is suggested that the relative position of the ligand in the binding pocket between this "efficacy shift region" on TM-III and the opposing arom. cluster on TM-VI and TM-VII leads either to agonism, i.e. in a superficial binding mode, or it leads to inverse agonism, i.e. in a more profound binding mode.  This relationship between different binding modes and opposite efficacy is in accordance with the Global Toggle Switch model for 7TM receptor activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJqfgDA6O7ubVg90H21EOLACvtfcHk0ljGu4nyBAxCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltl2ns7g%253D&md5=9d994028f084be1fcd9a6b58a9547785</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609796200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609796200%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DB.%26aulast%3DMokrosinski%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DBrandt%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DR.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DIdentification%2520of%2520an%2520efficacy%2520switch%2520region%2520in%2520the%2520ghrelin%2520receptor%2520responsible%2520for%2520interchange%2520between%2520agonism%2520and%2520inverse%2520agonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D15799%26epage%3D15811%26doi%3D10.1074%2Fjbc.M609796200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bender, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vortmeier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ernicke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosse, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huster, D.</span></span> <span> </span><span class="NLM_article-title">Structural model of ghrelin bound to its G protein-coupled receptor</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1016/j.str.2018.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.str.2018.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=30686667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=537-544&author=B.+J.+Benderauthor=G.+Vortmeierauthor=S.+Ernickeauthor=M.+Bosseauthor=A.+Kaiserauthor=S.+Els-Heindlauthor=U.+Krugauthor=A.+Beck-Sickingerauthor=J.+Meilerauthor=D.+Huster&title=Structural+model+of+ghrelin+bound+to+its+G+protein-coupled+receptor&doi=10.1016%2Fj.str.2018.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Model of Ghrelin Bound to its G Protein-Coupled Receptor</span></div><div class="casAuthors">Bender, Brian Joseph; Vortmeier, Gerrit; Ernicke, Stefan; Bosse, Mathias; Kaiser, Anette; Els-Heindl, Sylvia; Krug, Ulrike; Beck-Sickinger, Annette; Meiler, Jens; Huster, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-544.e4</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The peptide ghrelin targets the growth hormone secretagogue receptor 1a (GHSR) to signal changes in cell metab. and is a sought-after therapeutic target, although no structure is known to date.  To investigate the structural basis of ghrelin binding to GHSR, we used solid-state NMR (NMR) spectroscopy, site-directed mutagenesis, and Rosetta modeling.  The use of satn. transfer difference NMR identified key residues in the peptide for receptor binding beyond the known motif.  This information combined with assignment of the secondary structure of ghrelin in its receptor-bound state was incorporated into Rosetta using an approach that accounts for flexible binding partners.  The NMR data and models revealed an extended binding surface that was confirmed via mutagenesis.  Our results agree with a growing evidence of peptides interacting via two sites at G protein-coupled receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJVWAM5_EcyrVg90H21EOLACvtfcHk0lj5rGvcRlOyBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSltrw%253D&md5=169f718765ba8c38e22729d02063575f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2018.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2018.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DB.%2BJ.%26aulast%3DVortmeier%26aufirst%3DG.%26aulast%3DErnicke%26aufirst%3DS.%26aulast%3DBosse%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DKrug%26aufirst%3DU.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DHuster%26aufirst%3DD.%26atitle%3DStructural%2520model%2520of%2520ghrelin%2520bound%2520to%2520its%2520G%2520protein-coupled%2520receptor%26jtitle%3DStructure%26date%3D2019%26volume%3D27%26spage%3D537%26epage%3D544%26doi%3D10.1016%2Fj.str.2018.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shamovsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alderin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bladh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den Heuvel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josefsson, B.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristoffersson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnanen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisius, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Männikkö, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordén, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rognan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosendahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrinjar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbahns, K.</span></span> <span> </span><span class="NLM_article-title">Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7706</span>– <span class="NLM_lpage">7723</span>, <span class="refDoi"> DOI: 10.1021/jm900713y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900713y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7706-7723&author=I.+Shamovskyauthor=C.+de+Graafauthor=L.+Alderinauthor=M.+Bengtssonauthor=H.+Bladhauthor=L.+B%C3%B6rjessonauthor=S.+Connollyauthor=H.+J.+Dykeauthor=M.+van+den+Heuvelauthor=H.+Johanssonauthor=B.-G.+Josefssonauthor=A.+Kristofferssonauthor=T.+Linnanenauthor=A.+Lisiusauthor=R.+M%C3%A4nnikk%C3%B6author=B.+Nord%C3%A9nauthor=S.+Priceauthor=L.+Ripaauthor=D.+Rognanauthor=A.+Rosendahlauthor=M.+Skrinjarauthor=K.+Urbahns&title=Increasing+selectivity+of+CC+chemokine+receptor+8+antagonists+by+engineering+nondesolvation+related+interactions+with+the+intended+and+off-target+binding+sites&doi=10.1021%2Fjm900713y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related Interactions with the Intended and Off-Target Binding Sites</span></div><div class="casAuthors">Shamovsky, Igor; de Graaf, Chris; Alderin, Lisa; Bengtsson, Malena; Bladh, Hakan; Borjesson, Lena; Connolly, Stephen; Dyke, Hazel J.; van den Heuvel, Marco; Johansson, Henrik; Josefsson, Bo-Goran; Kristoffersson, Anna; Linnanen, Tero; Lisius, Annea; Mannikko, Roope; Norden, Bo; Price, Steve; Ripa, Lena; Rognan, Didier; Rosendahl, Alexander; Skrinjar, Marco; Urbahns, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7706-7723</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERG ion channel and cytochrome Cyp2D6 are studied by principal component anal.  It is demonstrated that an efficient way of increasing metabolic stability and selectivity of this series is to decrease compd. lipophilicity by engineering nondesolvation related attractive interactions with CCR8, as rationalized by three-dimensional receptor models.  Although such polar interactions led to increased compd. selectivity, such a strategy could also jeopardize the DMPK profile of compds.  However, once increased potency is found, the lipophilicity can be readjusted by engineering hydrophobic substituents that fit to CCR8 but do not fit to hERG.  Several such lipophilic fragments are identified by two-dimensional fragment-based QSAR anal.  Electrophysiol. measurements and site-directed mutagenesis studies indicated that the repulsive interactions of these fragments with hERG are caused by steric hindrances with residue F656.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdnucSk9AFKrVg90H21EOLACvtfcHk0lj5rGvcRlOyBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsLc%253D&md5=5c2c3fba29d17ae235e77c88d0aaf8ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm900713y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900713y%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DAlderin%26aufirst%3DL.%26aulast%3DBengtsson%26aufirst%3DM.%26aulast%3DBladh%26aufirst%3DH.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DL.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3Dvan%2Bden%2BHeuvel%26aufirst%3DM.%26aulast%3DJohansson%26aufirst%3DH.%26aulast%3DJosefsson%26aufirst%3DB.-G.%26aulast%3DKristoffersson%26aufirst%3DA.%26aulast%3DLinnanen%26aufirst%3DT.%26aulast%3DLisius%26aufirst%3DA.%26aulast%3DM%25C3%25A4nnikk%25C3%25B6%26aufirst%3DR.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DRipa%26aufirst%3DL.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRosendahl%26aufirst%3DA.%26aulast%3DSkrinjar%26aufirst%3DM.%26aulast%3DUrbahns%26aufirst%3DK.%26atitle%3DIncreasing%2520selectivity%2520of%2520CC%2520chemokine%2520receptor%25208%2520antagonists%2520by%2520engineering%2520nondesolvation%2520related%2520interactions%2520with%2520the%2520intended%2520and%2520off-target%2520binding%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7706%26epage%3D7723%26doi%3D10.1021%2Fjm900713y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lj5rGvcRlOyBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Molecular
Operating Environment, Chemical Computing Group (CCG). <a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular%0AOperating+Environment%2C+Chemical+Computing+Group+%28CCG%29.+www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esler, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coish, P. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickens, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brands, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierer, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloomquist, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claus, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fathi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khire, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristie, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenleber, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelekhin, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vakalopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardell, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bullock, W. H.</span></span> <span> </span><span class="NLM_article-title">Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">5202</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1021/jm070071+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070071%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGqt7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5202-5216&issue=21&author=J.+Rudolphauthor=W.+P.+Eslerauthor=S.+O%E2%80%99Connorauthor=P.+D.+G.+Coishauthor=P.+L.+Wickensauthor=M.+Brandsauthor=D.+E.+Biererauthor=B.+T.+Bloomquistauthor=G.+Bondarauthor=L.+Chenauthor=C.-Y.+Chuangauthor=T.+H.+Clausauthor=Z.+Fathiauthor=W.+Fuauthor=U.+R.+Khireauthor=J.+A.+Kristieauthor=X.-G.+Liuauthor=D.+B.+Loweauthor=A.+C.+McClureauthor=M.+Michelsauthor=A.+A.+Ortizauthor=P.+D.+Ramsdenauthor=R.+W.+Schoenleberauthor=T.+E.+Shelekhinauthor=A.+Vakalopoulosauthor=W.+Tangauthor=L.+Wangauthor=L.+Yiauthor=S.+J.+Gardellauthor=J.+N.+Livingstonauthor=L.+J.+Sweetauthor=W.+H.+Bullock&title=Quinazolinone+derivatives+as+orally+available+ghrelin+receptor+antagonists+for+the+treatment+of+diabetes+and+obesity&doi=10.1021%2Fjm070071%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity</span></div><div class="casAuthors">Rudolph, Joachim; Esler, William P.; O'Connor, Stephen; Coish, Philip D. G.; Wickens, Philip L.; Brands, Michael; Bierer, Donald E.; Bloomquist, Brian T.; Bondar, Georgiy; Chen, Libing; Chuang, Chih-Yuan; Claus, Thomas H.; Fathi, Zahra; Fu, Wenlang; Khire, Uday R.; Kristie, James A.; Liu, Xiao-Gao; Lowe, Derek B.; McClure, Andrea C.; Michels, Martin; Ortiz, Astrid A.; Ramsden, Philip D.; Schoenleber, Robert W.; Shelekhin, Tatiana E.; Vakalopoulos, Alexandros; Tang, Weifeng; Wang, Lei; Yi, Lin; Gardell, Stephen J.; Livingston, James N.; Sweet, Laurel J.; Bullock, William H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5202-5216</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The peptide hormone ghrelin is the endogenous ligand for the type 1a growth hormone secretagogue receptor (GHS-R1a) and the only currently known circulating appetite stimulant.  GHS-R1a antagonism has therefore been proposed as a potential approach for obesity treatment.  More recently, ghrelin has been recognized to also play a role in controlling glucose-induced insulin secretion, which suggests another possible benefit for a GHS-R1a antagonist, namely, the role as an insulin secretagogue with potential value for diabetes treatment.  In our labs., piperidine-substituted quinazolinone derivs. were identified as a new class of small-mol. GHS-R1a antagonists.  Starting from an agonist with poor oral bioavailability, optimization led to potent, selective, and orally bioavailable antagonists.  In vivo efficacy evaluation of selected compds. revealed suppression of food intake and body wt. redn. as well as glucose-lowering effects mediated by glucose-dependent insulin secretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrdFtfyC6CSrVg90H21EOLACvtfcHk0lgo9mEaGgBA6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGqt7vK&md5=ebaa1f1db240b5834d8975a55a6a8f71</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070071%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070071%252B%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DJ.%26aulast%3DEsler%26aufirst%3DW.%2BP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%26aulast%3DCoish%26aufirst%3DP.%2BD.%2BG.%26aulast%3DWickens%26aufirst%3DP.%2BL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBierer%26aufirst%3DD.%2BE.%26aulast%3DBloomquist%26aufirst%3DB.%2BT.%26aulast%3DBondar%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChuang%26aufirst%3DC.-Y.%26aulast%3DClaus%26aufirst%3DT.%2BH.%26aulast%3DFathi%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DKhire%26aufirst%3DU.%2BR.%26aulast%3DKristie%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DX.-G.%26aulast%3DLowe%26aufirst%3DD.%2BB.%26aulast%3DMcClure%26aufirst%3DA.%2BC.%26aulast%3DMichels%26aufirst%3DM.%26aulast%3DOrtiz%26aufirst%3DA.%2BA.%26aulast%3DRamsden%26aufirst%3DP.%2BD.%26aulast%3DSchoenleber%26aufirst%3DR.%2BW.%26aulast%3DShelekhin%26aufirst%3DT.%2BE.%26aulast%3DVakalopoulos%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYi%26aufirst%3DL.%26aulast%3DGardell%26aufirst%3DS.%2BJ.%26aulast%3DLivingston%26aufirst%3DJ.%2BN.%26aulast%3DSweet%26aufirst%3DL.%2BJ.%26aulast%3DBullock%26aufirst%3DW.%2BH.%26atitle%3DQuinazolinone%2520derivatives%2520as%2520orally%2520available%2520ghrelin%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D21%26spage%3D5202%26epage%3D5216%26doi%3D10.1021%2Fjm070071%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isin, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weidolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claesson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolgos, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenna, J. G.</span></span> <span> </span><span class="NLM_article-title">Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2010.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.cbi.2010.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=21074519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVyiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=65-71&author=R.+A.+Thompsonauthor=E.+M.+Isinauthor=Y.+Liauthor=R.+Weaverauthor=L.+Weidolfauthor=I.+Wilsonauthor=A.+Claessonauthor=K.+Pageauthor=H.+Dolgosauthor=J.+G.+Kenna&title=Risk+assessment+and+mitigation+strategies+for+reactive+metabolites+in+drug+discovery+and+development&doi=10.1016%2Fj.cbi.2010.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development</span></div><div class="casAuthors">Thompson, Richard A.; Isin, Emre M.; Li, Yan; Weaver, Richard; Weidolf, Lars; Wilson, Ian; Claesson, Alf; Page, Ken; Dolgos, Hugues; Kenna, J. Gerry</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">65-71</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug toxicity is a leading cause of attrition of candidate drugs during drug development as well as of withdrawal of drugs post-licensing due to adverse drug reactions in man.  These adverse drug reactions cause a broad range of clin. severe conditions including both highly reproducible and dose dependent toxicities as well as relatively infrequent and idiosyncratic adverse events.  The underlying risk factors can be split into two groups: (1) drug-related and (2) patient-related.  The drug-related risk factors include metabolic factors that det. the propensity of a mol. to form toxic reactive metabolites (RMs), and the RM and non-RM mediated mechanisms which cause cell and tissue injury.  Patient related risk factors may vary markedly between individuals, and encompass genetic and non-genetic processes, e.g. environmental, that influence the disposition of drugs and their metabolites, the nature of the adverse responses elicited and the resulting biol. consequences.  We describe a new strategy, which builds upon the strategies used currently within numerous pharmaceutical companies to avoid and minimize RM formation during drug discovery, and that is intended to reduce the likelihood that candidate drugs will cause toxicity in the human population.  The new strategy addresses drug-related safety hazards, but not patient-related risk factors.  A common target organ of toxicity is the liver and to decrease the likelihood that candidate drugs will cause liver toxicity (both non-idiosyncratic and idiosyncratic), we propose use of an in vitro Hepatic Liability Panel alongside in vitro methods for the detection of RMs.  This will enable design and selection of compds. in discovery that have reduced propensity to cause liver toxicity.  In vitro Hepatic Liability is assessed using toxicity assays that quantify: CYP 450 dependent and CYP 450 independent cell toxicity; mitochondrial impairment; and inhibition of the Bile Salt Export Pump.  Prior to progression into development, a Hepatotoxicity Hazard Matrix combines data from the Hepatic Liability Panel with the Estd. RM Body Burden.  The latter is defined as the level of covalent binding of radiolabeled drug to human hepatocyte proteins in vitro adjusted for the predicted human dose.  We exemplify the potential value of this approach by consideration of the thiazolidinedione class of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAv1YMcAPyUrVg90H21EOLACvtfcHk0lgo9mEaGgBA6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVyiu7c%253D&md5=54ef4b6d98e18d3b7d3ae75ad0d6c114</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DIsin%26aufirst%3DE.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWeaver%26aufirst%3DR.%26aulast%3DWeidolf%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DClaesson%26aufirst%3DA.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DDolgos%26aufirst%3DH.%26aulast%3DKenna%26aufirst%3DJ.%2BG.%26atitle%3DRisk%2520assessment%2520and%2520mitigation%2520strategies%2520for%2520reactive%2520metabolites%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D192%26spage%3D65%26epage%3D71%26doi%3D10.1016%2Fj.cbi.2010.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easterwood, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huebert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yost, G. S.</span></span> <span> </span><span class="NLM_article-title">Metabolism and bioactivation of 3-methylindole by human liver microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">140</span>, <span class="refDoi"> DOI: 10.1021/tx060239e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx060239e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCit7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=140&issue=1&author=Z.+Yanauthor=L.+M.+Easterwoodauthor=N.+Maherauthor=R.+Torresauthor=N.+Huebertauthor=G.+S.+Yost&title=Metabolism+and+bioactivation+of+3-methylindole+by+human+liver+microsomes&doi=10.1021%2Ftx060239e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism and Bioactivation of 3-Methylindole by Human Liver Microsomes</span></div><div class="casAuthors">Yan, Zhengyin; Easterwood, LaHoma M.; Maher, Noureddine; Torres, Rhoda; Huebert, Norman; Yost, Garold S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-148</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Metab. and bioactivation of 3-methylindole (3MI) were investigated in human liver microsomes.  The metab. of two deuterium-labeled analogs of 3MI permitted a relatively unambiguous identification of multiple metabolites and glutathione (GSH) adducts of reactive intermediates.  A total of eight oxidized metabolites were detected, five of which were assigned as previously identified 3-methyloxindole, 3-hydroxy-3-methylindolenine, 3-hydroxy-3-methyloxindole, 5-hydroxy-3-methylindole, and 6-hydroxy-3-methylindole.  Among the three new metabolites, one was either 4- or 7-OH-3-methylindole, and the other two were derived from addnl. oxidn. on the Ph ring of 3-methyloxindole.  When GSH was added to the microsomal incubations, seven conjugates that had mol. ions corresponding to the incorporation of GSH and an atom of oxygen at m/z 453 (group I) were produced, and two addnl. conjugates had mol. ions at m/z 437 that corresponded to the incorporation of GSH with no addnl. oxygen (group II).  Two conjugates in group I (m/z 453) were apparently derived by GSH addn. to the 5,6-epoxide metabolite of 3-methyloxindole.  These two GSH adducts were tentatively identified as 5-(glutathione-S-yl)-3-methyloxindole and 6-(glutathione-S-yl)-3-methyloxindole.  The most abundant conjugate in group I was identified as 3-(glutathione-S-yl)-3-methyloxindole, which substantiated the presence of the putative 2,3-epoxy-3-methylindole intermediate.  The remaining four adducts in group I were likely formed by conjugation of GSH at different positions of the Ph ring, possibly via oxidn. of 5-hydroxy-3-methylindole and 6-hydroxy-3-methylindole to two very interesting new electrophilic benzoquinone imine intermediates.  For the group II conjugates (m/z 437), two isomers were identified as 2-(glutathione-S-yl)-3-methylindole and 3-(glutathione-S-yl-methyl)-indole.  The former adduct was primarily derived from the 2,3-epoxide intermediate by thiol conjugation followed by dehydration.  The latter adduct was consistent with the authors' previously published work on the dehydrogenation of 3MI.  In those studies, the authors showed that the reactive intermediate, 3-methylenenindolenine, was formed by hydrogen abstraction at the Me group and was trapped with GSH.  The putative dehydrogenation bioactivation mechanism is also substantiated by the finding that CYP2E1 selectively generated 2-(glutathione-S-yl)-3-methylindole but did not produce 3-(glutathione-S-yl-methyl)-indole.  In summary, the results not only confirmed the formation of 2,3-epoxide-3-methylindole in human liver microsomes but also suggested that the phenolic metabolites of 3-methylindole were dehydrogenated to previously uncharacterized reactive intermediates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo100nHRgVS8bVg90H21EOLACvtfcHk0lhsmBksriF8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCit7rO&md5=e6348f323b09b598ba2d098079f5c056</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Ftx060239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx060239e%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DEasterwood%26aufirst%3DL.%2BM.%26aulast%3DMaher%26aufirst%3DN.%26aulast%3DTorres%26aufirst%3DR.%26aulast%3DHuebert%26aufirst%3DN.%26aulast%3DYost%26aufirst%3DG.%2BS.%26atitle%3DMetabolism%2520and%2520bioactivation%2520of%25203-methylindole%2520by%2520human%2520liver%2520microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26issue%3D1%26spage%3D140%26doi%3D10.1021%2Ftx060239e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alelyunas, Y. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi-Kilby, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span> <span> </span><span class="NLM_article-title">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">172</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2009.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejps.2009.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=19429424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=172-182&issue=2&author=Y.+W.+Alelyunasauthor=R.+Liuauthor=L.+Pelosi-Kilbyauthor=C.+Shen&title=Application+of+a+dried-DMSO+rapid+throughput+24-h+equilibrium+solubility+in+advancing+discovery+candidates&doi=10.1016%2Fj.ejps.2009.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates</span></div><div class="casAuthors">Alelyunas, Yun W.; Liu, Ruifeng; Pelosi-Kilby, Luciana; Shen, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">172-182</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A rapid throughput equil. soly. measurement is described.  The method utilizes central liq. storage where compds. are stored as 10 mM soln. in DMSO.  The DMSO is subsequently removed to generate solid like material used for soly. measurement.  A full range of available technologies is used including automated liq. handling, automated data collection using both HPLC/UV and LC/MS/MS.  The method is fully validated and has been used to measure soly. for over 20,000 compds. across all phases of drug discovery.  A detailed discussion on data interpretation and comparison to traditional soly. measurement using solid material is presented.  An inhouse soly. predictive model has been developed from the vast data set and has been employed successfully as part of compd. design resulting in over 30% redn. in the no. of poorly sol. compd. synthesized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqUrCZlVKS_bVg90H21EOLACvtfcHk0lhsmBksriF8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ms7k%253D&md5=6ee437462b50cc0c4acfd6d2f27b6405</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2009.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2009.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DAlelyunas%26aufirst%3DY.%2BW.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DPelosi-Kilby%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DC.%26atitle%3DApplication%2520of%2520a%2520dried-DMSO%2520rapid%2520throughput%252024-h%2520equilibrium%2520solubility%2520in%2520advancing%2520discovery%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D37%26issue%3D2%26spage%3D172%26epage%3D182%26doi%3D10.1016%2Fj.ejps.2009.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span> <span> </span><span class="NLM_article-title">Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1715</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1002/rcm.5026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1002%2Frcm.5026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=21598331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtlagu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1715-1724&author=Y.+Zhangauthor=N.+Liauthor=P.+W.+Brownauthor=J.+S.+Ozerauthor=Y.+Lai&title=Liquid+chromatography%2Ftandem+mass+spectrometry+based+targeted+proteomics+quantification+of+P-glycoprotein+in+various+biological+samples&doi=10.1002%2Frcm.5026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples</span></div><div class="casAuthors">Zhang, Yiqun; Li, Na; Brown, Paul W.; Ozer, Josef S.; Lai, Yurong</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1715-1724</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">P-Glycoprotein (P-gp/ABCB1) is expressed in membrane barriers to exclude pharmacol. substrates from cells, and therefore influences the ADME/Tox properties and efficacy of therapeutics.  In the present study, a liq. chromatog./tandem mass spectrometry (LC/MS/MS)-mediated targeted proteomics was developed to quantitate P-gp protein.  With the aid of in silico predictive tools, a unique 9-mer tryptic peptide of P-gp protein was synthesized (with the stable isotope labeled (SIL) peptide as internal std.) and applied for quant. LC/MS/MS method development.  For LC/MS/MS quantification, the N-glycosylation of the peptide, polymorphism and transmembrane region was intended to be excluded during the peptide selection.  The lower limit of quantification was established to be 0.025 nM with the linearity of the std. curve ranging to 20 nM of P-gp signature peptides in the matrix digested surrogate bovine serum albumin.  The digestion efficiency, both the accuracy (relative error) and the precision (coeff. of variation) of the method, was verified by using the synthetic quantification peptide and the synthetic surrogate substrate peptide that mimics the sequence of tryptic peptide and assocd. flanking tryptic cleavage sites at the N- and C-terminals.  By applying the method developed, the abs. amts. of human, dog and mouse P-gp (Mdr1a) were quantified in various biol. samples.  LC/MS/MS-mediated P-gp quantification was achieved as a highly sensitive, selective and reproducible assay and could be directly applicable to many current research needs related to P-gp.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrryW5IZccQR7Vg90H21EOLACvtfcHk0lhsmBksriF8tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtlagu7c%253D&md5=a3538519f54b61e55916d995dbe9f6f0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2Frcm.5026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.5026%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DBrown%26aufirst%3DP.%2BW.%26aulast%3DOzer%26aufirst%3DJ.%2BS.%26aulast%3DLai%26aufirst%3DY.%26atitle%3DLiquid%2520chromatography%252Ftandem%2520mass%2520spectrometry%2520based%2520targeted%2520proteomics%2520quantification%2520of%2520P-glycoprotein%2520in%2520various%2520biological%2520samples%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2011%26volume%3D25%26spage%3D1715%26epage%3D1724%26doi%3D10.1002%2Frcm.5026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sjöberg, Å.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannergren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingolf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungell, A.-L.</span></span> <span> </span><span class="NLM_article-title">Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">166</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2012.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ejps.2012.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=23103351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fos1Srsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=166-180&author=%C3%85.+Sj%C3%B6bergauthor=M.+Lutzauthor=C.+Tannergrenauthor=C.+Wingolfauthor=A.+Bordeauthor=A.-L.+Ungell&title=Comprehensive+study+on+regional+human+intestinal+permeability+and+prediction+of+fraction+absorbed+of+drugs+using+the+Ussing+chamber+technique&doi=10.1016%2Fj.ejps.2012.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique</span></div><div class="casAuthors">Sjoberg ¡ÑÜAsa; Lutz Mareike; Tannergren Christer; Wingolf Caroline; Borde Anders; Ungell Anna-Lena</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">166-80</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this study was to evaluate the use of human intestinal tissue in Ussing chamber to predict oral and colonic drug absorption and intestinal metabolism.  Data on viability, correlation between apparent permeability coefficients (P(app)) and fraction absorbed (f(a)) after oral and colonic administration, regional permeability, active uptake and efflux of drugs as well as intestinal metabolism were compiled from experiments using 159 human donors.  Permeability coefficients for up to 28 drugs were determined using one or several of four intestinal regions: duodenum, jejunum, ileum and colon and 10 drugs were studied bidirectionally.  Viability was monitored simultaneously with transport experiments by recording potential difference (PD), short-circuit current (SCC) and the resistance (TER).  Intestinal metabolism was studied using testosterone and midazolam as probe substrates.  There was a steep sigmoidal correlation between P(app) in the Ussing chamber, using jejunal segments, and oral f(a) in humans, for a set of 25 drugs (R(2): 0.85, p<0.01).  A clear sigmoidal relationship was also obtained between P(app) in colonic segments and f(a) after colonic administration in humans for a set of 10 drugs (R(2): 0.93, p<0.05).  Regional permeability data showed a tendency for highly permeable compounds to have higher or similar P(app) in colon as in the small intestinal segments, while the colonic regions showed a lower P(app) for more polar compounds as well as for d-glucose and l-leucine.  Bidirectional transport (mucosa to serosa and serosa to mucosa direction) in jejunum showed well functioning efflux- and uptake asymmetry.  Intestinal metabolic extraction during transport across jejunum segments was found for both testosterone and midazolam.  In conclusion, viable excised human intestine mounted in the Ussing chamber, is a powerful technique for predicting regional fraction absorbed (f(a)), transporter-mediated uptake or efflux as well as intestinal metabolism of drug candidates in man.  Furthermore, a sigmoidal relationship of P(app) vs. f(a) was obtained when permeability data from the present study were merged with data from 2 other independent laboratories (R(2): 0.83, p<0.01).  The correlation curve reported can be used by any laboratory for predictions of human permeability and f(a)(.) In addition, for the first time a correlation curve between colonic P(app) and human colonic f(a) is reported, which demonstrates the usefulness of this methodology in early assessment of the colonic absorption potential of extended release formulation candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-JxodOyNmjxpyrDyM_m9cfW6udTcc2eZVrlbkwRtGS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fos1Srsg%253D%253D&md5=03bdd068c6297471a2086e0f7f2cc0a2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2012.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2012.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DSj%25C3%25B6berg%26aufirst%3D%25C3%2585.%26aulast%3DLutz%26aufirst%3DM.%26aulast%3DTannergren%26aufirst%3DC.%26aulast%3DWingolf%26aufirst%3DC.%26aulast%3DBorde%26aufirst%3DA.%26aulast%3DUngell%26aufirst%3DA.-L.%26atitle%3DComprehensive%2520study%2520on%2520regional%2520human%2520intestinal%2520permeability%2520and%2520prediction%2520of%2520fraction%2520absorbed%2520of%2520drugs%2520using%2520the%2520Ussing%2520chamber%2520technique%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D48%26spage%3D166%26epage%3D180%26doi%3D10.1016%2Fj.ejps.2012.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drmota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, N.</span></span> <span> </span><span class="NLM_article-title">Adenosine is not a direct GHSR agonist-artificial cross-talk between GHSR and adenosine receptor pathways</span>. <i>Acta Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>190</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1111/j.1365-201X.2007.01691.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1111%2Fj.1365-201X.2007.01691.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=17428235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2007&pages=77-86&author=N.+O.+Hermanssonauthor=D.+G.+Morganauthor=T.+Drmotaauthor=N.+Larsson&title=Adenosine+is+not+a+direct+GHSR+agonist-artificial+cross-talk+between+GHSR+and+adenosine+receptor+pathways&doi=10.1111%2Fj.1365-201X.2007.01691.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine is not a direct GHSR agonist - artificial cross-talk between GHSR and adenosine receptor pathways</span></div><div class="casAuthors">Hermansson, N.-O.; Morgan, D. G. A.; Drmota, T.; Larsson, N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Physiologica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-86</span>CODEN:
                <span class="NLM_cas:coden">APCHC4</span>;
        ISSN:<span class="NLM_cas:issn">1748-1708</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aim: To assess if adenosine is a direct growth hormone secretagogue receptor (GHSR) agonist by investigating the mechanism behind adenosine induced calcium release in human embryonic kidney 293s (HEK) cells expressing GHSR.  Methods: Calcium mobilization, cAMP (cAMP) and IP3 expts. were performed using HEK cells stably expressing GHSR and/or adenosine A2B receptor (A2BR).  Results: Adenosine has been widely reported as a GHSR agonist.  In our hands, adenosine and forskolin stimulated calcium release from IP3 controlled stores in HEK-GHSR cells but not in non-transfected HEK cells.  This release was not accompanied by increased IP3 levels.  The calcium release was both cholera toxin and U73122 sensitive, indicating the involvement of both Gαs/adenylyl cyclase and Gαq/11/phospholipase C pathways.  Importantly, the GHSR inverse agonist [D-Arg1 D-Phe5 D-Trp7,9 Leu11]-Substance P (SP-analog) blocked the adenosine stimulated calcium release, demonstrating that GHSR is involved.  Assessment of the GHSR-dependent calcium release using adenosine receptor agonists and antagonists resulted in a rank order of potencies resembling the profile of A2BR.  A2BR over-expression in HEK-GHSR cells enhanced potency and efficacy of the adenosine induced calcium release without increasing IP3 prodn.  Moreover, A2BR over-expression in HEK cells potentiated NECA-induced cAMP prodn.  However, GHSR expression had no effect on intracellular cAMP prodn.  Conclusion: In HEK-GHSR cells adenosine activates endogenously expressed A2BR resulting in calcium mobilization.  We hypothesize that the responsible mechanism is cAMP-dependent sensitization of IP3 receptors for the high basal level of IP3 caused by GHSR constitutive activity.  Altogether, our results demonstrate that adenosine is not a direct GHSR agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4xsD9OHtxHLVg90H21EOLACvtfcHk0ljzPeytgdaBIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVaqtbs%253D&md5=70f0cb61ba1421cb2d30c51ef4044a43</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-201X.2007.01691.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-201X.2007.01691.x%26sid%3Dliteratum%253Aachs%26aulast%3DHermansson%26aufirst%3DN.%2BO.%26aulast%3DMorgan%26aufirst%3DD.%2BG.%26aulast%3DDrmota%26aufirst%3DT.%26aulast%3DLarsson%26aufirst%3DN.%26atitle%3DAdenosine%2520is%2520not%2520a%2520direct%2520GHSR%2520agonist-artificial%2520cross-talk%2520between%2520GHSR%2520and%2520adenosine%2520receptor%2520pathways%26jtitle%3DActa%2520Physiol.%26date%3D2007%26volume%3D190%26spage%3D77%26epage%3D86%26doi%3D10.1111%2Fj.1365-201X.2007.01691.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grillet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourrier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ansanay, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durroux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhaire, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernout, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrétien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapleur, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">D-myo-inositol 1-phosphate as a surrogate of d-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1016%2Fj.ab.2006.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=16965760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2006&pages=126-135&author=E.+Trinquetauthor=M.+Finkauthor=H.+Bazinauthor=F.+Grilletauthor=F.+Maurinauthor=E.+Bourrierauthor=H.+Ansanayauthor=C.+Leroyauthor=A.+Michaudauthor=T.+Durrouxauthor=D.+Maurelauthor=F.+Malhaireauthor=C.+Goudetauthor=J.+P.+Pinauthor=M.+Navalauthor=O.+Hernoutauthor=F.+Chr%C3%A9tienauthor=Y.+Chapleurauthor=G.+Mathis&title=D-myo-inositol+1-phosphate+as+a+surrogate+of+d-myo-inositol+1%2C4%2C5-tris+phosphate+to+monitor+G+protein-coupled+receptor+activation&doi=10.1016%2Fj.ab.2006.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">D-myo-Inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation</span></div><div class="casAuthors">Trinquet, Eric; Fink, Michel; Bazin, Herve; Grillet, Florence; Maurin, Fabrice; Bourrier, Emmanuel; Ansanay, Herve; Leroy, Cedric; Michaud, Audrey; Durroux, Thierry; Maurel, Damien; Malhaire, Fanny; Goudet, Cyril; Pin, Jean-Philippe; Naval, Magali; Hernout, Olivier; Chretien, Francoise; Chapleur, Yves; Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-135</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phospholipase C β (PLC-β)-coupled G protein-coupled receptor (GPCR) activities traditionally are assessed by measuring Ca2+ triggered by D-myo-inositol 1,4,5-trisphosphate (IP3), a PLC-β hydrolysis product, or by measuring the prodn. of inositol phosphate using cumbersome radioactive assays.  A specific detection of IP3 prodn. was also established using IP3 binding proteins.  The short lifetime of IP3 makes this detection very challenging in measuring GPCR responses.  Indeed, this IP3 rapidly enters the metabolic inositol phosphate cascade.  It has been known for decades that lithium chloride (LiCl) leads to D-myo-inositol 1-phosphate accumulation on GPCR activation by inhibiting inositol monophosphatase, the final enzyme of the IP3 metabolic cascade.  We show here that IP1 can be used as a surrogate of IP3 to monitor GPCR activation.  We developed a novel homogeneous time-resolved fluorescence (HTRF) assay that correlates perfectly with existing methods and is easily amenable to high-throughput screening.  The IP-One assay was validated on various GPCR models.  It has the advantage over the traditional Ca2+ assay of allowing the measurement of inverse agonist activity as well as the anal. of PLC-β activity in any nontransfected primary cultures.  Finally, the high assay specificity for D-myo-inositol 1 monophosphate (IP1(1)) opens new possibilities in developing selective assays to study the functional roles of the various isoforms of inositol phosphates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRFlTq9szK1LVg90H21EOLACvtfcHk0ljzPeytgdaBIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktrfJ&md5=fce292860fb4d99a590a9118772d9f58</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DFink%26aufirst%3DM.%26aulast%3DBazin%26aufirst%3DH.%26aulast%3DGrillet%26aufirst%3DF.%26aulast%3DMaurin%26aufirst%3DF.%26aulast%3DBourrier%26aufirst%3DE.%26aulast%3DAnsanay%26aufirst%3DH.%26aulast%3DLeroy%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMaurel%26aufirst%3DD.%26aulast%3DMalhaire%26aufirst%3DF.%26aulast%3DGoudet%26aufirst%3DC.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DNaval%26aufirst%3DM.%26aulast%3DHernout%26aufirst%3DO.%26aulast%3DChr%25C3%25A9tien%26aufirst%3DF.%26aulast%3DChapleur%26aufirst%3DY.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DD-myo-inositol%25201-phosphate%2520as%2520a%2520surrogate%2520of%2520d-myo-inositol%25201%252C4%252C5-tris%2520phosphate%2520to%2520monitor%2520G%2520protein-coupled%2520receptor%2520activation%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D358%26spage%3D126%26epage%3D135%26doi%3D10.1016%2Fj.ab.2006.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergsdorf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kropp-Goerkis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaehler, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketscher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boemer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parczyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, B.</span></span> <span> </span><span class="NLM_article-title">A one-day, dispense-only IP-one HTRF assay for high-throughput screening of Gaq protein-coupled receptors: towards cells as reagents</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.1089/adt.2007.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=10.1089%2Fadt.2007.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=18315499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=39-53&author=C.+Bergsdorfauthor=C.+Kropp-Goerkisauthor=I.+Kaehlerauthor=L.+Ketscherauthor=U.+Boemerauthor=K.+Parczykauthor=B.+Bader&title=A+one-day%2C+dispense-only+IP-one+HTRF+assay+for+high-throughput+screening+of+Gaq+protein-coupled+receptors%3A+towards+cells+as+reagents&doi=10.1089%2Fadt.2007.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A One-Day, Dispense-Only IP-One HTRF Assay for High-Throughput Screening of Gαq Protein-Coupled Receptors: Towards Cells as Reagents</span></div><div class="casAuthors">Bergsdorf, Christian; Kropp-Goerkis, Carmen; Kaehler, Irene; Ketscher, Lars; Boemer, Ulf; Parczyk, Karsten; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Assay and Drug Development Technologies</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-53</span>CODEN:
                <span class="NLM_cas:coden">ADDTAR</span>;
        ISSN:<span class="NLM_cas:issn">1540-658X</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Compared to biochem. high-throughput screening (HTS) assays, cell-based functional assays are generally thought to be more time consuming and complex because of addnl. efforts for running continuous cell cultures as well as the numerous assay steps when transferring media and compds.  A common strategy to compensate the anticipated redn. in overall throughput is to implement highly automated cell culture and screening systems.  However, such systems require substantial investments in sophisticated hardware and highly specialized personnel.  In trying to set up alternatives to increasing throughput in functional cell-based screening, the authors combined several approaches.  By using cryopreserved cell aliquots instead of continuous cell culture, cells in suspension instead of adherent cells, and "ready-to-screen" assay plates with nanoliter aliquots of test compds., an assay procedure was developed that very much resembles a std. biochem., enzymic assay comprising only a few dispense steps.  Chinese hamster ovary cells stably overexpressing a Gαq-coupled receptor were used as a model system to measure receptor activation by detection of intracellular D-myo-inositol 1-phosphate with the help of homogeneous time-resolved fluorescence (HTRF, CISbio International, Bagnols-sur-Ceze, France).  Initially established in 384-well adherent cell format, the assay was successfully transferred to 1536-well format.  The assay quality was sufficient to run HTS campaigns in both formats with good Z'-factors and excellent reproducibility of antagonists.  Subsequently, the assay procedure was optimized for usage of suspension cells.  The influences of cell culture media, plate type, cell no., and incubation time were assessed.  Finally, the suspension cell assay was applied to pharmacol. characterization of a small mol. antagonist by Schild plot anal.  The authors' data demonstrate not only the application of the IP-One HTRF assay (CISbio International) for HTS in a high-d. format, but furthermore the successful use of cryopreserved and suspension cells in a one-day functional cell-based assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5f7PM16SSl7Vg90H21EOLACvtfcHk0li-oJNwITFrVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFKqtb8%253D&md5=4966cfdf7e3c87080a7993e623b3f6de</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1089%2Fadt.2007.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fadt.2007.108%26sid%3Dliteratum%253Aachs%26aulast%3DBergsdorf%26aufirst%3DC.%26aulast%3DKropp-Goerkis%26aufirst%3DC.%26aulast%3DKaehler%26aufirst%3DI.%26aulast%3DKetscher%26aufirst%3DL.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DParczyk%26aufirst%3DK.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DA%2520one-day%252C%2520dispense-only%2520IP-one%2520HTRF%2520assay%2520for%2520high-throughput%2520screening%2520of%2520Gaq%2520protein-coupled%2520receptors%253A%2520towards%2520cells%2520as%2520reagents%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2008%26volume%3D6%26spage%3D39%26epage%3D53%26doi%3D10.1089%2Fadt.2007.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QAK','PDB','3QAK'); return false;">PDB: 3QAK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO','PDB','4BUO'); return false;">PDB: 4BUO</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i83"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00828">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_00852"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00828?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00828</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_001.csv">CSV</a>)</p></li><li><p class="inline">Biological data for the enantiomers of compounds <b>3c</b> and <b>3d</b>, <b>3c′</b> and <b>3d′</b>, respectively; analytical data of compounds <b>2b</b>–<b>g</b>, <b>3f</b>, <b>10b</b>–<b>g</b>, <b>12b</b>–<b>i</b>, <b>12k</b>–<b>m</b>, <b>14</b>, <b>15</b>, and <b>16b</b>; synthesis and corresponding analytical data of compounds <b>3b</b>–<b>e</b> and <b>3g</b>; atomic coordinates of the GHSR homology model based on the X-ray structure of agonist-bound rat neurotensine receptor 1 (accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BUO">4BUO</a>) as a template with bound agonists <b>1</b>, <b>2a</b>, and <b>12j</b>; range and protocol for secondary pharmacology data reported in Table 6 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_001.csv">jm0c00828_si_001.csv (4.6 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00828/suppl_file/jm0c00828_si_002.pdf">jm0c00828_si_002.pdf (2.28 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00828&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00828%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00828" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679967faae543c6a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
